var title_f0_55_880="Advanced lipodermatosclerosis";
var content_f0_55_880=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F73283&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F73283&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Advanced lipodermatosclerosis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 248px; height: 284px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    In advanced cases of lipodermato- sclerosis, fibrosis binds the skin to the underlying tissue. Significant leg edema, erythema, and hyperpigmentation are present.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Patrick C Alguire, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f0_55_880=[""].join("\n");
var outline_f0_55_880=null;
var title_f0_55_881="Cold sore PI";
var content_f0_55_881=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PI%2F80183&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PI%2F80183&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Cold sores (fever blisters)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 396px; height: 228px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Cold sores are caused by an infection with a herpes virus. They start out as blisters that break open and then form a scab.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Neville B, et al: Color Atlas of Clinical Oral Pathology. Philadelphia: Lea &amp; Febiger, 1991. Copyright &copy; 1991 Wolters Kluwer Health.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f0_55_881=[""].join("\n");
var outline_f0_55_881=null;
var title_f0_55_882="Inability to lift the tongue";
var content_f0_55_882=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F50442&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F50442&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Inability to lift the tongue",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 379px; height: 327px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAFHAXsDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD0hiVThPmHqM08HMu9vlfrgcAfSiInHPLdhTVlZd4bAI5+Yc14sT1mNnO8njAHIIqpGvIJ4JPUk1NN0CkjOMkg9f8ACmM4C8fjx0pyeuoEN9uciLdx3+lRZAKjGBTgCzM2Dzx0pQh4KcAniuKpK7uWkJIcNycjt7VEQ5fjgelOkDdcqFx0FQPgYAPTOc96xZSJcZkxzgHFIwO7IJ68gmk3AH3xjPpTG+8ZB0H97tUgKQFUlQFz1qEMTCAFwjdfU08Mdxdm6n04xSqpYFnIBPTHGKTAaZBll28qvKsKUoQcqQDjBHYUxY8glSN3fP8An/OaccoowCx7gUkAv3txyPlHp1oh9yzNnBHSkT5ypUAcdc1J8qMyLux0wc5xQBPypOOT9aXcsZwf4uc9T781BkHOFwDxgjtTo4jIFAxx0/wqtWA2WRt4KBjjn2piyTGUsFXAP1q2bbG0vgduoGaf5MWVDZY9ccjFUoNhcqGQkgMzL06HrViOYJGXYIEOTyx4/wA+tS+RHvK4Xg4z7ZpTbo5OACfpVqDC41NSdRsYBX5ycA5HqOKlTW0yGcKHAwGfJz+Hp0pBZwqgI2gMDj3NKtkmCIypB/u4p8sxWRK2uwmM+W5ViendfoKZHr0UduN5LnOOW5b8/wDPWoG00nG8oVxuJXHGOgJ45pBpBUrujchunT9Mj1NFqgcsRZfEaBWEfDjHI/xqB9Xluv3cQkYN0VVP5c1bTR49yFyqEj+9noKsNp6xSFX6Y3Hvx+NHJN7sPdRlASPnfu2g5GXwPT2pkzyGTG5gMYxuyB/hWtJsii3xuSDuxxjaOnTpUHmY8wjazAjp1yfpV+wFzGPdNJt2nJQHGVqKG5kgCqw59TWpMsUuBuAYjJ5/+vSXEEWGVNoGPlBHJ9ql0miubSzIUuVYL8uCeRzyKfhWJx7EnrVd7YrkMMEcY60wrInOzjpnH3eaizQixsCzAxkD3I5odfMO0detVvNAXaoALHqRmpxIcbTnryegpXEMZDtT5iOfXrTQMgn5iAM/hUzIjl+cdlOOAaqxKwlZyWZcc5NAEsWV6oQW/vdqkcgNgnJNRmTBbgFgPpxTWfawDcD6UDLC5O0heP5VZjPr8wHeqsLMAdpBz156VPE2EJZgQDgUxMlJJFNwApJHSkyCcAZ+lP42nsf1FUmIqXMZkQhR1H5VQEZByeRn0rYzu69h0rPuIdshB4z2q+hUXYVGweWzj3q8CpAIYCs5M7sAZI455zVpHCqARz9Kd7DNXf8AMSSPbFNmY55Hb1p3y7lJYn6io5QWwO3UV03sjMBnALElj3P9ailb+FRjnqRyakd2ZTu4xx6VDJ35yF4zWc5dAQKRg4IH1prv2yNw4zUUhII5HH4UpYMMkDHTniuWTLQOwZQCcnr9ag3biQFIPr6U6Z2ZwAPbNRq29sn+H045rJlIcSF5kJ4psZ8wFmAA9fT8ajILAg/MfcU9C6q2SMDmkA0nCqqqCB1JP8qlCcsHbDY+6OaZGRIcbtwP5CnOxXOz5c9z6UhMMuyFYwOOB6HFPBDg4HT8Me9MUBY8DnJOT0zUCFnIEYOwcY+n+f0oAkMgTOQSCcY681OibipPPbj+VLbwvK5Y5wf0q66pbAZIB4AY+vtWkabeoNkcFuSSGA/OpspEAoAIHOF61Vnu/LjHAGTj6VVeUyNHkNtz1Axzj1/Ct4xSFa5Ld3DqCc9x71D9sJKZZeeMDilba25HTI5I2sP8PSq6AO+OQRng8A1fKUrFtZDubc2RnJwe316U15cFcfdPoMn9KVQI3JbauDwSf8+tO/decNjowbBBGWGCM9AD/jWiiTdEckjm3BiVwFboSBjOe1K93PmAIqkL8wIJycHrjHp/WoEZmViQoAAJ6Cqkr7HIVnUn5eSefb0p2LRvWWqSJcIoJf5s8DP0xjiuje4VoFfyp43GT1KluAOqnI/GuJtGZSpLGJRxuwPxrq7SdpbKVYppUBXCr5yKCOBg5xnntXRSpp7mNXTYrXK757dh9plDKdytvG45A4568+/6VReVHgct5o3u25AWPA7Eg+oP51cukjZy1uiTsG2bjK2wHrjrj8qrG3VIbcMyIojDyNE5ARWOQDxkH2PSm4WJuQ28QkUZRpCAWOSD16Y79ajkceWQX2kvgkn26D/9dWYcPbO9vDPISxzIWZE29Bweex5xTILZmjiaRl2bWkUEEhMttxgnjPPPtWTVyrlRXkWbbho0AJGVIyfY4ohYmREdSoHOMcn6nt3p8Uxglc27oAzkF26YyRtAP4nr0pDC7tKIwrLH8rPw5LHjk9OgPFZtXKuJ9oBbbx04Ofw6/wCFWJApygOV6dKpfZgtwRljjJBBz9O1AZUYr5jDYCcoNw+ntUOI7LoTXFsUwIzhuhbrVB0fBAA25AIxk4rRW6Bt1DncA2RjnFPJjZsL97GSKxlTsBVSXeNrMpGO4xml5ZFKrxnFMmhZG3BmCg/54psbkoAWx9e9Z+TAnWMOCnHHJ7VXkQMQTnjt71OuFRSP73J9aZIsjAtHhgTwSKBFeFzG3AOSaswP8w6HPqaJo9iAqB6YFQRr8xyxCnscUWHuX0baxG3JqYMDjJUkjjHeqat83B6Hg+lWgckKCPpTEOK/N9PWopowcntnkCgHbJgnj16VI3KkAD05q4gUJfkfjkZ70FSTncBntnpUs0bMQSeR+lCYVQrDkVSVxmqrhWxgEY5z1okBVSQp57H07VEqBGVgcA9D1qVtu4gMfz6VtfQgaUAUZ4qtKc8IcEn8KsSJgFQxGepqtKAOT0HSspsaK7d1QcgdccZo2ssa5JOeoxUrEBCrYHrkVXcKWPzHC89a52WiNwigljnnJzUTsVIDcA8nHpTpX2KG2ls4/H2oOOOOe1ZlD4nG8/7QyRzTiWLbV4Y5GOtRW52ly2M52ip9uJtwyecZJ6UMXUlRVjTaoGAKrO2TuzjJwAef0p8js/SPLeo/nTIvlLLux3yM0PUXmOwXGVOAOM+tT26xx4Dhc9sj9aiMzRKeMsRnNVzK0kgLvsyRzjPFbQp9QszRe4EZGwAepH5VXuJXVi24sWGQc44qNQ01uy8Hb83HOD3qAPIzsm8FkBIG4ZI7/Wt1ESROrJ5J3Kwbg5GMgikjCvBIR2wQdh6A8/pmooNRUz8kEZ+ZSMcEc1Va5SNnBYYGQcf4VagPU0tOkjFyEd8RN8pJBIHv6ioJpBC5SUAMpPIJ61QhuAw3hyw/umoLyUOSzO2STncec+9Uo6BbU2J7yIzqYz96IFuBgEgg/wCfeprmZH02ORXSRoj5ZXOcqRnPocHP51y29VG7jjpgU8aifJdFZtjEdfari9xcnY1BcAwsGABOduD3/wAKzjc/McgbsnjpWc94WUgMRz65pPMbdkknIpWubRgbEcsRjjJijDnJBznr6810GiT28No5msrNtnzF3jiznsASucVylnHNckKu0KMKCzADr6k1uJGba22zx21xySNl2HwO5ASTr9RXTTWpnUirWNomy1Ak20VmsMYBkmjiUsRj7oKr149cDNOtZrX+z4Hgiii+QnZFsY7stznqOlYVpPCiosccQw+ELZQcds7sjrRbXTxQRRssihXBHl5VSCc8EttHJx+FaaPUwcGb0xK2RaYoqRDaqAAsNoIJLdeuemKaIU8m3hgMKIAizXPlE7Sw+VRgfe5yfxrlpL10RoWnJMjDCthhgnJyfXOehNTSarHI0WJsQo6lUaHAUA+zH6nism0P2bOqljDQtDbBltI8ooC5LAfdJA4A5HftVaKNpLEtCiHzXaR2YZ2AHHTvyR+HesmbUZ7pzE17bGJzsV8Mq5OAcfL2Hf0FLcajczxNBbyWixgMjFZcBh9Gx7Y6ev0TSb0Ekyee2ULMiRsW8zYWc9wMk4Xj0pySRIzs0sjru2RoBkEDqcDOPxoWGGCzi+03ElzKwEi267QjAk5ZmVifw4z6UXdxGm23eR2ijBQKikAHByMY55x1rNwsUpXK8zLgY6jpkcAfX1p8cpyxkILgbuDnJIqG4RyilEcLjCdSx7ZPHyjnoeTQUXzdryMRu28Dg9ic/wCelZSRa1RcjlMwXg5PfGB/nrVaVQGQoOe5xQpYjdtIU5Vckdv8gU15vmwyMMjcTzwOlZThoOxYGXwrEEddo4BpQ+AMjDLz9KgCkHv7EGklwXzuBGeQec1g0KxPMUKoWDEkZz71HIFUqCNwA55704bSN2AE9PTimRhnZjjAzgk9KBIEcRnac8+1WM5BKdQOlVJNqjH93/GpIJdyMMlcD9KCn3LZy4G4ke+KljIIx27VDCAQVDHd155FTK2QfX+dUmSwdNwIPJFQMrkklsZq3w2G5/KomRSxJbH+frWgkTyfKuXOTnqTTiQx4+7+tRkZIPQD8qkDgDGMbueKdxjWYkNjJBqLgEcg4p7NgEj5sd/Won3Fydq4/rUSAZcOCoGe+QKrMBtO5cFjye2KknBwXBwxPIqsDmTD5OeTjisGND5Hwi8Z59KZJkHn7wGcdaajHchIyD/DSbWMpkIb0A9B/kUrDQ9IkSRR/Gevufep5G2xnB47VGIyoB5559KjnlPGSRjtmhj3YvBG4jrn5SP1qJp2RgoB69SKR5Qg3D7uOfaoSwm2+hHbnB/CtIQHYnclyBk8+h6e9MkIUKSrDHB6H+lJM2yGOQMGDcDDfpx7etUL26CGN41bZjDq44Ddxx7YP410xhcNzZDfIksIPDbXGMEe/wBD0/8A11gXl20b/I7AqePX6ioEvpUBCMSuOh5GKoXUrTNgEkjjg8VsoXWgRjZ6lwXBQ5HXpkUt1N5iq2SSeD+VUAQTiVsEjIBpztlWGcEd60VMssQ3hXABOD1zxRNOHHzMOuRVIsvGR1/zxTigyM529uKagFrkpZh15B5P0pgwTksMZ4FMlmICqj8ZA/8A11GxydpIbHOPWqVMpIsFEXAU7j6Vct1XaN2AD2POKpRgk5SM5/CpGZHX5mlB6Y601Cw/I07aTyyyoV49+gqUM8aPl1Bc84J/KsPzEVcCRuOlP80FT87kdKtKxLiaflxMo+dlYdx1NMvY4wY/IZ2RAF3OOp9epH4VTE6rwSwP0pzXAIxyce1JpBZ3FkcYVRgIuccAcmq7MVb5WBB7Gg5ZsZ4J655pCMFSe2DjtUOBSSHvJJgHOD+lNjlcjDMSufXrUrhXUsx5xjGOvrUYjXnAO49ahwFoaumy7QWebY54BVAf5kAVsDU9PjBKRyNcZUebclpD1yWwDx0Axg9T0rnRuij4GA2Md8Cmfa0gmzGqHBB+Ybz+vFNaGLhzM6KHUEv2YSyyeRGAzM4+aZsjhVA/HGeg68VaaKaZmeZDEoT5UAA4z056Drz1J6CuXh1maN1FuC7ZDbQuR8pyOO/OPyq9GLy6mNxfyrGcjAxtYj6KBz/jU3TE4NGvceXstgeXWI5VeAgLE5JqIMt1MrMSIhwSM4Cj0pZdhRYFWKALy/m8ux7Ad+h4/pUUweBGRVzIcKRjlR9e3b3rOULCTFFwC5T+Ec8e9T8Ln5hg+1VJlKygLkNkbl9X9OPQUfaF3beo6DPrWE49irXLpLMhKljj1pysPLcE/Mc4xxUMbZHAyfXtSqRuI4/AVkQPEWwEkZA9eRmkhGzLSYyR68E06NzwsYHznuOQf8ip9oQqR1zgjHWiwXHKMEk+3AqZCu7BGDx3qmmBMxyAv8qsg8kj5ge57UIGW16E+vX3pvzDpgilT5gDjFBC5+4p9zWqEJETIODjPH1qV8IMjGOo4qKFWVsgYP6VMQfm3EDvS6DK7Er6ZPOBUZwQCxzj0HU09iAxADEnrxUCodoJPA5HvzWcnoBBIx84Bufr3qCY53EAkjjOOlTBmEmGHJIBHpUrqTnCg56kVna4yBI2fYS5BYZ/SnrEFG0568AcUAgMuBuyO3b/ADmmySFdzNgBRgDoaNAEnlAznGMZxVGW6DHggkf54qtfzZR1HGT27VDAnyjbneB830pwXMzS1lcmkbLbWznOCB6etNaUQzr5h+U9/QHvTShmU9yoyRjnHqKoXEqmAplgyH5SOPwNdcYjJLu5kfcFYYB7Dg+9UzPvTbuwTySahV0HQ5BOahknCEkruBHpmuqEBimRkOD37jmlJVgCcKeuBVRLlRIxbkHjAPAomnUnC9+wrVRGWzMu3DjkcCmNdc/JyD0NZ0pmZGJXauP4u1V7S6lD+XHE0jHgFulNprZBdbm1GjyEfKeewrTt9IubhF2xsPfFdN4d0dRbwPMo81gCxArq7ewCgfKBTjHmVziqYxp2ijzqHwjeTHBU/MeBuBq0vg+dUZZZZBIDghgMD26ZHevSY7TGGAwQcgjqD65qQWoweOe9aKCMHjKh5XceGJLdC7uxUcnZmuauEVJGUQTZJ6kgV7hc2iuhDDII5rj9c8OtFLkbHRgCHQ5XJGcZ9eelJw1NaOLd/eOMt9GMt9YW8txbW8N2xxcS3GI48DJ3ELxzx9T9SFsrBrudkRHABIV+oI9R0PP0rfg0bfKAPmPoO1dTp2kLFGAijH060TUehc8RJdTix4dvQMoy/iaD4fviw+T8c9vz+temRWKjAAGfbtVkWQPBXp7VKiY/W5nk0mi38RwIm47rVK80q8ibdNFImRnDDHHUHmvZWsV/u1WudPVx8w3dueeOgH5U1C5Sxsl0PHlR1jzz9GODSLMwHygEdcZ5rtNc0CyaWWS8vZbCCKIy+ZFtO7DDK4ZTkld2B6gV5v4jvLW3128i0mS5utKVwLeeZNkjrtGSwwP4s9hxjgUnTaVzqo11VdkbKzMzAYJPbnFNOxuMDPfIrKtZWuIzJCQ6+3arImMZ2ygqffistGdCS6Gha3JgB8ttv49R6frUyXzKRK4Bx0ANZqN5h4OwfSrMcpTBjJVlOVYdvxqWtBOKLcF2biUhI5LeJzwIyWGe5JY8mtmC6RLBolOLYOG+6CzN0AycYHfGOfSsMhpGEk8gY5yQDlif9omr1vNMkgULFGCMEhtxx6Yzx0zj86RlKK6E8jAyDHmZbPzHrtHuf6Cqhl8pflHThAWJwe9Wbq6BnEfWQrhpHcEAfTnHsKoM8lxkkfu0wqKRj/8AX61hKNhxNK0cld7Nknt3rRh+cg/MSOnSudtZ/KuChORnBx0ret2LOFGee9c7VmTNE4QK6Ec+vHapGVnPD5GOBjoajRWaTIYlRT/MbEhGeOBg9elSZjEU72yACTzVhcszbTkDpiqquwjZlHDc5PUVMpORyFyueOadgLccgHA6+g+tTnJ9fzqrGQQDwGz3qQyKDjP61aAmUY5YjHbFFwVC4Uhm7+1ESArx09j/AFouZFjj3beFGTk0nsMrTsDbEjrnmoIXKxDcdzZ6daklw6/OOW7Z6VViBhULJlnz2HArNj6DpQfN8xf7vHPPNOL7MFGA5HXmouGlXcx5GOf8+9SkBXUttYZ+6e5qbCAABmAAY45AqrNKGlZFIXjPJ61ZuF2kliB8vIxwTWVKu52bnIBPFFr6AivMm9m3AbcetQE7MMOcduzD0NSiQkE+vryPxqncEAlgSVfG4EjI9q6oU7I0uSyTKmGh4A7MBkZ6g/41l3LgP8uAT27VO5jRQdxOeeeazrmRXYBcE+tdUYDTQvmgkgjB96rybcE8A+3eoXZQpzkdvvU2EmV89I/51utBN9R6xGU46L6gda39G0hrpg23bGOrY5P0qxoelG7dXlBEXUDHJrurGyWNQFUAenpWsYX1OGviW9InPTaDG8Xl4yB3IzWAdFay1yGCSPaxcce3XtXqaWW5clSR9KxNXs1W+s5SACrgdO3SnVjaDaMKVdp2Zv6Pa/KuB14Fb0Fpzg/KB7VHocIJiwuQCM10MMY89wVGCe9TBaEMyorUOcEgcdTViaxKW4J79QBWgYBltpG3tjvQ+PJxg+mKtCOdngA4xWZeQbl2tyoOcZrormPDVmXUeGHHFZt6jMua1hW5lNvDHGkhDbVbdgY6Z/z1rYstNkaIEJtDdGJ4FQRxB5MY7jrXUxg+WvzDaB0wCKzbux9DPXTFjbhmJ25LdB9KhS3G8Bhmt3h2VTkA8Y61A0QDH1zwa0WwrmS1sMnjB9KS6sHjjVmUAN05rUiQFtzYzmrOpoDZoM9CPxqosGed+ILJJ7aRHUFWUqQa8kh0MtdvDsyytjGOor3PVYwIJG4wATXIaHboTJL1eQ5JH6Ypt62NaVV007HIx+DUEbPAxjmGCT6/UVjalp11aKftKgr/AHhyPwr2FYCInVQNrYyMdcVmX+nxzRuroCpBBH50pU01oOGKkndnjJZ4HO3dgfnVu3uVfjj39BWt4i0F7ItNbqTD3Hda5YqY23Bs+nvXLJOO56lGsqiN55Qp65+lSefIxjRmZiB8oA6Vl2k2VHIz+tXvPKR/IWB9RUtGjRctvPad2EDbRkImM8+vb+dX4ypkjiCmSU7iSo6cD1rnzeuzFYiVH9454/WrFs5eLykLrGx+dwSGkOe9S2tiJR6k0gGxmJ+TdtXHc+1a+mXO5FAAJHXmsmSJSygBvJT7pOctxzxU+nzgz5bqe3YVz1Iky1R1UZBC44GMnFJghGwpyOcmorNxJ3/XpUu/enljO7p9azSMCMvlMnOCcAdh3pchkIC5PvTZAUicbefU/wCfamqS5Yj5SopNWGXLYB1JxjH86uLIoUBs578GqVqwLqzYIPNaSuoUDA/T/CqiJlcPsUjJznvUczNLNEhDAHrzxxTpPndAF6c0iRnjfhQeQcY4qfIojDkSmIjgD73FIBukbK5Ge/ankfOefmP8QHQUOrrlmwAf8aVgK20kDruXpSlW3jPz+2anfdw2Onb1qMEl8/Liiwrla6dkUjccNxjOc1l3cxVdqMFPXBFaN8+BJtcKOKxLtg5Z924dPTrWkIXYR1IJHMbM8W7gfNj+XvWdc3CSBuFz0yBg065mUFgHHuCMGsyYEk4J9gP611wiaJ2CW5Y/KGz6c9Kryyt/GOe3NKsZU/cY1R1a4S1tmlkwMDpXQl0QXS1KOs6rFaQF5WwOmO5rpvBaLq1rFc4/dkfKvXpXj2sTtfzl3Y4H3V9K2PCnirU/D0axQJHLCG3AOOn41uqTWp51XE87aWx9MaRBjAAwMetdFBGAoxXkXhP4raTLtTWIZbKXoXVS6f4itzVvi7oFnEy2AuL6TtsTYv4sf8KpaHKz1aFAbdlyi7BnDZy2T0HvXD/EfWbPQdLlu764ijZBuijZgGc9gB1NePa18Y/Fd0ZF09rfTojwDFHvcf8AAmzz+FeZ6pNe6pdvd6lczXVy/LSyuWY/nVtXVmLW9z7c+GWvW3iTw5ZarZMBHOvzJ1Mbj7yn8a7DzdrNggt64r4e+G/j3WvAl1J/ZpS4spTmW0nzsY+oI5U+4r3PS/j9oUrQC90bU7cscSlJEkVPcdCfpxWUYyjoXzI96WPKq7nAK8AU24jC26sAc55ya5fwd410LxKZX0bUI7h0A3QsjJIo/wB1hz+GRXTyXDOgXaxX121ommIqsgkzuH/1qy9QiTdgDpWzG8QJ+0IwDcBgOlYl6wjWSWT5IkyS7nAUe5qJRRVyvbptkbODj0INdBCPm2DC9Meleb+BfGGn+KL7VbfT2JezmKAZyZEH8Y9s5r0GznZXBZc4GPmrCC1aKvoawjGUxt684OahMTNKwAxyTk0gugGUE4HbNSx3EfmbgevHWt1FEakKrkYPXNLfRERoGbJ/lXPeJfHfhvwx5g1/W7GzkJ/1TPukP/AFy36V5f4l/aR8GWMUn9lpqOrXA4RY4fIj/Fn5x/wE00kK5vfGTxPD4T8MGeWRVnupltoEI+8SRuOPQLk/lVzw5CrwRMuNpAIIPX0NfG3xK8e6t8QNd/tDVSkUUY2W9rFnZCmegz1J7nvXrvwT+MdtFFbaH4qkWBkAjgvmPykdAsnp/vVMotNSDm0PomVAsTIB1Oc4rOuI854zWp9oilskeB4ZY3O9ZI5A4YEdsVSlHHPHaqdugjm9TtwyEEZry3xRZpp83m/cjY9ewr17UE6gjn0rzH4nbV0VgxG52AAPU1FSF0zehNxkrHLxMFk4PHUEVoRygg5G7Prya5HRtRbelvM24AYUmunh29cdRXDc9xPmVy6FBOCrYPp3qcsYztcLGqDIx8zH6YqsBheemPrmoiRvG0/M2O9J6E2ua0XmSiRpi6xk7TuPP0B7Z9BUTMqujCTGD93+7S2wMkax4VFGWYqCzt9eeB7inzpDHsCKpbIPB+X/AOvUSV1chPU39KkZ2A4UmtMKVkB2de4rA0lyHU+vAweDW1JIwZQBxjJPesLGEtxJMsH29QcEEdBUK8SgFNwz1z1pwIBLjAyQOOtSvtJUoeF6kUmgJISA2MHJNaWQQM/oKoI7HnkHtirUVwBGBgDHbiiOgmNAb5huyBwfzpsp3PtkIGVz9KcTsjCnjPPFIGyDIynsFPTioKHiNEiByS3TpTwu4gFh8ozxTxEOCGIOcnJpxRQnQcnk1SRLZVlGWJY4yeDiqs0e1gQeBycVbkkJ3YBx0WqM8uFUllz6E/59KqxNyleTfdLnjHcVjXmSGkiyQP8AZyK0LmdXUuHKkcEDtWDe3BUnyyVOMZU9a3ii4mbcv+8Jbg1XG5ySeB3pZpmkfOCT15qWKHP3lIPfJrqhEq9xGXbETkBfU1wHiO7a8uTHGf3Sn866vxRffZrYRL8sj8D2rm7Ky3jc3eu2jC7ucWKq29xGLBY7jkir8Wnj+7zW/DYKuMirHkomFxz0rq5XY47nPf2djnbTxYHHTit2QxRqWkbC+5qrNe2+TGrKWx61NlHcaUnsZL2ijOQM+9VZLZeRitKRwec8djVSWUKeTxRZdBO6K4tR1PFTJEqjp71C1yo5zVeS9UDg0WSMWa1vK0MgeN2Rl6MhwR+IrWj1/UkQqNSvgp4I+0yY/nXH/bQBnNBv8nG79aVlcDsV8TavDnyNY1GP/dupB/Ws7U9d1TUYfJv9Vv7mEf8ALOa5d1/InFc99uz3zQblWH3utCjG+wmWBLLbTCW0mlglXo8blSPxHNatr4w8UQNmDxFq6H2vH/xrAkloWQfWplCLd2hptHa23xD8axyrKvifVCw4G+bePybIq/c/EzxxcIwk8SXigjB8tUQ/gVUEVw0Eo7mrgkUpQqcexLk+5i6ojyySSyszyuxZ3Y5ZiepJ71y9ymyUiuyvULhtilh7DNY82h31y+Y4CM9N3GaJtLdmlGnOb91XOforVk0DUo22vauD+FUri0nt2ImiZcdeKhST2NpUpx1aNnwr4x17wrcCTRNSnt1zlos7o2+qHg17l4Y/aD0+S1SPxLp1xDcDhpbQB0b32kgj9a+bKKTgm7kXPp7Vfjt4YQf6Jb6jdE9vLVAPxJrynxt8TH8RXyvFY/Z7ZBhEaTc31Neb0UOKasxxk4u6Oot/EaiRGdGDKcgivU9EvY72winj5DL3rwSvRvhhqmS9i7YZfmT3rkrUVBc0T0sJiXKXJI9LBGCcnnnNRyHGdqk/hSlnVevHXmoppGxwPlrmZ6Gxas7ghwJVAQc7D0b2OCOK1C8EpkYeTk9Ej4C57AHtWFbMCwzjJ47/ANK37XHlKSw2R8bSVUD1IXqTSW1jKejLem5il2d16lT0/wAa3YyGIwMnNYNkFaZQibVb8yK3AwQgDhsdaxtqYT3JFiCkkr05GOKYiKX4IAJ6VIT2DnOeopNjJvKkf4VMkBGJgbthjgnAGO9WGAZiR39zVJOSXAwc5qyvmsoKnCn2FZjsXkTcg3ZJIHPpUkoKBPl79BTVDG46grjGMVZ25Ugjn0xQkJsQLvwScDHSmSnZkZ+QjofWkwyMQ2cdvYUy6GY1xkEcg4qiSgzpNuC5LIe3r9aq3DI6KCpDgfl9almPlSbmJDdGx0rNv7xIySpG4DmtIK4Mq3xFsWZHKgcjcuc/WuVvpy7s2AO3AxVzU73zMj9c5rHUeZNjeMHqa3irlrQt2aBvmce4HrT9QvIrG2kmkYKFBJJqzBGsUJ3nj8OK8p+I3iP7TcHT7Rv3an94wPX2rshC+hnOooK7GT6wdX1NpCTszhR6Cuo00gRjFeWWNz9nYnBNbcOtX7r/AKPhF9e9d8JxgtTzHGdWWh3uoXsVnDukfHoB1NYM2pXl1MFth5KZ69Sar6HBJeTmW8YyMOm7tXS2Fij3gRVrixGLl9nQ9XDYFL4yCx0d7gb7su/rk10djpMCrtWJTn/ZqW+228KouMU/T5yyF8fL3NeTUm3LU9enBKPuoe+h200YBjX8ua5zxB4ImeJpNOkaNwCdkg4NekaWCyDawAPBbv8AhWhNbIUwse/HRmNa0qk4axZjWhCquWaufKGoy3lpcvb3KGOVDgg1V+2SdzXuHxE8KRanbSym3K3aruikTufQ+1eESxtFI0cilXU4IPUGvUo1vaLzPBxWF9hLyZMbt8YzSfan9arUVtc5bIuC8b1NPS9OepqhRRzMXKjVW9B6mpBeDPXmsetHQtLn1fUEtYOM8s390USmormY4UnOSjHdmxpK3WpXK29jE80pI4UdK9P0T4eTtAsuoyFWH3kUjIrX8F+FbLSrICOFnkIyzEfMx+prtVjSNQiKykdQRivNqYudR+5oj2aWX06SvUV5fgcna+FILVCBESh/iPX8ae2hqgHAK9cGuomu1iXYVJcdM8ZqG7lQoNwwG9qzSvudnPJKy2OK1DS415A4PT2NYl5pUEqfMoz3BFdpqSDcqAnB/rVQ2AC5f3wa3pysTL3lqeX3/hW1nB2J5beqVzOpeGbi2yYjvUetesTIFu2TbxUF3aIwIKjJ9q6oSuclbDxb2PEp4JIH2yqVNRV6LrGlxSuyMgauP1DS/IP7ok+xrQ8+pRcNVsZVX9Ev203U4LpD9xufp3qiQQeRSUpJSVmYxk4u6Po3TJ4r61jlTBVgGB5PGKtSQRnd8pyB615n8L9cbDadM/3eUz6eleoqFcZBIJ59a8yUXFuLPdhUVSKkjLkASTAGBnrzW7pce4ZBYqevAx+PNZNyOOSTg+mKs6XP5ci/u425wN4zWSdmE02jorZMMFZcZ6E96vjAJ5PTjPOapwn5VIIPHO0f4VZSQLExyNynp3/ClLc52Xo2DLs28nngVIxBLYHSordgytwF/Q5qeNCuRktuFRbQRTQDywRxt5x61I1vKWJXO08jt/WpzCGwccJ196mGMffYewqLFFgkqdxAzmrMhDICSemeBUK5O4bc8cA1C0kisuTgL61K0EyV8McBiWXsDzVKUgouC3XkYwasMMuHLLk/Wop08wjyCGYd+49xRuGxk6kwXphST3PBrkdc1AxKUzg4x1612t55kcUkkpAAHpXl2vl/Mdic9SK6Yq1kOCuZ894WYlj9Oas6am51dumenrWDBDNLLnBIzjjtXQ2qyWq5wMKMk10RjbQbuM8Z6oNK0aSQtlyMKM9Sa8Mkd552dzl3OSa6fx/r76tqRhQkQQnGM9TXLRjLgV3wVkedWnzysadpCszqB93vXT2VkBHgLkHpWLpMQAHFdpaxKtqh74xUTZ10YaKxW0UtHcsuOp611mnFYdQUnAyvU1zyxBUR1HOavsXMay85JwPpXmVJans046G1rE6CFz3JwKhW5K6YgHAJGfes67lM7xIAcD9adets8mFfucce5rlnK+p001sjvNBeSe3j5wo4A9a6NPu7d5wp5XFc94eURwxg8cA8CuoRdwCqPmB79a2p7HLV+IrzWonhdVRuRjjnNfOXxd0N9N10XYB8q44JI/iH/wBavpyISMJFON4yR5bYK/hXlPxc083vhy4yxZ4mMynnqOvH0rqovkmmcmIpurTlH5nz3RSmkr0jwAoop6IzuqIpZmOAAMkmgCaws5r+8itbVN80rbVGcV9AfD3wjHo+mZlgklmfDF0Tqe+WPGPbNY/wx8Cy2tp9suYYTeSEA+a20xD0H9a9itreOFEjnkd9o2iMPgA46jtjivLr1XWlyx+FHuYXD/V480vif4FGAKsOVjKrkckA1K8qiMnPygdGOabdFMboyV/2WGDWRqMpDbQ2COSQaUY2OlrmINRmeR1IzgdBWgiiW3jds4x2rJhm3JhwBk8EnrWvA+ISVOBjpnGKqwS0Vird7XjYKoyfSqDTDCxt+Zq3OCZVcLjkdu1UdY2xzI6dhgimroUY30Oe1FGS8yDnnINOmXzId49anuF89M9GFU52YRkDj2xW8JDqQuc9f4+04/KsXVbcGMsF5FbWoo24sD9096oXIEtqSTiuqLujhqQsziNTtsDzVH1xWXXRXoHlSIe3Fc8etU+55dSPKy5pN6+n6jBcxnBRgT9O9fQej3C3dkjqQQyAivm+vZfhlftc6MiMfnjOyuLFR2kd2Ane8PmdlcKCmcE471HbxjdkMOvrUl0PKhx0JqjbXID7WPHoa4ZHedfYnEeJGyDxkc/lV0Rgwtlhgc1jaZMmPv8AHTPpWtG6Op549M0r3RzSVmW7Jt4Jzu7BRV+PzFLFQrMegNZFsW3YjJHHUjFbEDHCqAWyeW7CoTEyWJH2EHAJ64700ADgqPyqw8extwPJHPFRO0oYhVUj1JFGwkyxM29cADHqaiAO4BieRUkrGMENjaRwepqvGEZ/lBVj39azbGiyqBUOT29M0wRIQSwIbsc0+PBjfOMgdaVZfMTaACR3zQmriZXvNsltLGybiV2/WvLdQsGmmkjI4yeleqlx5e3A3txk9q5PULLZdnfxuOeeK0lK9maUtLnI6dpwt5NjgFOtZ/ji8TStEn8jmUr1zXbGyYKSuM+teZfESOaSYwuMKwzk98V2YWTlLlIxD5IOR425ZmLN1JyadB/rVqzdxBJCPeq0R2TKfQ16R5EZX1Om0gZKn0rsQwjgABHIzXI6YqiRQDndyK6SM/ujkggVyV5WPZwqUrFhXJIUdBV6SYFbeFRwBz9azITiMnoM07zk80yc7R0zXmy1PYjGxs2TRvdyYGdo2gelM1GJjKhBywOc+1L4fh3Rs38Tck1oywjy97DPbrWfLoXGSjI6DwveC4hQJjcuMnFdpbvuj5PIGCWPavM/Bkg+0TxgjOc/SvRNPfeNhfKHg1pS2McRG0jSCSIXk2kqACW7fQ1yfi4S3VneQNCy29xGwVioK7yO3vXbpBE8ckCsBOq7kfzVEJGMjJOMd657xBambRbiNJFYEHpk5bHBHt0roOeLTdmfHkiNHIyOMMpIIPYimVNco8VzLHL99XKt9Qeahr1T5tqzsFd78KPD7apq5vJYPMhtiCpP3d+f1xXH6Pp0+q6lBZWi5lmbaM9B6k+wr6X8F6FDoujw20YJSPGW2/eY8k/nXJiqllyLd/kell2H5pe1ktF+f/AOgs7by1Kvgb8FQpxn6YrW3qFQnDBf4WHP+etTxWW7TWu57WdlQ7QQQo5HBBOe/bFZFzdRwKobg9Qa5oqx6bfOR6lIiRAhhkHoa5m6k8272fNgqfrVy9vll2ucgdgazYQ8lwz/AF6Cm0VGPKtS2fmUbAfpVm2nf7jZz9ah3EEFzwOmP61CmBIDyMdfcVRG6Lc12NxQjPHJxzWVefvU7ELwPar5AkkfapOecn0rN1VTFGNgwSO3ehmkErlKRXVUkQ5B4qDUUCRJJnmpElzbbTyR0pt26z2nzfeHSnE0lFnOXB+Y84DVmXWUikXtjirl85UAHBINZuqyBIjg8kYrppyOKuranI6lIP3npk4ArGrQ1E/MwzxnNZ9dHQ8Oq7yCvQfhTeeXcz27HqQwzXn1bPhS9ay1u3kXoW2msK8eaDNMLPkqpnu2p3G2EAHn0zXMzXhEnynBzyK2biMXkSyK2TjtWPe6c65I+9715Uu57FtTb0S9dxweO/512NuWKKY1x6knJrjvC1o5lVQu7/Zr0y2toI4tyRgsVBII5BxUQak3YyrWiMs0O0bV3MOpzWijlIlTOTke+Kq2iHcWAO3PK1aiU7jtHI75oMWywoIbIY7R2NNyW5IPNODj5ecknk08uQcbc++KYiJ2yfnU59MdKhibkFCdwpd24hhkgdfalTJ6Nz71ztll6PIYPKAcjmop1WP592OeB3pxYBF5BYjuelQTknPTIGBzTvYkpg75d0hLPnoR0qtexB9p28dz2qYttL4OGx1xxin2+HlKEq4PGGbGTRHU1Whm7cRcfpXEeNrD7SYxgKxOATXpVxAyQl2ChCTjHSua1mOSPy7uKNJZbaRZhGy5DFSD/SuunPkkpFzgqkHHujxTXfBb2dxI8o8xM8MnSuTutL8lm+U8etfQ3iLX18Qut08Sx/uljwW3Nxnljjk8/livO/Enh3VZbSW9ttMuXs0GWlWPjHrivZrKMVzJnzNNyvys47Sl/dIzdVOK6C3Ia3YmuWsLgRSJv+6Tg+1dFaSAW7AtyTmuHELRHvZc3exZlkC27YH3jimpC1xMkS8DjIpjZkijCfjWvpMBNwHYZ5BP0rgl5Hs89ldnU6NZLBH5bFPmHPqfpUN38hKADHXA6VowOjxoAVHBJP8A9aqUp815C3AA4xRYzpyu7sytHlNpqfmA8E8ivQbS5Hy5fjHBzjNedSja2Qec9h3roNIvyY1DfeUc8flRBWZ1Vo81mj1XQb1YoYZ7UCSeN2aSEx4Xywpyd3PoO1M1yOKWaSW2O4OC7AI21WOeASo7Vz+j367EOPnI2bu4FdDLCt7FGXuGkYMChRMlhjJyAezN/hmumJ50ock7s+YPi94Zk03WpdSt4mNpcHMjKCVV/rjv/PNcBbwS3MyxW8bSStwFUZJr7F1bTLK8iuIJiZJSclZFADL6H0PvXn+i+BrTRNUubmC2fc2V+UjKg88e30rZYhwjy2uznngI16nOnZPf/gFD4Y+C10SP7VevG97MCGH8MYGCBnv7n2r1SDZbq0tyVT5c57KAOpqvZLGiFUjBiwoZgMkf4c1r2M1pFqDQap9rthJA6RXEO8lXA4JBOcdenf061lCLqSvLqdcrU4csFohNRuAYILYgxNbop4YsJsrn5jnAIz0x/F25rlL+6V965O3BPH05q9qmoGZ5JJcB5SWfBZstnJOWJP8A+uuUnuDNMygYjzjPc1o42dkXShZXZIU8/BAPHJx2q5bKFXJ4JPFQWgZRnGcdP8mrDyDdtQhm68dqTViZSu7Fe9faYmyck464oIyVc8HGM0yVmeeIk/KGAZfen3gVC0icg/eGfepKtshsEvkzsFfClepOaq3RMtzjIxzxnrTGZvMDJtJ/Pj0qSaUvbhkAGzr7HNMpKzMmcmMshAAHNMwv2RixJz0o1FlKs+ctVfzS9oFB6daI7m0tjBuyrStjjHNYF9JvyT0GetbN8Srs3rXP3YLBlFdFLc8zFytEwLoh2P145qhit1tHuJF3x8isu5tZbd8SoVrskrHz/OpNlWrFk2y8hb0YU0JuIC9TWjpemy3FzGFBJyDWNSSjF3NaScpJRPZfCM5mt0U84Ara1C085ge3XrVXwbpwgs1yCTgZrppY402qyHpivnZyclofRzVmVfC1l5V0pyRxxivQE2+SQ7BVx161haNDhdy/KTxnHNbLuNhDAlfftTpe6rnFWfMyvDDiRipPXHTqParewYwM59fSo1BZuCcdAQeaCw5zkEVsjEsQ7gCDhh605mbceG/DNVw5EgMfPHT1qczP7/h/+umhlQk7F3Dnvg04BRnbyTgAn+tQZLMNnbkjNWCckrgYPXNclyx/y4yduPeq1w43lsKNvpU8TlOCeOwPWoLvBY7Mc+opNgUppGMjFlAB6f41HFKscp2D7vIB6Cnl0MZR2AbOAGNVQ6BsAcg5AAzn2pwZojWuLlXtNuxdxGQOpGKy2zJgAnaexqzbSkcgAk/3uf0qG6jYYYkAf1rrTujWCS0MbRfDkf8Awke+V1NufmEXq2a9ctIESzVAoCEYK9q81eR1dTGSXUghlPINejeG9Tt9V01yzqLlABInTB9fxrelNydpM4cTR5Hzpbni/wAdfhpaT2M3iHQYDFeQ/vLiCMfLIvdgPWvFrNxIEXOOK+zb+4EbMrrlSCGB6EV53afB3w1qF/JdCW8VZHLmNWAVST0FKVXmvBCw9T2Urs8V0+2IdEX5yx6D071fswwb92dw9c123j74ezeDrd72GQz2MnypIFIMWezf41xlhtCAEke9RCL+0dkq3O/dL803lxqw3DPDH61Zhv4xA0ZwWrLu3yGhBPJG3NEETIOvPenbqd1KzjZk7nc25hgH0pqzNE4K5x3x3FIzMOOq9sUzJZMDBP1qrJo647HT6HqyoVXP056E969A0fU5IJUmjWSSMLiQKxTngg7hyDkA/pXjUDlTg8YNdjpOqIyI/mlOAHVTjbz1qqbcWZYigpI9GltTfLHKIg0u0NkMBGV5G1ySoznGBnPNVbizaG4dPKeaELgMrBBgDsWPJ68VRsdYCwx2iXSNZs8bOgQLnZzz6jLZwT1UdKbq2qRytIYYTEhJBAldt3Ocncx5+lbOKaujz4xmpcrHXVwYphHcRt+7G3yzkZXthh09ao6leLDcXECCF495KFGZgoyeFZucc9/QVj31/gs7tlt2TuOe3p3rHuNRZuFY7jxn0+lC0VjrjRe7LNzdPeXRVGIUHtTYFVHzkkZ6jnPHpWfCzKSgABPPvVgMY8ICR2q7FTV9EXZZQrAHjAzzSq4AD4bDds5qCCLCkMN24etVr6Z4G3byMcgUmrnPJdEaWxS2ZwAoOR2I96tP5AiMjEMh4Azk1zMmrFiXYbuKqPqbkbEO1epHWo5WyZT6G+JoSmFGH+uKqywMttKithy2euQRWQdRdX6DB7Yq/bXRZRIR8oPLZqZLlLhNN6FG5U7nWTk4quyhbcjHLc1oXVs9yzMBsbgYPpVe++Vo03dB06Co57M19poctqSFm9icVUi0g3hIDYrp7G0jvtRhhPzBmAwK9AsPCf2h/LsLIkjgtjAH49KpYlU2eTi056I8hfTrixh2nLDsawL6xlnbMnFfRus/De/NirQTQvIB86lSMfj3rFf4XRi3WSaaTeRyR0/KtauOvGyPNp4ZKV2eAx6csTZxk12PhC2Ez/JGFYnFdP4h8Fx6QAysZQfzrb8GeH0t4hNIBvPIFebVxPtVy9T1sLRVOXOb2k2q29uqDjPWtBolkOCgLDoRVq1sxuRSAckDmrM6RQbkVQNvp3qFGysbzndiWI8lAnAGMEZpXZ5Cqn7ueQe9VkYO+FbPpWhDnGQOem70oj2OabLSR4ixjnpxUDoA2SST2FSks+M9QPzqswLSAANn2NaXM0CSKH+RR+VTq5wMDj3FV0ymODgd8fzqUSAgHAPvSTGRgqpDZzxjGKe/CgjOc+gqMtlMnGD0GadFglgSDkZ45Arl8i2OIBO09cc1BI3PUYAwcH8alb5WyDnjFVtgI4OCRzxSAzr2TkBeB1xWTegxOhGc57N07CtS7Alcg5NZ13/qsDDAAk5HJpX1NoGlBeRiHzQuxA3loOTuwBnn/PWtGK3jdUuLuXyoXOBhdzEewz7VyMe+VY1TJA+Z1JPrzWr9o8y7WNQFRMIASM5PXp1/+tXTCfc05exrSRxEsqMCo4BIxTLC4utMvFu7KQwzpkBsZBB4II7in3KJaJEsj5Lruwm3PT8T+eKRUlkRniikMYxzjI5rou07rcTSkrPY1n1uPUtgkUW90Bho85De4NdLo2IoECnI6/WvNpkYNl0KMpyGPGK2dK8TvZgJexmVRxvjwG/Loazi7Tc31Oarhml7h3fiS2i1XSLm0lTzIZImR1PTGP6V8kSl7O/lszkvE7IR3OD3r6u0bXtPvonFteQPIRjynO1x/wABPNeL/ED4fSN42tL2ymLadd3AEquwDwDPIHqOtdFSXu37mFD3J2kcLb6XqOoSxvbWF5Mg5DRwswP44xXWaT4N8Taq3y6RJAmPme5ZYx9cHn9K9ttWiigSKFVSJFCIoGAABgAVdtDnPWinDRJs1ljJfZR4zf8Aw91eytwwiiuR3SLIYfn1/CuWuNLmSV4zHIJoxl4iu1hj2r6TZiCcOwGKztd0ew1jSpUvgonRSYZFUqVbPTd9OeuPWt40b7MqnmM4/EfN/llXYqDn+JWpqb4ZC8ZyD1XpXq+jeCLR7Yy62ZZpZC22KNygQZ4Jx1Jqe68E6dtCW5ljHoX3c/UjNSqTkrnd/aUE7HnOnXrRoFRirf3WHFX59RniBDghSeRu/wAK7MfDp5Not5fNXBJAVdy468Z9qo3ngq6Fm80MgkhBxnbgg9qr2c0hfXqU5HInbMcgkAD8ahl8pWwkY4Oa3IdEuCqQiNzIW2kZAxW9pfglWRTcyFSeSByalFzxUY7s8+zMJjJlnU9wOladlsdN23Mg6+uK9W/4QjSH0qODFyLnzN7TCQDcuGwNuMDG79KyLz4cXif8gq5in5PyyyFCcYxztx7cmtXcyjjqc99Dzt5ZjK6xkCMcEmnT2SNh5m3kgEc8c+la+o6bdaffLYX9nNBeHpG4xv8AdSOCPcV1dp8Mrm6topLvUEtgesax+Yy/Q5AqXLWxc8RCKvex5bdaem8OMBP9o9ahFnGpJVQEHQ+te7wfBrRnVG1LUNQuCVyFadY/yAX+tZuq/B3S0tkOm6tewyMMqtwEnVfbgKR+Zq+WT1aOOWLpvRM8S1K3VCvP9Kbau3leTt+8cjFdd4p+HXiexUywQw6lAB9+1bDge6Ng/lmvPPtpgLJJuR1O0qwwQe4I7UqjT2MqVR3Ool+RVAwQAOnWtex8E614gtop9MgAhPHmXD7F/DufwFQ/DPSLvxVqKKls8lhG26acrhOP4c9z04r6Ks1jtbVIYlACgDGMAD0FcEU5zdtjWpiXCPKtz560T4ZeJLbxSkd3DDHbQkO8yygqw6/L3zx7V7vpcKwwJbQKMAY4pb58SFh361b0tCqZQZdv61UaaVTQ5alRz1YlxGETHUd65HXX+yuDn92x/KunvpjGSr/eHUVxPiW8ikDQAh5e2OQKzxE7e7HcKcOZnKap/wATO9EYAMSHLH1rTt4ljjCgAY4xUFpbC3QgMWPfI5NWC4LY3H09Kxp0+rPSirKyLlsHId1PyjggAE/karXsxdyY2MiA56Y//VUZkj8kqNyzg/L3Vv6iob1sxgjdnuN2fwrZ7ENak1o+F3KqDrgD+taUMkhBY9CM4rF09iq/e5PPXtWxEgAIGCO3POKzOeZM7seTySOmetRxOFclOcjgGnyAhCuOD2PekAGV3dulK9yRxL4ztGcetN344O3PueaR+rDPB4GexqIbhxg072Cw0sFbj7vXHpUkTDaDnt1xioC5DAbuDSI4Dnb0PFcxoXNx2Mw59x2qIseW6DHY4P1prnaCy42j8KVxwHUkjOenNAFGVcbsA/e4wec1SuFDqQ4PPO7GKvXMo3E/d7YPSqzS7l2hEyBye5+tIcTGWQxXpMi5APQHAGOf8alV4ml812/dozOAp5Yk8jHft+FJqcW8gqeSAflHX/OKhSOOZd6/Ls6IB6Dqa1hJ7HTFrctWM4a4ElwS2Tl9nPfpWpea3JcobS2lcWuRkDgORnGfUDNYrwSw20koIKEZGP0x+lNsNkB/fNukKhlAz8v/ANetVNrQ05U9TUkLxOV3gt1K1DgMzZ+VgeBioLbm5LSPjPP4VauYN4DIyEISMbsn/CrjqUtHYlS3jkwHUPkZGQOMVYgjdZEaKWXKH5VLkqPwPFV0EqxBl5BWpIZDkLgFsdcfnRZMzlFPc3rTVpICFuLfcOoKNtP5HOfzrYs9csycSO0Jz0kUjP0NcmkijC7s9yDUp2EYQ85IPYVorx2OaWGizuW1C2kYeTJGT2AxVLU75jZyR7nEbc9eM+w6dK5eGESAKyBsdRjpxSTWyjOGdQeBhiF/w71arSiYvCeZ0sFytzHHcZXDAKTmrIjVmBHP0rkrcXELqsNwV2kFQwGMirS3epIeJQ5J44B5+lXHEaakywkujOukETKgEScIVPJOTzz9eR+VVp1VbZ0APzEc7vT2rJbX5Ar500RPwV2ykjHcEEd+vWo5tcjkVQ0UqE9eMjPt61v7ePcx+rT7BtRbo4UCQnk+ororSBTGMgdMdK5iGe3kvBMl0Szja0RUqEweDnvnnp6V09jcxlQC6EjvuFZOomwcX1NIRDZx6VLAHiwyHBB/rUC3Eag5kQfVxTZL2IDiWPPs4NaKoiHEqeJrSLUre0EqoZ7acSxSEcr/AHgPYg/yrUtnGEIbAGMYrnNZ1CNLfcJE3bgvUHvzVm0v4zjMidPWs5VlzlcjsdAWOc5Jpl26kjYGAHYnODVAXalHZSWVMbioztz0zj1qjf6xb2gXz25YEhQQWwPbOaftdBKDeiRoTSELx2715L4s+G9p4j+Ikmo3Mrw6bJDG80cWA00vIPPYYAzXZT+JrZlO2K4K/wC6P8azotfhF20kiTooxglO34GsKtW8bI2hSnF3SO70u2ttN0aC00+FILaIbUijGAB/nvTw3c1zMfjGwhgdQLr512keTj0Pc1Xm8ZWiA7Ybgkf7oz+tJ1EkkhKjN9Dd1F8Dd3WqcOpjyyY5Y8jghmAIx9a5DU/Fss4K29uEyPvOSf0rnp7uacsrnIc9MYFYSqTb906KeElJanZax4hjVcQOskrcAjkD3J71zD3LNKXOXkfksc/lVa3R0bOwYH61pefaSKim3EUgwPMjkbB+oJPP0xQo31Z0xpKnoEMm9ctkD0PSpU2yMygsJQDgcEE+xqC7ZrO5DorJ8oYqW3fkccg1BqckPnwywYEcoDFR/Dzg/rWiGV7uSWadjsCSxffHI6HnioZJpJp2BwqgblJPX/Gl1G6Z7kvIWkkwFct1wOhPrSJiSRAfuDgY5qJEyZr2O5uDjIHYdc1oxE4wAcgY4qnGGSNdrMAuR0x+FXYCNg55PXBqWjklqTbyBkgMOnPalHJJxx25qLPyZGeOxFLGwDc9P0pCsTNgJhhk/SoGVMnPWpmkDHA49z/n2qVQCoyfzNVYLmNI5UZPJxjkU6ByznK8Adaao6HkjqKW3UhjnPNcht0JlXA2ghgeeD+lKJCSd5P3eBmo2YbSAOcEe1NDZiVQF3EnPPb1pkkd4GIyRtOc5B61WIwOFQnseuKuTvzn8OlVZAVDEEYBxkUIZVvlZiuf4wDxj+lZZd4LkGVNyLnOOp961QV6rjHRiR0PsKrXUaSsXO0gDH3SBTWhpCXRk8d2s0kcMYAd/nLHov0/KrEcUZZUaPblfv5rCjkMFykbruKAAZUAY59ufxrWsLlluRJKykIQqpnoPb1reLuaNW2LYhjS3VyG3Hge/t6+lT2bxWJIeMygjDj5T79ff6VBOxicgvtGSQ2c9eMfoael2kVuUeKQsyhomIxxjGSD14rUE20Na43u4jjMackgnd34H/16cyKA0ihgxHB6r+dMWMhidwIAyAvU1o6fZpcxNLJNIVKnCYK8/wBRj/PekkxuSRmxspUuFPoQD/SrEBTzlGcD34rWlt4UgQvGgUjg7fwzUAtbWdAR5ibTzg9+nGaeqDnTBFEjAo6oRzg9jj1pJw6upJAbpkULYMrHybjevJxzxx3/ACqaIsrFp1PJwcAEDrz+uapMLoIJEZfnVSc5yOc0+RmB4QYYkHmrEEEL5YHCjg7GwSPp/WrEVsrBhD8zkACJhgqT3z/SrsQ5JFZT+52b/lyD0yc8jr6e1Qywx5KMFyfpn61YNo6mQDYxXIZQc8gjp296qy2l5FKqywyoDwpIGM9+R/nmm43BNdGVZbNMMTgH2Jqi0MmfklcjOAN5H6VouLiGNXlhdYmJTJHU98HvxUBClfOKKU37Dg4Io5Eap9ylJDIw+8xI6DJNTxWk7BT5pAI9TT0cBgRkKvOK0EWZ40ZYXaNuj4+XOeecdaXKErIx59M3HdI3Oeec1PDpsap8qktwTt4ya1xaytC8ot5tirvZypHH170sFrczLiOBiDxnoPr60uREuZkfZ1jYFFbJ6nPvx/n3pjxAsVVUHPWunHhuRlBa4RGJ4CRbuvHUkVk6jpsUEeftS+YOcjGaRMZxb0MpW27s7SM8D+dAk8zJVRjselQs6DYo3cc8nk80iSFzsB2gH5Rn26YqXY2cRQNxYSElgKb5cILb8nnrT1hldXlbJRMAgDIHbmj7OrRt82Gyflzk+tTYltIrOiZ4GcHsODUtpYC6jIglQODyjDGB6j2plzbSQKu9TtIyDjr61P4fuo7LWbdp/wDUOQrkdeo55pobk0robd25gI3EZxztzz+dY9yW5KEggZP0zXTa8hju7nzI2hBkJUEFuDyOfQg5rmJ42BbBHA4z3qpQtoTCV1ctrcvdWKCSQ+dEAg3Zwy/X1H8qqy3IjXywxVQc47AHrz9aigdg4ZCAM7SoAznb1qBiZIJUJA2kYBH1xS2QbD5y9w48s8ggMwxyK1bK1ZVJcEehzVLToSSu4nnHTnpzXSLFi1ZjLHGy4A461Nrs56s7aEbHyyNp+Zuox0qxG7qnHTPTHWoVKhM+Y3PU1NEGIGdp+lRIxQ8scEkYx6/SnIXJySuAPSo1bI5GB0GBSpnbt5IPQ1IyYOCwB7DsKtCQD/nn+PWqhwoAB9sCo/Mk/h2EdjVE2uVImGAQAffHSpcrwV6++KgiXYTjIz6d6mXBYDOQo7iuU2ZFIdx+QAYGOtPXDISynfnp2FNnQhiwAxgfjSAj5uoB4ximgHlQpbfkgjGKrzfLEMs23OeeoqzGrbAw2jJ7nnFRSgDAkHAOMetAikwUkqGbjpn19vSqbqWkz0cDkev+cVfl2gqWwVz1xUUoBLqVAPfHOKa1KTsVvJWXYcbjjpTliMMpONwJGaVFxuZ847Y5JqUkOhVs8HIPcD6VpEpTZEDI7naRu3b8qMn15FXYYfOCiXcAuBlmA4yScAdPpVMZ3oYz5Y7n3pI5TbxlA3DA/d6Z61smXe60NkxfIwgAYbeB0x+NTxXBjnCwzYCjLMucjPrWNa3DKBGYAwIyXJ+8fU59xWhHOskEh+Vg4OQo3AnPHI4wSB0q9xbbmg8LXJzHcJJs/wCWZ4YjPYH65qZJYVDBvug4y3rWZHIrxjdBEPmGd7YGD61at763UqzrEjMxxHHlgo9gPSqSE0yaOaMsDt+Rj9zcRnitSJYEgRBKqlhyhzkHGOvTHXH0qhGUNw00RENvn5QPpgcnH5VZi3EgkKQff9aqxLZOBAIS0gVtue2M89j+dWY1XymaCPDdst0zgYJ7jnPNVzBHKggdj5mQVUY4OT075rTxFGo2K678RhsDGQOvHv7DpVqNyJMrySyLGv7kLnooK5PPpjNSu0iQLI6PGynkyLggn/8AVSvJ5bHB35HzbQcn2x/SmXMUheEglUKqw3fdU85BGeuOe1PlIHzAXmimNVDujhdoGd2T1P59q5Wz06S7uJIoLdl3jJJmwUx3Kt0yc49RXRW97HZSKhiLPI2zHtnGeen1q2pcRERO6Ev87g4LKDxzQotaFRk4XSMtfD8UV+sJljY45HJ2nPOTkA8V0iSO0rpHI8qDC7o12oAOw9RWPc3w09ZGMZMkgIVU+Y9ejHIx+A79at2jTPuupTsLLu8naAEHud2T+VDg72M5uUtZE32iR2VI4ApJxl34Hr0/xqvIL+5maOOe2ikIwV8osc/j9KjS4nadjB5EaqMZfPyn8M5qLULSWdGfUHx83SMui/Tnk1HIxKNmQX9uglC319dzumcxQIcD24HFZ00eiRxs11Bftjkjj+pGa3LO3tIrQjylCMuCNoPTHGTUQjhmJQt5IUgq6En8duf5elHI3oaqdjDltLBHjOnwLLE/IaacMRnB6L1HPrmoZLeIo2I4UKnloVPrgZyT9KtX8dxFenyX85FYoxHOGxnPsevFQTvG0KukcYlQZfJwe39TUchopvuVbyIQvILd1xOBDITwo547/r71Ucz6e+LiPBU7dwO5SfqODU7v54meb5Xx93AOPTn8OtVoJ9sbLK5AYkMJDkA+o9BVqCsX0LFxcLPChmXAI+ViD+tZN4jdY1Xy0AOFBxin3JMUQYoMH7pBJOc1TS5P2VXfPzgrHznkUNDjpqjTN0skaQBVMig5LOT5i9voQDj3rOvlUQFomV1BGMHuefSoZmAlRgwJQhc49ufpUV7M8jGKM+YmO5+6cnFDfVitZ6FZrghWVh874IIHpx/LNWYUaVnkwcsRlc9frVextgH3Pjf0wegrahhRBlsMp59DWLdxTklsSW6OiBcZOOOKewyoyvGc/WnQA7FABXHPAqQpvaPdhsdM9uKNkc27J0bEZXy+3GRn8DT42AjJ3ANjpnn8KgdirMEGQBz2xREdybQQwFZMaROWBwwGWPHtTkfsBxjPtVdgwB3jGBx708EfKE69zSAe53ZBOD168VD5pXjCnHcgU9j1bPH8+1R7kHAXimAsvCBgSPShG2FiGyDxzz2pHAK84PbrUceQQh6+ua5mWKzMGyecHFSkqxBzjtwaZIBxghh0NEWG44PPbvQhi8c4UEeg7UyTacs3UnBxTnHLYzz2qBsn5duD0+n1piIHZWO059j3FM3lEY7mLY61K6sW5XnPAFLIDhsY9CMdqcdCgYBhtA7AdevrUTxgPkMMHgDHSpDGMDbndkck4qT5OC/ABHOM1qiNipvKMFKseOwIPTn8KZcIrx4y2D0ZeKuyInCgdueP896gdJOHjbIzn8KtFRnYy0YggN82DwW5rWhuSWzG2CWyokAAH4CqksDLMXl6kdBzn+WBUSeX5v3ST1+bpmqTaNeZSRqtIEuV8z94rAsRjgj9DjrVr7bGrjb8g2nDBMAY46fgKyxON+6RFYL8uM4471aS8w+EiU9cEjoK2TRW5qB0mWPam7AxGeWAGOcjB45HpWzahor4h4m2Z+YGQHCgZ/p+tYNtqE/nZPlogwoCqMZ75yPpVyG7KTljIHxyFJ/StoIykmbjHF9FbQxg3EKsZHfJdmY+3/AB7c+tSxzZuBayAqJAQAOeevHP1NZsF6GKzvkvuMhJ7ljzz1/+tWnY3Bhhk+9tiR0hwAF2scAYPqDIevQV0KPMzFppGtpOnFkM6yEqhyQ5O9cY6jHBPUZ9qwdQiubTVp4r2LfOY92UbdvAJbdx6jPXp0rord4RYWnlQjfcqBLOq7tozndtU8DOBjjPPpWTqVqkus6gFikZ4JQq4OTjb0+nTsauVGKjoY05tydyTS4rQ20l0kSefHtBV8gqjYBPUgcke/BqRw0FySkpwOwKtt6cZGPbqB1ouJ1i0a7thIwA2QgEFTkyE4wR2AA6etWY54pI33onmmZYhl8PJllAYZyMDk5PWj2MemgnN7sxfETxySRRMo/tDy3PnLJuBjHJVjwc8ccd+tVbPUG1OXFwxaZABnOQfQ8fzNaviO3S3u7OfyQEm82MqrBh8w9AowT6VkazZQ2LRXVussFxFInmMnI24GWwOjDHI9T0rOUPe1NoSTikdNpVmHuVDPgMu5QiEk8gADt3/Sm6hGk0kwCsYFfC+YhMm487MAc4545NRxL9midLjaJmZPImZgV6g4JHQnI/HHpTJYojO8E0XlRgCdvNY7edwYEjlRwcH345Fa8iStYxu+a9yBgLe3dVj3AScjgEqcDpjpz1+tVo3t4rkDz2mkVclAhIUe5xg9aV9OvI2Sawd2tlblLhnkjzxnBAzg4PGKpXFyPPhabT2t/kCj5y3zg/MSV6Z6/Ng/nWTgarUspfsdSnuIfstzZ3K4bH8DADDleMkqTxweKwNRPPzxh5Ac7wdufw/DvUkrx3DEtA5kC/eTDjHQnj29qzTJH5oj86YjkFSRtI7YqZPQ0hG2pELnBkiBKAMOX7Y4z9KrCQxm42urgYJC9dpHJxjtjmia48oHe7NwfldcEgjH3h+NUWcNO8ifICm3apHPr/AIVgzoSLEk6eW8Z+VWOVIAHPTr6deKz5GDgBuSJPvAc4/DrSrG80XIA2f5/wqeG2CPn5jxycdKhy6DuokEaSTOxUhUZgTk96ljgCksPvN1B7ipljAY4yfUYpoZ34XBP90jg1DRlKp2HoFO0fgDngVc2Foh5Zwe/v9KgQAFQqqCeCM8CpmYooDHORzkdaRi3cljb94AAPVu3SrG5d6kgnuBiqYO1TwRzyT61LE+SWfIxwAKzbCxNJJ85chsscYFNiO0HYTzwOahjfIy245JxU8ZwpGRnHOB29Kl7gOQbc4HOOTipGXbjnPqRTY5FIHXg9M9ackrByzDj3FADXb5zk0wgE/MzE+1JMwLNjAp6Mu0ZAz9aNQI/7xA+tJtyOME0jlg25eDUrli46DjpXKaDS7MR34x9aIwoYknPP5UsYLY5PHQD9aCAGyc+tPzEO2tgKu3B5wKikV1kkcZ7k59PpSnG7BPIGcE09fnxyTjtnqKEGxTc4cqeXB/L/ADinwJtaTcM5GOTijDJJwDjJ681LgjOcg8HmqiNkRX+E/MOmDxUDkAFc/KRgdMirMq7mKuQGz0xVeZMDDcKDgYOMirTsJIbHMy4VjnHX1q4oKoQSSCMgLzzjNUDBnOW+UHggc/WraEAHLNwOOa1iTJE7okuPMOFAxnIzgdsfhUEll+68xQuwnC8VOjAYODlu/wBPwpd+xcZJ28KBmtlZ7kXa2MyVIw+AQAx+XtkDvULOQQUc4yOScVuXFvDOPmwqgDjPcdPpWfPYDfhckHuSPzquR9C41bblWO5wcgqTnGDTluWV2JwQRx2xUc9q6MERAwPp3qhI7x8MrD0yOKaco7m8KsWdFDqODhfu9MZ68Vow6kCEDFcp/EAM98c/i36Vxqz4cGNyrY5UHn8qktLyRJi2N4I4wfxrSNaxTjGR6F/a7pLDMJ5FjjKuzbQwDADqTzg4P5mrGm6sbhHkulDTzPJJ/EDhs8A+nSuBTUN0ZVtp44yoOKsw6hHbQJ5ezcflPGMD/J/SuiNdMxlRVvM6+/vllitUPzESbSM7iRtOMj8TyBVlNRCzCAMJEmk2FgCCAqtjB7Y3D8vSuMmulbyndo2KkAncd3Prk+56Y6VNc38Iu4yifKgO3LDkEfT19fSr9or3I9lfQ6/Xbwouns86vm5QSKsRTcpBDHkgc8duDnFWtSvrRXSFleSIyBZVV9xVWIyMknOMNjBPWuI1K/gnmi2h9wk3M5IIOM9eOtTXur+Y0KSSbXD7g4c/LgZ796bmuolS0R1mnajDpMktpcym502Ribeb0U9CxGSCCB3ByD7VcvZYbnUDNaXyRXIRRHKW+TB+UrnOCPu8fWvPo9Sa1upZIn3Qyn5oz0Y1FPqaNOWtmkhLIS65O1iT0BGMUe2Qewbd0dtPqt7bNCHCWZkBAKH925zk5yexYjFZV/4gdnWKWXa6HeowCrfKOhIyM46e9cympyEeUVMkW3BWTk9ex/AVnXE0jsxCfIe3YVEqyNI0EtzXv76IXEcgVI3IYmRDwegyR+FZFxdi4m3g7HJJYxd/wqBSxlUiQoAOSCP8/nTMRpjBBY87iK5pTvsae7EmYyDfk4dwBlW5A9MVZh2ww7UI3Hk8Zqor84Qb/U+lSxxyFxgcY78//qrO1yHUuizHwSWwV6jtzUgO8kYwT7nrTtuI9xwewycU5cAZ4GeeaDJyuOWJdmSc9s55pqlECbkLZ4GPWjcjFBuVc8YHeo5ZMtgEfKMA1LJJDt3Avw2cYFIQo3Bj8vUCoUYs4JbPY59aX5nYAHkenas2y0iYIGx7HnnipXO5flPB49abGx+8QQMdCOlQiXdv2EZVuRgjOai4EqsVADMMYz0qZWDR5HJ9KoKxJ2u2MVOjM4HqBnPSkh2LkZ+XPGF560jOWA6A+1MDEJ8wJHfikDjqvT0xRcQrqWJIPHXBpNuepI/GgAHqPoajYDdxkj60hXLDMSxXIA7U4ZB5PXnioY33soNWFBbK8dfSuU0BeDzznvSMzA9c4PftQ+OjDp6U5VOSeqtzgmn5ARkjzMY78j1p6jaR0HcjPNMkOGJIB2kD6UsXJIU5OeuetNAJLGDnbgZoRThgeQeoFTsg4BbGT1BpChLDHLcduKoVyFSFOO2MA+tRyDc3I57nPXmrDx7QvRGzwe31qNo8sCe9O40RoPl9Pc8UDgEAcnnIHrTlXgYb5u4oXgjdnb0yvrWsWSyJYn2KpbJz6VIpbcwIAVh1I6/1FQSAg8NgZzwenNMlR1jPPTgnNaxYmrlsMB5ZZvmxlcNzwPb+tSs+1cFyG7cEZBFZwZmfMrAAAcZAo427kfbt9K3hIylE0CeiyOuOqg4HNUp4YpzsfBUHnI4PfqP8aZIWRxtIDEjAOefelcSAHGHLD1Jye2fetU0yGmtipJYQsxl2k5boDjj1z2qjPpjqHKyk8bsHOP5ntWysjKMDIJA3KTj0xx/So/NYSFWO9Txgn+lDjFgpzRhz2l3bJ8ytIBjjHI9eOaZJdlJNjhxt4wefy/E1u4DPkKNg4YnPTPXimSDHKtvH8Rbip5F0NFWl1MuOeDcW3gsOgYeg5p3mRFtznHbIq88NvkMigHGRjGR2OaQ2NqZWZmG48FgBjkdfrVKBX1hogaWJCqAEkNn7xDfr0qtNKCykuzc5OTnFWnsYolBi3MMYAyM9aVrZJSTznbuYHk/j0p8rF9YaKkd3tfnc3pjmpWuRIvyj5hyMirEFqofJKDDbugAxjPXPJ9qlgSEBcrHgtgNxn3/GlydxPEMoLLJswACD/dGalR53jbBUMONrDnj+Va1vJAGZQFAHTLEZ4+hHpQ4DEMH3HgZ68enFHItxOs2ZaWrlAXYqc8Y5B/EfWrH2NI8lmTYMEE5OP0q4GWPbxvyOm3AzioGkUIq9Tj5v89qLJC52wzCY3RFVe4OfYdutM81tw2KSh6kDrUYGWdtqg44IGKnjjzgbSB1J3f1qXoO48pvKgls9+cfgKUqRtwzZ7buaaV3MVBJGO56d80uVQkJ0UYIPaobGhwcAEbctjPHrUDlirEABscmpQ2N3I+bn+dRxDqCQR6VlJlolgjKoB1PTkY96e4CyckYPBA6j8adEpUAMwxn86fKibckYGO3ashpkbENkjgg9+eKYpA+UEgMe1IwYZyeD6nNSIindnp1FJjGCMZ2g5U88dqsxJskyCQue1V2bfnj8fQ1MoyAMn2zSAczDdxkjPWkLAJxkE/hTfMIIU42D25pXc8BSCT7UbCHJjaMrz6ilZCGIwKbuZk+U4Pak2E8nGaYhtux+XpnqD6VcyVbDHr0oorkiaMfk4HJx1xSRnJ2qpJJA69/85oopsBZkOAh+9nHHeo7dWEjqAeOxPaiin1HfQsgjaoGcHj9aeVIABwQBgUUVdiGMaLcmS2WUjC9vpTFA2gNz9RRRQhrYbIoUkvnIb/IqNgQC6Lx055FFFWgsNaME4KjJyenenbCWST5ScdCOO1FFWiZaET24+Z12k8Er2/OmPDhg4ABYdQOuKKK1QiPySxIZshcH6VLBAcHIyvXtzRRVpkvsTkLkOQQRnGcH9efaoTAu/eNxzwxOMCiitbkWIPLO1k3rswTkj3qHy84VsbScH34ooqyrIVYt8jMiqEUcAZ6+nPaldC0JDRZx85O7tRRQmS0EkDrApDgBvmBXgdOeKZFGkmBEdxPAJGDn/JooqmS1oRSxMCnUYONp6+/I/wA81DJFuwV5Dcc89Mf/AFqKKlsLWEt7cKpWBgOck+n/ANerUUTvOgC7irDAZs9feiihMAaVpQQuWxwNx6fhUZtgjZbcpcEkhuooopSKW9h8apJFgjdx8oI4p8K7pEQBWkbC4JOKKKzKSJFj2n7vCknIPfFRlhM5EYKHHzA+mPWiis3uNCouSSx3MBu+gqWMLuGT04xiiis5MZKvzkKCdg6Gp1QoclQSfx/GiipGRyRoZTvH/wBek8sFcA//AF6KKl7hciU4kJUBWP41KORkqcgc4NFFHQoRVG3B5HWmjIBH93viiiiwmN37eMnHfFIHYjOAfwoooQmf/9k=);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Difficulty lifting the tongue to the upper dental alveolus.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Glenn C Isaacson, MD, FAAP, FACS.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f0_55_882=[""].join("\n");
var outline_f0_55_882=null;
var title_f0_55_883="Sodium acetate: Pediatric drug information";
var content_f0_55_883=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Sodium acetate: Pediatric drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_general\" href=\"UTD.htm?12/43/12979?source=see_link\">",
"    see \"Sodium acetate: Drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?13/16/13571?source=see_link\">",
"    see \"Sodium acetate: Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list_set htclist drugH1Div drugBrandNames\" id=\"F1062142\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Therapeutic Category",
"    </span>",
"    <ul>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Alkalinizing Agent, Parenteral",
"      </span>",
"     </li>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Electrolyte Supplement, Parenteral",
"      </span>",
"     </li>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Sodium Salt",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block don drugH1Div\" id=\"F11445040\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Neonatal",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Sodium acetate is metabolized to bicarbonate on an equimolar basis outside the liver; administer in large volume I.V. fluids as a sodium source. Dosage is dependent upon the clinical condition, fluid, electrolytes and acid-base balance of the patient.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:0em;text-align:justify;\">",
"     Maintenance sodium requirements: I.V.: 3-4 mEq/kg/day; maximum dose: 100-150 mEq/day",
"    </p>",
"   </div>",
"   <div class=\"block dos drugH1Div\" id=\"F1062137\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Usual",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_general\" href=\"UTD.htm?12/43/12979?source=see_link\">",
"      see \"Sodium acetate: Drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Sodium acetate is metabolized to bicarbonate on an equimolar basis outside the liver; administer in large volume I.V. fluids as a sodium source. Dosage is dependent upon the clinical condition, fluid, electrolytes, and acid-base balance of the patient.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;text-align:justify;\">",
"     Maintenance sodium requirements: I.V.:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Infants and Children: 3-4 mEq/kg/day; maximum dose: 100-150 mEq/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Adults: 154 mEq/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Metabolic acidosis: If sodium acetate is desired over sodium bicarbonate, the amount of acetate may be dosed utilizing the equation found in the sodium bicarbonate monograph as each mEq acetate is converted to a mEq of HCO",
"     <sub>",
"      3",
"     </sub>",
"     ; see sodium bicarbonate monograph",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F221554\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Injection, solution, as anhydrous [concentrate, preservative free]: 2 mEq/mL (20 mL, 50 mL, 100 mL); 4 mEq/mL (50 mL, 100 mL)",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F221545\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F1062145\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Parenteral: Must be diluted prior to I.V. administration; infuse hypertonic solutions (&gt;154 mEq/L) via a central line; maximum rate of administration: 1 mEq/kg/hour",
"    </p>",
"   </div>",
"   <div class=\"block scp drugH1Div\" id=\"F221574\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Compatibility",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     <b>",
"      Incompatible",
"     </b>",
"     with acids, acidic salts, alkaloid salts, calcium salts, catecholamines, atropine.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Y-site administration: Compatible:",
"     </b>",
"     Enalaprilat, esmolol, labetalol, nicardipine, ondansetron.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Compatibility in syringe: Compatible:",
"     </b>",
"     Cimetidine.",
"    </p>",
"   </div>",
"   <div class=\"block sta drugH1Div\" id=\"F1062139\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Stability",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Store at room temperature of 20&deg;C to 25&deg;C (68&deg;F to 77&deg;F);",
"     <b>",
"      incompatible",
"     </b>",
"     with acids, acidic salts, catecholamines, atropine",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F1062144\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Sodium salt replacement; correction of acidosis through conversion of acetate to bicarbonate",
"    </p>",
"   </div>",
"   <div class=\"block arm drugH1Div\" id=\"F221573\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Cardiovascular: Hypervolemia, thrombosis",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Dermatologic: Chemical cellulitis at injection site (extravasation)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Endocrine &amp; metabolic: dilution of serum electrolytes, hypernatremia, hypocalcemia, hypokalemia, metabolic alkalosis, overhydration",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Gastrointestinal: Flatulence, gastric distension",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Local: Phlebitis",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Respiratory: Pulmonary edema",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Miscellaneous: Congestive conditions",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F1062147\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to sodium acetate or any component; alkalosis, hypocalcemia, edema, cirrhosis, excessive chloride losses, hypernatremia",
"    </p>",
"   </div>",
"   <div class=\"block pre drugH1Div\" id=\"F1062136\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Precautions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Use with caution in patients with hepatic failure, CHF or other sodium-retaining conditions",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F1062135\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Avoid extravasation",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13300048\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F6222956\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:0em;display:inline\">",
"     There are no known significant interactions.",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F221552\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     C (",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F13888238\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Animal reproduction studies have not been conducted. Sodium requirements do not change during pregnancy (IOM, 2004).",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F1062141\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Serum electrolytes including calcium, arterial blood gases (if indicated)",
"    </p>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F1062134\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Sodium is the principal extracellular cation; functions in fluid and electrolyte balance, osmotic pressure control, and water distribution; acetate is metabolized to bicarbonate which neutralizes hydrogen ion concentration and raises blood and urinary pH",
"    </p>",
"   </div>",
"   <div class=\"block adi drugH1Div\" id=\"F1062148\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Additional Information",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Sodium and acetate content of 1 g: 7.3 mEq",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 12793 Version 29.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-85.214.214.87-89768E4622-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f0_55_883=[""].join("\n");
var outline_f0_55_883=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1062142\">",
"      Therapeutic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11445040\">",
"      Dosing: Neonatal",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1062137\">",
"      Dosing: Usual",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F221554\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F221545\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1062145\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F221574\">",
"      Compatibility",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1062139\">",
"      Stability",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1062144\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F221573\">",
"      Adverse Reactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1062147\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1062136\">",
"      Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1062135\">",
"      Warnings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13300048\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6222956\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F221552\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13888238\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1062141\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1062134\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1062148\">",
"      Additional Information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_PED/12793\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_PED/12793|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?12/43/12979?source=related_link\">",
"      Sodium acetate: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?13/16/13571?source=related_link\">",
"      Sodium acetate: Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f0_55_884="Laronidase: Pediatric drug information";
var content_f0_55_884=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Laronidase: Pediatric drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_general\" href=\"UTD.htm?11/43/11957?source=see_link\">",
"    see \"Laronidase: Drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?36/21/37203?source=see_link\">",
"    see \"Laronidase: Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"block black-box-warn drugH1Div\" id=\"F6187724\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     ALERT: U.S. Boxed Warning",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     The FDA-approved labeling includes a boxed warning. See Warnings/Precautions section for a concise summary of this information.  For verbatim wording of the boxed warning, consult the product labeling or",
"     <a href=\"file://www.fda.gov\" target=\"_blank\">",
"      www.fda.gov",
"     </a>",
"     .",
"    </p>",
"   </div>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F187005\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Aldurazyme&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F854886\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Aldurazyme&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list_set htclist drugH1Div drugBrandNames\" id=\"F1048167\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Therapeutic Category",
"    </span>",
"    <ul>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Enzyme",
"      </span>",
"     </li>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Mucopolysaccharidosis I (MPS I) Disease, Treatment Agent",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block dos drugH1Div\" id=\"F1048160\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Usual",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_general\" href=\"UTD.htm?11/43/11957?source=see_link\">",
"      see \"Laronidase: Drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Children, Adolescents, and Adults: I.V. infusion: 0.58 mg/kg/dose once weekly",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F186987\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Injection, solution [preservative free]:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Aldurazyme&reg;: 2.9 mg/5 mL (5 mL) [contains polysorbate 80; derived from or manufactured using Chinese hamster ovary cells]",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F186974\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F1048170\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     I.V. infusion:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Determine the number of vials to be diluted. Remove vials from the refrigerator and allow them to reach room temperature. Do not use if the solution is discolored or contains particulate matter. Determine the total infusion volume based on the patient's weight [dose delivered in a total volume of 100 mL (&le;20 kg) or 250 mL (&gt;20 kg)]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     From an NS infusion bag, remove and discard volume of NS equal to volume of laronidase injection solution to be added to the infusion bag. Add laronidase; do not agitate solution as it denatures the enzyme. Administer with an in-line, low protein binding 0.2 micron filter.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     An initial 10 mcg/kg/hour infusion rate may be incrementally increased every 15 minutes during the first hour if tolerated; increase to a maximum infusion rate of 200 mcg/kg/hour which is maintained for the remainder of the infusion (approximately 3 hours). See the following:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Initial infusion rate: 10 mcg/kg/hour for 15 minutes: If stable, increase rate to:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     20 mcg/kg/hour for 15 minutes: If stable, increase rate to:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     50 mcg/kg/hour for 15 minutes: If stable, increase rate to:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     100 mcg/kg/hour for 15 minutes: If stable, increase rate to:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     200 mcg/kg/hour for ~3 hours (remainder of the infusion)",
"    </p>",
"   </div>",
"   <div class=\"block scp drugH1Div\" id=\"F187025\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Compatibility",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Stable in NS.",
"    </p>",
"   </div>",
"   <div class=\"block sta drugH1Div\" id=\"F1048163\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Stability",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Store vials in refrigerator at 2&deg;C to 8&deg;C (36&deg;F to 46&deg;F). Do not freeze or shake. Diluted infusion solution is stable for up to 32 hours when stored at 2&deg;C to 8&deg;C (36&deg;F to 46&deg;F). Do not mix laronidase with any other drugs.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F1048169\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Treatment of patients with mucopolysaccharidosis I (MPS I) lysosomal storage disease who have one of the following clinical syndromes: Hurler's syndrome (severe), Hurler-Scheie syndrome (intermediate), or patients with the Scheie form who have moderate to severe symptoms",
"    </p>",
"   </div>",
"   <div class=\"block arm drugH1Div\" id=\"F187024\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Cardiovascular: Chest pain, edema, facial edema, flushing, hyper-/hypotension, pallor, poor venous access, tachycardia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Central nervous system: Chills, fever, headache",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Dermatologic: Hyperhidrosis, pruritus, rash, urticaria",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Gastrointestinal: Abdominal pain/discomfort, diarrhea, vomiting",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Hematologic: Thrombocytopenia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Hepatic: Bilirubinemia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Local: Abscess, injection site pain, injection site reaction",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Neuromuscular &amp; skeletal: Arthralgia, back pain, hyper-reflexia, musculoskeletal pain, paresthesia, tremor",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Ocular: Corneal opacity",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Otic: Otitis media",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Respiratory: Bronchospasm, cough, crepitations, dyspnea, oxygen saturation decreased, respiratory distress, upper respiratory tract infection, wheezing",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Miscellaneous: Allergic reaction, antibody development to laronidase, feeling warm/cold, infusion reactions",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Rare but important or life-threatening: Anaphylaxis, angioedema, cardiac failure, cardiorespiratory arrest, cyanosis, erythema, extravasation, pneumonia, respiratory failure",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F1048173\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to laronidase or any component",
"    </p>",
"   </div>",
"   <div class=\"block pre drugH1Div\" id=\"F1048159\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Precautions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     The risks and benefits of administering laronidase following a severe anaphylactic or hypersensitivity reaction should be considered. If laronidase is to be readministered, use caution and have appropriate resuscitation measures available.",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F1048158\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity reactions can occur at any time during laronidase therapy. Resuscitation equipment, oxygen, diphenhydramine, and a corticosteroid should be readily available to treat hypersensitivity or anaphylactic reactions. Use epinephrine with caution in patients with MPS I due to an increased prevalence of coronary artery disease in these patients. Injection contains polysorbate 80 (Tween 80&reg;) which may cause allergic reactions in susceptible individuals. In premature neonates, thrombocytopenia, ascites, pulmonary deterioration, and renal and hepatic failure have been reported after receiving parenteral products containing polysorbate 80 (Alade, 1986;",
"     <i>",
"      MMWR",
"     </i>",
"     , 1984). Infusion of polysorbate 80-containing solutions through polyvinyl chloride tubing may cause DEHP to leach into the solution; in immature animals, exposure to DEHP may adversely affect the development of the male reproductive tract.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13299577\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F186981\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:0em;display:inline\">",
"     There are no known significant interactions.",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F186983\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     B (",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F186994\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Teratogenic effects were not observed in animal reproduction studies. Patients are encouraged to enroll in the MPS I registry (800-745-4447 or www.MPSIregistry.com).",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F1048166\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Vital signs, FVC, height, weight, range of motion, serum antibodies to &alpha;-L-iduronidase, urine levels of glycosaminoglycans (GAG), change in liver size",
"    </p>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F1048157\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     MPS I is a mucopolysaccharide storage disorder caused by a deficiency of the lysosomal enzyme, &alpha;-L-iduronidase which is required for the catabolism of glycosaminoglycans (GAG). Laronidase catalyses the hydrolysis of terminal &alpha;-L-iduronic acid residues of dermatan sulfate and heparan sulfate decreasing the accumulation of GAG substrates.",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F1048172\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacokinetics (Adult data unless noted)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Distribution: V",
"     <sub>",
"      d",
"     </sub>",
"     : 0.24 to 0.6 L/kg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Half-life: 1.5-3.6 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Clearance: Plasma: 1.7 to 2.7 mL/minute/kg",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Alade SL, Brown RE, and Paquet A Jr, \"Polysorbate 80 and E-Ferol Toxicity,\"",
"      <i>",
"       Pediatrics",
"      </i>",
"      , 1986, 77(4):593-7.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?0/55/884/abstract-text/3960626/pubmed\" id=\"3960626\" target=\"_blank\">",
"        3960626",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Centers for Disease Control (CDC), \"Unusual Syndrome With Fatalities Among Premature Infants: Association With a New Intravenous Vitamin E Product,\"",
"      <i>",
"       MMWR Morb Mortal Wkly Rep",
"      </i>",
"      , 1984, 33(14):198-9.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?0/55/884/abstract-text/6423951/pubmed\" id=\"6423951\" target=\"_blank\">",
"        6423951",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Kakkis ED, Muenzer J, Tiller GE, et al, &ldquo;Enzyme-Replacement Therapy in Mucopolysaccharidosis I,&rdquo;",
"      <i>",
"       N Engl J Med",
"      </i>",
"      , 2001, 344(3):182-8.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?0/55/884/abstract-text/11172140/pubmed\" id=\"11172140\" target=\"_blank\">",
"        11172140",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 13320 Version 34.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-125.39.66.146-C1CFDD43C6-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f0_55_884=[""].join("\n");
var outline_f0_55_884=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6187724\">",
"      ALERT: U.S. Boxed Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F187005\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F854886\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1048167\">",
"      Therapeutic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1048160\">",
"      Dosing: Usual",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F186987\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F186974\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1048170\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F187025\">",
"      Compatibility",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1048163\">",
"      Stability",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1048169\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F187024\">",
"      Adverse Reactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1048173\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1048159\">",
"      Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1048158\">",
"      Warnings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13299577\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F186981\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F186983\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F186994\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1048166\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1048157\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1048172\">",
"      Pharmacokinetics (Adult data unless noted)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_PED/13320\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_PED/13320|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?11/43/11957?source=related_link\">",
"      Laronidase: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?36/21/37203?source=related_link\">",
"      Laronidase: Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f0_55_885="Pontine infarct from basilar artery disease";
var content_f0_55_885=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEURO%2F81264&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEURO%2F81264&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Myelin stain of the pons at necropsy after stroke due to basilar artery occlusive disease",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 342px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A large infarct (shown in white) involves the bilateral basis pontis and extends into the ventral portion of the pontine tegmentum.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Caplan LR. Posterior circulation disease. Clinical findings, diagnosis, and management. Blackwell Science, Boston 1996. Copyright &copy; 1996 Blackwell Science.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f0_55_885=[""].join("\n");
var outline_f0_55_885=null;
var title_f0_55_886="LIP lung biopsy";
var content_f0_55_886=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F71770&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F71770&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Lymphocytic interstitial pneumonitis (LIP)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 389px; height: 261px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A representative field of a lung biopsy specimen from a child with LIP, demonstrating a diffuse infiltrate of mature and immature lymphocytes, plasma cells, and histiocytes in the alveolar septae and pulmonary interstitium. Nodular formation of lymphocytes is also seen. Although fibrosis is not a typical feature, widening of the pleura with fibrous tissue is seen.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Cynthia Epstein, MD and Leland L Fan, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f0_55_886=[""].join("\n");
var outline_f0_55_886=null;
var title_f0_55_887="Human papillomavirus associated head and neck cancer";
var content_f0_55_887=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Human papillomavirus associated head and neck cancer",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?0/55/887/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?0/55/887/contributors\">",
"     Robert I Haddad, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?0/55/887/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?0/55/887/contributors\">",
"     Bruce E Brockstein, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?0/55/887/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?0/55/887/contributors\">",
"     Michael E Ross, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?0/55/887/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Apr 15, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Head and neck squamous cell carcinoma is diagnosed in approximately 500,000 individuals worldwide each year [",
"    <a class=\"abstract\" href=\"UTD.htm?0/55/887/abstract/1\">",
"     1",
"    </a>",
"    ]. Major risk factors are smoking, smokeless tobacco, betel nut chewing, and alcohol consumption.",
"   </p>",
"   <p>",
"    However, many patients with oropharyngeal squamous cell carcinomas, particularly those arising in the base of the tongue and in the tonsillar region, do not have any of these risk factors. Epidemiologic and molecular studies have identified the HPV-16 genotype of human papillomavirus (HPV) as a causative agent in these patients [",
"    <a class=\"abstract\" href=\"UTD.htm?0/55/887/abstract/2,3\">",
"     2,3",
"    </a>",
"    ]. Other high-risk HPV genotypes such as HPV-18, 31 or 33 may also be causative but are much less common. Human papillomavirus (HPV) infection is the most commonly diagnosed sexually transmitted disease in the United States. In addition to oropharyngeal cancer, high-risk HPV infection may cause cancers at other head and neck sites. HPV is also associated with condyloma acuminatum, squamous intraepithelial lesions and anogenital malignancy including cervical, vaginal, vulval, penile, and anal carcinoma.",
"   </p>",
"   <p>",
"    HPV and its role in head and neck squamous cell carcinoma are presented here. The epidemiology and other risk factors for head and neck cancer are discussed separately, as is the virology of HPV and its relationship to malignancy. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/6/20583?source=see_link\">",
"     \"Epidemiology and risk factors for head and neck cancer\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/53/26455?source=see_link\">",
"     \"Virology of human papillomavirus infections and the link to cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13763970\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1587553040\">",
"    <span class=\"h2\">",
"     HPV associated cancers",
"    </span>",
"    &nbsp;&mdash;&nbsp;Epidemiologic studies have demonstrated that there has been a decrease in the incidence of laryngeal, hypopharyngeal, and oral cavity cancers, beginning in the late 1980s [",
"    <a class=\"abstract\" href=\"UTD.htm?0/55/887/abstract/3\">",
"     3",
"    </a>",
"    ]. This decline is believed to reflect the gradual decrease in smoking, which is a primary risk factor for these cancers.",
"   </p>",
"   <p>",
"    Despite the decrease in tobacco use, the incidence of oropharyngeal cancer initially remained constant and then began to rise [",
"    <a class=\"abstract\" href=\"UTD.htm?0/55/887/abstract/3,4\">",
"     3,4",
"    </a>",
"    ]. Multiple lines of evidence established that the increase in oropharyngeal cancer is due to HPV related cancers arising in the base of the tongue and the tonsillar region. Furthermore, this association is primarily with HPV-16, which is known to be carcinogenic at other sites [",
"    <a class=\"abstract\" href=\"UTD.htm?0/55/887/abstract/4-6\">",
"     4-6",
"    </a>",
"    ]. Cohort studies from the 1990s suggested that approximately 50 percent of oropharyngeal cancers were attributable to HPV, while more recent studies suggest that HPV may account for much as 70 to 80 percent of these malignancies in both North America and Europe [",
"    <a class=\"abstract\" href=\"UTD.htm?0/55/887/abstract/3,4,7\">",
"     3,4,7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Multiple studies have analyzed the relationship between HPV infection and laryngeal cancer. A meta-analysis that included data from 2559 laryngeal cancer patients in 55 studies found that the overall prevalence of HPV positivity was 28 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?0/55/887/abstract/8\">",
"     8",
"    </a>",
"    ]; the most common genotype observed was HPV-16, with a prevalence of 19.8 percent. Among those with HPV infection, the risk of squamous cell carcinoma was significantly increased (odds ratio 5.39, 95%CI 3.25-8.94).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1587553047\">",
"    <span class=\"h2\">",
"     Prevalence of oral HPV infection",
"    </span>",
"    &nbsp;&mdash;&nbsp;A cross-sectional study of men and women, aged 14 to 69 years, studied the prevalence of HPV [",
"    <a class=\"abstract\" href=\"UTD.htm?0/55/887/abstract/9\">",
"     9",
"    </a>",
"    ]. The overall prevalence of HPV DNA in oral exfoliated cells was 6.9 percent, and the prevalence of HPV16 was 1.0 percent. The prevalence of HPV infection followed a biomodal distribution, with peaks at ages 30 to 34 and 60 to 64 years (7.3 and 11.4 percent, respectively). HPV prevalence was approximately three-fold more common in men compared with women (10.1 versus 3.6 percent), consistent with the observed sex distribution for HPV associated oropharyngeal cancer.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     BIOLOGY OF HPV",
"    </span>",
"    &nbsp;&mdash;&nbsp;Human papillomaviruses (HPV) are small DNA viruses that are widely distributed in vertebrates. These viruses contain an eight kilobase long double-stranded circular DNA genome. The papillomavirus genome comprises early and late genes that encode early proteins E1-E7 and late proteins L1-L2. The early proteins are nonstructural proteins involved in replication and transcription of the genome (E1-E5) or in host cell tumoral transformation (E6 and E7), whereas L1 and L2 are the structural capsid proteins of the virion.",
"   </p>",
"   <p>",
"    Two viral genes are mainly responsible for HPV related malignant transformation. The HPV E6 and E7 oncogenes encode proteins consisting of about 151 and 98 amino acids, respectively. They are largely responsible for the onset and persistence of the malignant process in both head and neck and anogenital cancers.",
"   </p>",
"   <p>",
"    The molecular profiles of HPV positive tumors are distinct from those of HPV negative cancers. The absence of genetic or epigenetic alterations in the p53 and pRb pathways in HPV positive head and neck cancers is in sharp contrast to what is observed in HPV negative head and neck cancer. In the typical HPV negative squamous cell carcinomas, p53 mutations have very frequently been demonstrated along with decreased p16 and increased levels of pRb. In contrast, HPV positive carcinomas are associated with wild type p53, down regulation of pRb, and upregulation of p16. They predominantly occur in patients with no excessive tobacco",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    alcohol consumption history. These differences in gene expression suggest that HPV positive and HPV negative head and neck cancers represent distinct entities.",
"   </p>",
"   <p>",
"    The virology of HPV and its role in the molecular pathogenesis of malignancy are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/53/26455?source=see_link\">",
"     \"Virology of human papillomavirus infections and the link to cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     CLINICOPATHOLOGIC FEATURES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Multiple studies have demonstrated that there are important differences between HPV associated oropharyngeal cancers and other head and neck cancers resulting from other risk factors (eg, tobacco, alcohol). These include [",
"    <a class=\"abstract\" href=\"UTD.htm?0/55/887/abstract/3\">",
"     3",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Pathology &ndash; The vast majority of HPV associated head and neck cancers are squamous cell carcinomas. Immunohistochemistry (IHC) for p16 is highly sensitive for HPV associated tumors and we recommend its routine use to determine HPV status in patients with oropharyngeal cancer. This diagnosis may be confirmed with either PCR for HPV or by in situ hybridization [",
"      <a class=\"abstract\" href=\"UTD.htm?0/55/887/abstract/10\">",
"       10",
"      </a>",
"      ]. Rare cases of HPV associated lesions arising in the head and neck that are high-grade neuroendocrine tumors (small cell carcinomas) have also been described [",
"      <a class=\"abstract\" href=\"UTD.htm?0/55/887/abstract/11\">",
"       11",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?12/4/12362?source=see_link\">",
"       \"Pathology of head and neck neoplasms\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?3/31/3578?source=see_link\">",
"       \"Extrapulmonary small cell cancer\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Epidemiologic factors &ndash; Patients with HPV positive oropharyngeal cancer are approximately 10 years younger when compared to HPV negative patients [",
"      <a class=\"abstract\" href=\"UTD.htm?0/55/887/abstract/2,4,12\">",
"       2,4,12",
"      </a>",
"      ]. Many of the patients seen with this entity are in their late thirties or early forties. This difference in patient age has major implications in terms of performance status, comorbidities, and ultimately, prognosis.",
"     </li>",
"     <li>",
"      Anatomic location &ndash; HPV associated tumors predominantly arise in the base of the tongue or the tonsillar region, although a small percentage of tumors at other sites are also HPV positive. Why the oropharynx is more susceptible to HPV transformation than other sites is unclear. Like uterine cervix, the oropharynx offers easy access for infection. The tonsils contain deep invaginations of the mucosal surface believed to favor the capture and processing of antigens, which may facilitate viral access to basal cells.",
"     </li>",
"     <li>",
"      Clinical stage at presentation &ndash; Multiple studies have shown that HPV associated oropharyngeal cancer is more likely to present with a relatively early stage",
"      <span class=\"nowrap\">",
"       (T1/T2)",
"      </span>",
"      primary tumor, but relatively advanced disease in the neck",
"      <span class=\"nowrap\">",
"       (N2/N3),",
"      </span>",
"      often with a large cystic lymph node than is sometimes mistaken for a cyst (",
"      <a class=\"graphic graphic_table graphicRef81775 \" href=\"UTD.htm?35/55/36733\">",
"       table 1",
"      </a>",
"      ). Despite the biologic aggressiveness of HPV positive cancer, these tumors appear to have a better prognosis than head and neck cancers not associated with HPV with a lower rate of distant metastases. As an example, in a retrospective analysis of a randomized trial, the incidence of distant metastases was lower in HPV positive as opposed to HPV negative patients (9 versus 15 percent) [",
"      <a class=\"abstract\" href=\"UTD.htm?0/55/887/abstract/13\">",
"       13",
"      </a>",
"      ]. Similar results were observed in another large retrospective series, in which the incidence of distant metastases was also lower in HPV positive compared with HPV negative tumors (10 versus 15 percent, respectively), although the difference was not statistically significant [",
"      <a class=\"abstract\" href=\"UTD.htm?0/55/887/abstract/14\">",
"       14",
"      </a>",
"      ].In the HPV positive group, distant metastases developed later in patients with an HPV associated cancer and in a much different pattern than in HPV negative patients [",
"      <a class=\"abstract\" href=\"UTD.htm?0/55/887/abstract/14\">",
"       14",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Second malignancy &ndash; A study that included 318 patients with oropharyngeal cancer found that those whose tumors were HPV associated based upon immunostaining for p16 were significantly less likely to have a second malignancy [",
"      <a class=\"abstract\" href=\"UTD.htm?0/55/887/abstract/14\">",
"       14",
"      </a>",
"      ]. The decrease in second malignancies included prior tumors, synchronous lesions, and metachronous second primary lesions (11 versus 20, 1 versus 9, and 6 versus 13 percent, respectively). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?14/58/15270?source=see_link\">",
"       \"Second primary malignancies in patients with head and neck cancers\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Although laryngeal cancers have been associated with infection with high-risk HPV genotypes, no correlation has been demonstrated between infection and clinical course in these patients [",
"    <a class=\"abstract\" href=\"UTD.htm?0/55/887/abstract/15\">",
"     15",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H1587553040\">",
"     'HPV associated cancers'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13764421\">",
"    <span class=\"h1\">",
"     PROGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Multiple clinical studies have demonstrated that the prognosis for patients with HPV associated oropharyngeal cancer is significantly better than that with HPV negative cancer of a comparable stage [",
"    <a class=\"abstract\" href=\"UTD.htm?0/55/887/abstract/4,13,16-18\">",
"     4,13,16-18",
"    </a>",
"    ]. These factors are illustrated by results from three large randomized trials in which the oropharyngeal cancer subsets of patients with advanced head and neck cancer were subsequently analyzed based upon HPV status.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In the RTOG 0129 trial, 433 with oropharyngeal cancer were randomly assigned to radiation therapy with either accelerated fractionation or standard fractionation [",
"      <a class=\"abstract\" href=\"UTD.htm?0/55/887/abstract/13\">",
"       13",
"      </a>",
"      ]. All patients received concomitant",
"      <a class=\"drug drug_general\" href=\"UTD.htm?20/51/21305?source=see_link\">",
"       cisplatin",
"      </a>",
"      . HPV status was assessed in 75 percent of oropharyngeal cancer patients, of which 64 percent were HPV positive.",
"      <br/>",
"      <br/>",
"      Overall survival was significantly better in patients with HPV positive tumors compared with those that were HPV negative (three-year survival rate 82 versus 57 percent, hazard ratio [HR] 0.42, 95% CI 0.27-0.66). Similarly, progression-free survival was significantly better in those with HPV positive tumors (three-year survival rate 74 versus 43 percent, hazard ratio [HR] 0.40, 95% CI 0.29-0.57).",
"     </li>",
"     <li>",
"      In the randomized TROG 02.02 trial, patients were treated with radiation therapy plus concurrent",
"      <a class=\"drug drug_general\" href=\"UTD.htm?20/51/21305?source=see_link\">",
"       cisplatin",
"      </a>",
"      , with or without the radiosensitizer tirapazamine [",
"      <a class=\"abstract\" href=\"UTD.htm?0/55/887/abstract/16\">",
"       16",
"      </a>",
"      ]. HPV status was assessed in 172 of the 465 patients with oropharyngeal cancer. Using p16 positivity as a surrogate for HPV positivity, two-year overall survival was significantly improved (91 versus 74 percent, HR 0.36), as was the failure-free survival (87 versus 72 percent, HR 0.39). Patients with p16 positive tumors had lower T stage (T1-T2) and more extensive nodal disease (N2-N3) compared with those with p16 negative tumors (37 versus 15 percent and 86 versus 65 percent).",
"     </li>",
"     <li>",
"      In the TAX 324 trial, patients were treated with either three or two drug induction chemotherapy followed by concurrent chemoradiotherapy [",
"      <a class=\"abstract\" href=\"UTD.htm?0/55/887/abstract/17\">",
"       17",
"      </a>",
"      ]. HPV status was assessed in 111 of the 264 patients with oropharyngeal cancer [",
"      <a class=\"abstract\" href=\"UTD.htm?0/55/887/abstract/18\">",
"       18",
"      </a>",
"      ]. Both progression-free and overall survival were significantly improved at five years (78 versus 28 percent and 82 versus 35 percent, respectively). The HPV positive group contained a significantly larger number of patients with early (T1-T2) primary tumors (49 versus 20 percent); advanced nodal disease was present in more than three-fourths of patients, regardless of HPV status.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Tobacco smoking is associated with a worse prognosis in patients with HPV associated oropharyngeal cancer [",
"    <a class=\"abstract\" href=\"UTD.htm?0/55/887/abstract/19\">",
"     19",
"    </a>",
"    ]. In an analysis of patients from two phase III trials (one with radiation therapy and the other using chemoradiotherapy), the risk of disease progression and death both increased progressively with an increasing smoking history; this increase was independent of tumor p16 status and of the specific treatment patients received.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13764375\">",
"    <span class=\"h1\">",
"     THERAPEUTIC IMPLICATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The treatment of head and neck cancer frequently includes a multimodality approach that may include chemotherapy, radiation therapy,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    surgery. The acute and long term effects of treatment are potentially severe and include mucositis, swallowing dysfunction, fibrosis, xerostomia and severe dental problems. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/1/22554?source=see_link\">",
"     \"Management and prevention of complications of head and neck cancer during initial treatment\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/42/30378?source=see_link\">",
"     \"Management of late complications of head and neck cancer and its treatment\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Patients with HPV positive tumors clearly have a better prognosis and might benefit in the future from attenuated therapy. Potential options may include eliminating or minimizing surgery and reducing the dose of radiation or chemotherapy. However, changes in the therapeutic approach to HPV positive oropharyngeal cancer can only be determined through prospective clinical trials and will need to be done carefully as to not compromise the excellent prognosis in these patients. Some of these trials are already in progress. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/55/15224?source=see_link\">",
"     \"Treatment of locoregionally advanced (stage III and IV) head and neck cancer: The oropharynx\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/6/3174?source=see_link\">",
"     \"Treatment of early (stage I and II) head and neck cancer: The oropharynx\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The HPV status needs to be taken into account when designing all clinical trials for the treatment of oropharyngeal cancer, given the more favorable prognosis for HPV positive oropharyngeal cancer patients and the fact that this subset represents a distinct and well-defined entity. Testing patients with oropharyngeal cancer for HPV positivity is also useful prior to therapy given its prognostic implications, but there is insufficient information to alter therapy based upon HPV status.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     BIOMARKER ANALYSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The gold standard for assessing HPV infection is in-situ hybridization to detect HPV DNA. Several biomarkers may serve as surrogates for HPV status or be useful in further refining the risk associated with HPV infection. Real-time polymerase chain reaction (PCR) to measure HPV16 viral load",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    immunohistochemistry to detect p16 expression are commonly used in the clinic [",
"    <a class=\"abstract\" href=\"UTD.htm?0/55/887/abstract/20\">",
"     20",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     p16 protein",
"    </span>",
"    &nbsp;&mdash;&nbsp;The p16 protein functions as a tumor suppressor by binding to the cyclin D1",
"    <span class=\"nowrap\">",
"     CDK4/CDK6",
"    </span>",
"    complex, preventing phosphorylation of the Rb protein. The p16 protein is overexpressed in HPV associated cancers.",
"   </p>",
"   <p>",
"    Either HPV status or p16 status can be used as a marker of HPV infection, depending upon availability in the treating institution, and studies using p16 as a surrogate marker for HPV positivity have demonstrated a similar impact on survival [",
"    <a class=\"abstract\" href=\"UTD.htm?0/55/887/abstract/21\">",
"     21",
"    </a>",
"    ]. The p16 status, as assessed by immunohistochemistry, may provide additional information beyond HPV positivity. In a study comparing the effect of p16 expression and HPV-DNA presence, cases that were HPV positive with high p16 expression had a better prognosis than those that were HPV positive but with low expression [",
"    <a class=\"abstract\" href=\"UTD.htm?0/55/887/abstract/22\">",
"     22",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Epidermal growth factor receptor",
"    </span>",
"    &nbsp;&mdash;&nbsp;The epidermal growth factor receptor (EGFR) is another important target in head and neck cancer, and assessment of EGFR expression may be a useful prognostic marker in conjunction with HPV status. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/0/34825?source=see_link&amp;anchor=H5#H5\">",
"     \"Head and neck squamous cell carcinogenesis: Molecular and genetic alterations\", section on 'EGFR and transforming growth factor-alpha'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In an organ-sparing therapy trial for advanced oropharyngeal cancer, low EGFR and high p16 (or high HPV titer) expression were markers of good response to treatment and outcome, whereas high EGFR expression, combined low",
"    <span class=\"nowrap\">",
"     p53/high",
"    </span>",
"    Bcl-xL expression, female sex, and smoking were associated with a poor outcome [",
"    <a class=\"abstract\" href=\"UTD.htm?0/55/887/abstract/23\">",
"     23",
"    </a>",
"    ]. Another study also identified p16 and EGFR status as a powerful predictor of survival with the highest survival seen in those patients whose tumor status was p16",
"    <span class=\"nowrap\">",
"     positive/EGFR",
"    </span>",
"    negative [",
"    <a class=\"abstract\" href=\"UTD.htm?0/55/887/abstract/24\">",
"     24",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In a randomized trial that compared radiation therapy alone to radiation therapy with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?9/58/10151?source=see_link\">",
"     cetuximab",
"    </a>",
"    , an EGFR inhibitor, the benefit of the combined therapy was most significant in patients with oropharyngeal cancer, which presumably contained a large number of patients with HPV positive tumors [",
"    <a class=\"abstract\" href=\"UTD.htm?0/55/887/abstract/25\">",
"     25",
"    </a>",
"    ]. Additional evaluation is required to determine whether EGFR inhibitors will be useful in patients with HPV positive oropharyngeal cancer.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Sodium-dependent vitamin C transporter SLC23A2",
"    </span>",
"    &nbsp;&mdash;&nbsp;A polymorphism in the sodium-dependent vitamin C transporter SLC23A2 has been identified that modifies the risk of HPV associated head and neck cancer [",
"    <a class=\"abstract\" href=\"UTD.htm?0/55/887/abstract/26\">",
"     26",
"    </a>",
"    ]. Among patients with a wild-type allele at SLC23A2, the risk of head and neck cancer associated with HPV16 positive serology was 5.0. However, among those with a homozygous variant genotype, the risk of head and neck cancer associated with HPV16 was attenuated. Furthermore, an increased risk of head and neck cancer was found for patients with a wild-type SLC23A2 allele, HPV16-positive serology, and high citrus intake, odd ratio (OR) of 7.4 (95% CI 3.6 - 15.1). These results suggest that SLC23A2 genetic variation alters HPV16-associated head and neck cancer while also suggesting a potential role of citrus exposure in this disease.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Human papillomavirus (HPV) infection is a sexually transmitted virus that is associated with condyloma acuminatum, squamous intraepithelial lesions, and malignancy, including anogenital malignancies (cervical, vaginal, vulval, penile, and anal carcinoma), and head and neck squamous cell carcinoma.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      HPV associated head and neck cancers occur primarily in the tonsils and base of tongue. HPV associated malignancies now account for more than one-half of cancers of the oropharynx and the United States and Western Europe. High-risk HPV infection may also be causative in some cases of head and neck cancer at other sites, including the larynx. (See",
"      <a class=\"local\" href=\"#H13763970\">",
"       'Epidemiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      HPV associated head and neck cancers affect younger patients without a history of excessive exposure to alcohol and tobacco. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Clinicopathologic features'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Two viral oncogenes (E6 and E7), which are expressed as a result of HPV16 infection, are mainly responsible for malignant transformation and ultimately, an HPV associated head and neck cancer with a molecular signature distinct from HPV negative head and neck cancers. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Biology of HPV'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      HPV associated oropharyngeal cancers tend to present with regional lymph node metastases relatively early in the natural history of the disease. Despite this, these cases are associated with a better prognosis and response to therapy than HPV negative tumors due to other risk factors. Tumor testing for HPV status may be useful in patients with oropharyngeal cancer as a prognostic marker; however, there is insufficient evidence to alter therapy based upon HPV status. (See",
"      <a class=\"local\" href=\"#H13764421\">",
"       'Prognosis'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H13764375\">",
"       'Therapeutic implications'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/55/887/abstract/1\">",
"      Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005; 55:74.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/55/887/abstract/2\">",
"      Gillison ML, D'Souza G, Westra W, et al. Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers. J Natl Cancer Inst 2008; 100:407.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/55/887/abstract/3\">",
"      Sturgis EM, Ang KK. The epidemic of HPV-associated oropharyngeal cancer is here: is it time to change our treatment paradigms? J Natl Compr Canc Netw 2011; 9:665.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/55/887/abstract/4\">",
"      Chaturvedi AK, Engels EA, Pfeiffer RM, et al. Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol 2011; 29:4294.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/55/887/abstract/5\">",
"      Kreimer AR, Clifford GM, Boyle P, Franceschi S. Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol Biomarkers Prev 2005; 14:467.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/55/887/abstract/6\">",
"      Hobbs CG, Sterne JA, Bailey M, et al. Human papillomavirus and head and neck cancer: a systematic review and meta-analysis. Clin Otolaryngol 2006; 31:259.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/55/887/abstract/7\">",
"      Mehanna H, Beech T, Nicholson T, et al. Prevalence of human papillomavirus in oropharyngeal and nonoropharyngeal head and neck cancer-systematic review and meta-analysis of trends by time and region. Head Neck 2013; 35:747.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/55/887/abstract/8\">",
"      Li X, Gao L, Li H, et al. Human papillomavirus infection and laryngeal cancer risk: a systematic review and meta-analysis. J Infect Dis 2013; 207:479.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/55/887/abstract/9\">",
"      Gillison ML, Broutian T, Pickard RK, et al. Prevalence of oral HPV infection in the United States, 2009-2010. JAMA 2012; 307:693.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/55/887/abstract/10\">",
"      Pannone G, Rodolico V, Santoro A, et al. Evaluation of a combined triple method to detect causative HPV in oral and oropharyngeal squamous cell carcinomas: p16 Immunohistochemistry, Consensus PCR HPV-DNA, and In Situ Hybridization. Infect Agent Cancer 2012; 7:4.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/55/887/abstract/11\">",
"      Kraft S, Faquin WC, Krane JF. HPV-associated neuroendocrine carcinoma of the oropharynx: a rare new entity with potentially aggressive clinical behavior. Am J Surg Pathol 2012; 36:321.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/55/887/abstract/12\">",
"      N&auml;sman A, Attner P, Hammarstedt L, et al. Incidence of human papillomavirus (HPV) positive tonsillar carcinoma in Stockholm, Sweden: an epidemic of viral-induced carcinoma? Int J Cancer 2009; 125:362.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/55/887/abstract/13\">",
"      Ang KK, Harris J, Wheeler R, et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med 2010; 363:24.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/55/887/abstract/14\">",
"      Huang SH, Perez-Ordonez B, Liu FF, et al. Atypical clinical behavior of p16-confirmed HPV-related oropharyngeal squamous cell carcinoma treated with radical radiotherapy. Int J Radiat Oncol Biol Phys 2012; 82:276.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/55/887/abstract/15\">",
"      Stephen JK, Chen KM, Shah V, et al. Human papillomavirus outcomes in an access-to-care laryngeal cancer cohort. Otolaryngol Head Neck Surg 2012; 146:730.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/55/887/abstract/16\">",
"      Rischin D, Young RJ, Fisher R, et al. Prognostic significance of p16INK4A and human papillomavirus in patients with oropharyngeal cancer treated on TROG 02.02 phase III trial. J Clin Oncol 2010; 28:4142.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/55/887/abstract/17\">",
"      Lorch JH, Goloubeva O, Haddad RI, et al. Induction chemotherapy with cisplatin and fluorouracil alone or in combination with docetaxel in locally advanced squamous-cell cancer of the head and neck: long-term results of the TAX 324 randomised phase 3 trial. Lancet Oncol 2011; 12:153.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/55/887/abstract/18\">",
"      Posner MR, Lorch JH, Goloubeva O, et al. Survival and human papillomavirus in oropharynx cancer in TAX 324: a subset analysis from an international phase III trial. Ann Oncol 2011; 22:1071.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/55/887/abstract/19\">",
"      Gillison ML, Zhang Q, Jordan R, et al. Tobacco smoking and increased risk of death and progression for patients with p16-positive and p16-negative oropharyngeal cancer. J Clin Oncol 2012; 30:2102.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/55/887/abstract/20\">",
"      Shi W, Kato H, Perez-Ordonez B, et al. Comparative prognostic value of HPV16 E6 mRNA compared with in situ hybridization for human oropharyngeal squamous carcinoma. J Clin Oncol 2009; 27:6213.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/55/887/abstract/21\">",
"      Rischin D, Young R, Fisher R. Prognostic significance of HPV and p16 status in patients with oropharyngeal cancer treated on a large international phase III. J Clin Oncol 2009; 27:15s.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/55/887/abstract/22\">",
"      Weinberger PM, Yu Z, Haffty BG, et al. Molecular classification identifies a subset of human papillomavirus--associated oropharyngeal cancers with favorable prognosis. J Clin Oncol 2006; 24:736.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/55/887/abstract/23\">",
"      Kumar B, Cordell KG, Lee JS, et al. EGFR, p16, HPV Titer, Bcl-xL and p53, sex, and smoking as indicators of response to therapy and survival in oropharyngeal cancer. J Clin Oncol 2008; 26:3128.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/55/887/abstract/24\">",
"      Reimers N, Kasper HU, Weissenborn SJ, et al. Combined analysis of HPV-DNA, p16 and EGFR expression to predict prognosis in oropharyngeal cancer. Int J Cancer 2007; 120:1731.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/55/887/abstract/25\">",
"      Bonner JA, Harari PM, Giralt J, et al. Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med 2006; 354:567.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/55/887/abstract/26\">",
"      Chen AA, Marsit CJ, Christensen BC, et al. Genetic variation in the vitamin C transporter, SLC23A2, modifies the risk of HPV16-associated head and neck cancer. Carcinogenesis 2009; 30:977.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 3378 Version 17.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-203.80.222.8-EE4A41C0CF-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f0_55_887=[""].join("\n");
var outline_f0_55_887=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H16\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13763970\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1587553040\">",
"      HPV associated cancers",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1587553047\">",
"      Prevalence of oral HPV infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      BIOLOGY OF HPV",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      CLINICOPATHOLOGIC FEATURES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13764421\">",
"      PROGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13764375\">",
"      THERAPEUTIC IMPLICATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      BIOMARKER ANALYSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      p16 protein",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Epidermal growth factor receptor",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Sodium-dependent vitamin C transporter SLC23A2",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ONC/3378\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ONC/3378|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?35/55/36733\" title=\"table 1\">",
"      TNM stage oropharynx",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/6/20583?source=related_link\">",
"      Epidemiology and risk factors for head and neck cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/31/3578?source=related_link\">",
"      Extrapulmonary small cell cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/0/34825?source=related_link\">",
"      Head and neck squamous cell carcinogenesis: Molecular and genetic alterations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/1/22554?source=related_link\">",
"      Management and prevention of complications of head and neck cancer during initial treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/42/30378?source=related_link\">",
"      Management of late complications of head and neck cancer and its treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/4/12362?source=related_link\">",
"      Pathology of head and neck neoplasms",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/58/15270?source=related_link\">",
"      Second primary malignancies in patients with head and neck cancers",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/6/3174?source=related_link\">",
"      Treatment of early (stage I and II) head and neck cancer: The oropharynx",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/55/15224?source=related_link\">",
"      Treatment of locoregionally advanced (stage III and IV) head and neck cancer: The oropharynx",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/53/26455?source=related_link\">",
"      Virology of human papillomavirus infections and the link to cancer",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f0_55_888="Physiology of amniotic fluid volume regulation";
var content_f0_55_888=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Physiology of amniotic fluid volume regulation",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?0/55/888/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?0/55/888/contributors\">",
"     Michael G Ross, MD, MPH",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?0/55/888/contributors\">",
"     Marie H Beall, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?0/55/888/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?0/55/888/contributors\">",
"     Charles J Lockwood, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?0/55/888/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?0/55/888/contributors\">",
"     Vanessa A Barss, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?0/55/888/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Aug 23, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Amniotic fluid (AF) is the liquid that surrounds the fetus after the first few weeks of gestation. During much of pregnancy, AF is derived almost entirely from the fetus and has a number of functions that are essential for normal growth and development [",
"    <a class=\"abstract\" href=\"UTD.htm?0/55/888/abstract/1\">",
"     1",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      It helps to protect the fetus from trauma to the maternal abdomen",
"     </li>",
"     <li>",
"      It cushions the umbilical cord from compression between the fetus and uterus",
"     </li>",
"     <li>",
"      It has antibacterial properties that provide some protection from infection",
"     </li>",
"     <li>",
"      It serves as a reservoir of fluid and nutrients for the fetus",
"     </li>",
"     <li>",
"      It provides the necessary fluid, space, and growth factors to permit normal development of the fetal lungs and musculoskeletal and gastrointestinal systems.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Aberrations in amniotic fluid volume (AFV), both low (oligohydramnios) and high (polyhydramnios), are associated with a multitude of pregnancy-related problems. As an example, one study examined the pregnancy outcome of 147 women with a sonographic diagnosis of oligohydramnios (AF index &lt;5 cm) [",
"    <a class=\"abstract\" href=\"UTD.htm?0/55/888/abstract/2\">",
"     2",
"    </a>",
"    ]. Compared to women with AF index &gt;5 cm, these pregnancies had an increased incidence of labor induction (42 versus 18 percent), stillbirth (1.4 versus 0.3 percent), nonreassuring fetal heart rate (48 versus 39 percent), admission to the neonatal intensive care nursery (7 versus 2 percent), meconium aspiration syndrome (1 versus 0.1 percent), and neonatal death (5 versus 0.3 percent). Another report assessed the adverse effects of persistent polyhydramnios in 65 women [",
"    <a class=\"abstract\" href=\"UTD.htm?0/55/888/abstract/3\">",
"     3",
"    </a>",
"    ]. The women had increased rates of both maternal problems (eg, diabetes, pregnancy-induced hypertension) and obstetrical complications (eg, preterm delivery, abnormal fetal presentation, fetal anomalies).",
"   </p>",
"   <p>",
"    A solid understanding of the basic physiological mechanisms responsible for both AFV and AF composition are required to devise effective management strategies for pregnancies complicated by disorders of AFV. Current knowledge in these areas is limited, but progress is being made.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     SOURCES OF AMNIOTIC FLUID",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are several sources for the production of AF. The relative contribution from each source changes across gestation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Early gestation",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are two fluid sacs that surround the embryo during early pregnancy: the amniotic sac containing AF and the exocoelomic cavity containing coelomic fluid (ie, extraembryonic coelomic fluid). These sacs contain large amounts of liquid relative to the size of the",
"    <span class=\"nowrap\">",
"     embryo/fetus.",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h3\">",
"     Coelomic fluid",
"    </span>",
"    &nbsp;&mdash;&nbsp;Coelomic",
"    fluid is present between the developing chorionic and amniotic membranes beginning at about the 7th week of gestation, reaching a maximal volume around the 10th week, and subsequently decreasing in amount until it completely disappears at 12 to 14 weeks of gestation with subsequent fusion of the amniotic and chorionic membranes. The source and mechanisms that regulate the volume and composition of coelomic fluid have not been investigated directly, although the quantity and composition of this fluid have been described extensively, particularly in regard to potential biochemical markers for fetal development [",
"    <a class=\"abstract\" href=\"UTD.htm?0/55/888/abstract/4-6\">",
"     4-6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The composition of coelomic fluid is similar to maternal plasma and different from AF, suggesting that maternal plasma may be its source. However, a pathway for movement of fluid from maternal plasma to the exocoelomic cavity has not been defined. Endometrial gland secretions may be one source.",
"   </p>",
"   <p>",
"    The cause of the disappearance of coelomic fluid is unknown. It is likely that solutes and fluid from the exocoelomic cavity cross the amniotic membrane into the AF and that coelomic fluid is an early source of AF.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h3\">",
"     Amniotic fluid",
"    </span>",
"    &nbsp;&mdash;&nbsp;The volume of AF increases prior to the transition from embryo to fetus (ie, 10 weeks of gestation). Early pregnancy AF is likely derived from three sources:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      The fetal surface of the placenta",
"     </li>",
"     <li>",
"      Transport from the maternal compartment across the amnion (transmembranous)",
"     </li>",
"     <li>",
"      Secretions from the surface of the body of the embryo.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The relative contributions of these potential sources are unknown. However, the important late gestational sources of AF (fetal urine and lung liquid) do not contribute to the AFV in early gestation. Both coelomic and amniotic fluids are present in anembryonic pregnancies, indicating that the fetus may not be the primary fluid source in early pregnancy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Mid gestation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Fetal urine begins to enter the amniotic sac and the fetus begins to swallow AF in conjunction with the transition from embryo to fetus, although the daily volume flows are quite small at mid gestation [",
"    <a class=\"abstract\" href=\"UTD.htm?0/55/888/abstract/7,8\">",
"     7,8",
"    </a>",
"    ]. The fetal lungs also begin to secrete liquid into the AF at this time.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Late gestation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Abundant human and animal data are available regarding the source and composition of AF during the latter half of gestation. The developing human fetus becomes sufficiently large near term to allow noninvasive methods (eg, ultrasound) to estimate volumes and flows; in addition, direct measurements in chronically catheterized ovine fetuses can be conducted at this time. There appear to be two major sources for both AF production and clearance near term:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Production &mdash; fetal urine and fetal lung liquid",
"     </li>",
"     <li>",
"      Clearance &mdash; fetal swallowing and intramembranous pathway.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The intramembranous pathway refers to water and solute exchange that occurs directly between AF and fetal blood [",
"    <a class=\"abstract\" href=\"UTD.htm?0/55/888/abstract/1,9,10\">",
"     1,9,10",
"    </a>",
"    ]. This occurs primarily across microscopic fetal vessels present on the fetal surface of the placenta in primates and over the whole membrane surface in species with vascularized membranes. Smaller contributions may occur across the umbilical cord and fetal skin, however, transcutaneous flow ceases with skin keratinization at 22 to 24 weeks of gestation. Aquaporins (cell membrane water channel proteins) in the chorioamniotic membrane and placenta may play a role in intramembranous fluid resorption [",
"    <a class=\"abstract\" href=\"UTD.htm?0/55/888/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The minor sources of AF production and clearance include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Production &mdash; secretions from the fetal oral-nasal cavities",
"     </li>",
"     <li>",
"      Clearance &mdash; transmembranous pathway.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The transmembranous pathway refers to water and solute exchange between AF and maternal blood across the decidua and myometrium. In contrast to intramembranous flow, which occurs from one fetal compartment to another, transmembranous flow takes place between maternal and fetal compartments. Transmembranous water and solute fluxes are immeasurably small, although these exchanges were once considered major contributors to AFV and composition [",
"    <a class=\"abstract\" href=\"UTD.htm?0/55/888/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Both the transmembranous and intramembranous pathways permit flow of water and solutes in opposite directions (ie, osmotic flow of water and diffusion of solutes), while the other pathways only allow flow of water and solutes in the same direction (ie, bulk flow) [",
"    <a class=\"abstract\" href=\"UTD.htm?0/55/888/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Aside from transmembranous flow, all AFV ultimately derives from water flow across the placenta from mother to fetus. Alterations in maternal hydration can result in changes in AFV, presumably due to changes in transplacental water flow [",
"    <a class=\"abstract\" href=\"UTD.htm?0/55/888/abstract/12,13\">",
"     12,13",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Daily fetal urine excretion and fetal swallowing are the best-described processes for AF production and clearance. However, there remain major differences in the magnitude of current estimates of human fetal urine production [",
"    <a class=\"abstract\" href=\"UTD.htm?0/55/888/abstract/14-16\">",
"     14-16",
"    </a>",
"    ]. We feel the best estimates of daily amniotic volume flows in the near term fetus are [",
"    <a class=\"abstract\" href=\"UTD.htm?0/55/888/abstract/17\">",
"     17",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Fetal urine production &mdash; 800 to 1200",
"      <span class=\"nowrap\">",
"       mL/day",
"      </span>",
"     </li>",
"     <li>",
"      Fetal lung liquid secretion &mdash; 170",
"      <span class=\"nowrap\">",
"       mL/day",
"      </span>",
"     </li>",
"     <li>",
"      Fetal swallowing &mdash; 500 to 1000",
"      <span class=\"nowrap\">",
"       mL/day",
"      </span>",
"     </li>",
"     <li>",
"      Intramembranous flow &mdash;200 to 400",
"      <span class=\"nowrap\">",
"       mL/day",
"      </span>",
"     </li>",
"     <li>",
"      Oral-nasal secretions &mdash; 25",
"      <span class=\"nowrap\">",
"       mL/day",
"      </span>",
"     </li>",
"     <li>",
"      Transmembranous flow &mdash;10",
"      <span class=\"nowrap\">",
"       mL/day.",
"      </span>",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    These values are experimentally derived, in many cases using animal models.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Fetal urination",
"    </span>",
"    &nbsp;&mdash;&nbsp;The daily volume of fetal urine excreted is approximately 30 percent of fetal body weight [",
"    <a class=\"abstract\" href=\"UTD.htm?0/55/888/abstract/1\">",
"     1",
"    </a>",
"    ]. Hourly flow rates progressively increase from 2 to 5 mL at 22 weeks of gestation to 30 to 50 mL at 40 weeks [",
"    <a class=\"abstract\" href=\"UTD.htm?0/55/888/abstract/18,19\">",
"     18,19",
"    </a>",
"    ]. The reduction in maternal plasma sodium concentration (about 5",
"    <span class=\"nowrap\">",
"     meq/L)",
"    </span>",
"    during pregnancy may increase the fetal urine output and contribute to AF formation by enhancing osmotic flow of water across the placenta [",
"    <a class=\"abstract\" href=\"UTD.htm?0/55/888/abstract/20\">",
"     20",
"    </a>",
"    ]. Variations in the estimated urine flow may be partially explained by maternal position when the measurement is obtained; maternal rest in the left lateral decubitus position markedly increases fetal urine production [",
"    <a class=\"abstract\" href=\"UTD.htm?0/55/888/abstract/21\">",
"     21",
"    </a>",
"    ]. Another factor affecting flow rate is the time before onset of labor; hourly fetal urine production is reduced in the 14 days prior to delivery [",
"    <a class=\"abstract\" href=\"UTD.htm?0/55/888/abstract/22\">",
"     22",
"    </a>",
"    ]. Although one report using three-dimensional ultrasonography to measure fetal bladder volume reported an hourly urine output of 125 mL at term [",
"    <a class=\"abstract\" href=\"UTD.htm?0/55/888/abstract/23\">",
"     23",
"    </a>",
"    ], this estimate far exceeds the estimated fetal swallowed volume and intramembranous flow rates, and thus needs confirmation.",
"   </p>",
"   <p>",
"    Fetal urinary flow rates decrease with conditions associated with placental insufficiency (eg, preeclampsia, fetal growth restriction) and increase with conditions associated with cardiac failure (eg, fetal anemia, supraventricular tachycardia, twin-twin transfusion syndrome). Fetal urination (and therefore AFV) is also adversely affected by obstructions in the fetal urinary tract.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Fetal lung secretions",
"    </span>",
"    &nbsp;&mdash;&nbsp;The fetal lung secretes 100 times as much fluid as is needed to expand the developing lungs to facilitate their growth. The excess fluid exits the trachea, primarily during episodes of fetal breathing [",
"    <a class=\"abstract\" href=\"UTD.htm?0/55/888/abstract/24\">",
"     24",
"    </a>",
"    ]. Approximately 50 percent of this fluid (170",
"    <span class=\"nowrap\">",
"     mL/day)",
"    </span>",
"    is swallowed and the remainder enters the AF compartment, which is the basis for fetal lung maturity testing [",
"    <a class=\"abstract\" href=\"UTD.htm?0/55/888/abstract/25,26\">",
"     25,26",
"    </a>",
"    ]. Lung fluid secretion is reduced during periods of fetal asphyxia [",
"    <a class=\"abstract\" href=\"UTD.htm?0/55/888/abstract/1\">",
"     1",
"    </a>",
"    ]. In addition, fetal lung fluid production ceases during labor and fluid is absorbed into the pulmonary lymphatics. In contrast, there are no known circumstances under which fetal lung fluid secretion is increased.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Fetal swallowing",
"    </span>",
"    &nbsp;&mdash;&nbsp;Fetal swallowing increases throughout gestation. Although swallowing-type movements can be noted by ultrasound late in the first trimester, these movements do not become well-coordinated until the third trimester [",
"    <a class=\"abstract\" href=\"UTD.htm?0/55/888/abstract/27,28\">",
"     27,28",
"    </a>",
"    ]. Direct and indirect measurements of ovine fetal swallowing suggest that the fetus swallows AF equivalent to 20 to 25 percent of body weight [",
"    <a class=\"abstract\" href=\"UTD.htm?0/55/888/abstract/1\">",
"     1",
"    </a>",
"    ] The volumes swallowed are significantly greater than in adults, relative to body weight [",
"    <a class=\"abstract\" href=\"UTD.htm?0/55/888/abstract/29\">",
"     29",
"    </a>",
"    ]. Low rates of swallowing compared to fetal urination in early and mid pregnancy account for the gradual increase in AFV during this period [",
"    <a class=\"abstract\" href=\"UTD.htm?0/55/888/abstract/29\">",
"     29",
"    </a>",
"    ]. In contrast, increased swallowing near term, and especially postterm, may contribute to the fall in AFV at the end of pregnancy.",
"   </p>",
"   <p>",
"    Fetal swallowing is decreased with a consequent increase in AFV in some fetuses with neurologic abnormalities, such as anencephaly. Fetal swallowing may be also be impaired by obstruction in the fetal esophagus or duodenum.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Intramembranous flow",
"    </span>",
"    &nbsp;&mdash;&nbsp;Intramembranous flow is thought to be largely driven by the large osmotic gradient between fetal plasma and AF. (See",
"    <a class=\"local\" href=\"#H13\">",
"     'Amniotic fluid osmolality, sodium, and chloride'",
"    </a>",
"    below.) The normal intramembranous flow rate has been calculated only in fetal sheep [",
"    <a class=\"abstract\" href=\"UTD.htm?0/55/888/abstract/9,30\">",
"     9,30",
"    </a>",
"    ]. Changes in AF osmolality were measured over time in sheep with tracheoesophageal occlusion and continuous urinary drainage [",
"    <a class=\"abstract\" href=\"UTD.htm?0/55/888/abstract/30\">",
"     30",
"    </a>",
"    ]. This preparation eliminated all major flows into and out of the amniotic cavity, except for the intramembranous path. Half of the normal osmolality gradient between AF and fetal blood disappeared in eight hours, suggesting that 400 mL of water per day was absorbed via this route.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Oral-nasal secretions and transmembranous flow",
"    </span>",
"    &nbsp;&mdash;&nbsp;These pathways account for small volumes of fluid exchange. They are difficult to measure and have not been studied [",
"    <a class=\"abstract\" href=\"UTD.htm?0/55/888/abstract/1,10\">",
"     1,10",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     AMNIOTIC FLUID OSMOLALITY, SODIUM, AND CHLORIDE",
"    </span>",
"    &nbsp;&mdash;&nbsp;The composition of AF reflects a combination of fetal lung liquid and fetal urine, both fluids with properties different from fetal plasma. The composition of AF is distinctively different from that of all other fetal and maternal fluids.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Osmolality",
"      </strong>",
"      &ndash; Fetal and maternal blood osmolalities are equivalent across gestation. Starting in the early fetal period, AF osmolality is slightly lower than that of fetal blood and decreases further as the pregnancy progresses. AF osmolality averages 260",
"      <span class=\"nowrap\">",
"       mOsm/kg",
"      </span>",
"      at term compared to a blood osmolality of 280",
"      <span class=\"nowrap\">",
"       mOsm/kg.",
"      </span>",
"      Fetal urine osmolality is usually 50 to 60 percent of AF osmolality, although the near-term fetus can alter its urine volume and osmolality in response to hormonal signals such as vasopressin [",
"      <a class=\"abstract\" href=\"UTD.htm?0/55/888/abstract/31\">",
"       31",
"      </a>",
"      ]. Lung liquid osmolality is similar to that of fetal plasma.",
"     </li>",
"     <li>",
"      <strong>",
"       Sodium",
"      </strong>",
"      &ndash; The AF sodium concentration is much lower than that of fetal blood. The fetal urinary sodium concentration is low, averaging 20 to 40 percent of AF concentrations. By comparison, fetal lung liquid sodium concentration is only modestly lower than blood sodium concentration and, thus, is significantly higher than that in the AF.",
"     </li>",
"     <li>",
"      <strong>",
"       Chloride",
"      </strong>",
"      &ndash; Lung liquid chloride concentration is almost twice the AF chloride concentration because lung secretion is driven by the active secretion of chloride into the future airways [",
"      <a class=\"abstract\" href=\"UTD.htm?0/55/888/abstract/32\">",
"       32",
"      </a>",
"      ]. Fetal urinary chloride concentration is very low, 10 to 20 percent of the AF chloride concentration.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Minor constituents of AF have been studied in an attempt to find biochemical markers predicting fetal condition",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    pending labor and delivery [",
"    <a class=\"abstract\" href=\"UTD.htm?0/55/888/abstract/33\">",
"     33",
"    </a>",
"    ]. There is little consensus in these areas, except for the prediction of fetal lung maturity (AF surfactant) and open neural tube defects (AF alpha-fetoprotein).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     REGULATION OF AMNIOTIC FLUID VOLUME",
"    </span>",
"    &nbsp;&mdash;&nbsp;The integration of all fluid inflows and outflows determines the ultimate volume of AF. Fetal urination, lung liquid secretion, fetal swallowing, and intramembranous absorption make significant contributions to fluid movements into and out of the AF sac in late gestation.",
"   </p>",
"   <p>",
"    Although many reviews have addressed the topic of AFV regulation, no study has proven if and how this occurs [",
"    <a class=\"abstract\" href=\"UTD.htm?0/55/888/abstract/1,9,10\">",
"     1,9,10",
"    </a>",
"    ]. For AFV self-regulation to occur, there must be a feedback mechanism to detect aberrations in AFV and return volume toward normal. These issues will be addressed by first considering normal AFV turnover and then discussing possible volume regulatory mechanisms.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Mechanisms",
"    </span>",
"    &nbsp;&mdash;&nbsp;The AFV does not change significantly from day to day, but the AF itself is completely replaced. In the third trimester 1000 mL of fluid flows into and out of the amniotic cavity daily so that even small changes in one of the paths of fluid migration could rapidly affect AFV [",
"    <a class=\"abstract\" href=\"UTD.htm?0/55/888/abstract/1\">",
"     1",
"    </a>",
"    ]. Conversely, regulation of AFV must be precise to maintain normal volumes with such high flow rates. If AFV is self-regulated in the latter half of gestation, then this must occur through adjustment of one or more of the four primary AF inflows and outflows (see",
"    <a class=\"local\" href=\"#H7\">",
"     'Late gestation'",
"    </a>",
"    above).",
"   </p>",
"   <p>",
"    Variations in fetal homeostasis affect the volume of fetal urine production, swallowing, and lung liquid secretion. In this respect, the AFV is a passive reflector of the fetal condition. This is illustrated by the fetus with decreased renal blood flow, which leads to decreased urine production and oligohydramnios, or the anomalous fetus that cannot swallow due to gut atresia, resulting in polyhydramnios [",
"    <a class=\"abstract\" href=\"UTD.htm?0/55/888/abstract/34,35\">",
"     34,35",
"    </a>",
"    ]. Maternal disease also affects fetal homeostasis, and, in turn, AFV. Maternal dehydration increases maternal osmolality, favoring transfer of water from the fetus to the mother, which, in turn, promotes transfer of water from the AF to the fetus, presumably via the intramembranous pathway [",
"    <a class=\"abstract\" href=\"UTD.htm?0/55/888/abstract/36\">",
"     36",
"    </a>",
"    ]. Likewise, maternal hyperglycemia can lead to increased fetal urine output and polyhydramnios. These types of alterations in AFV are presumably pathologic, and these mechanisms are not likely to be involved in normal fluid homeostasis.",
"   </p>",
"   <p>",
"    Variations in intramembranous flow may be an important mechanism for AFV homeostasis. The functional importance of the intramembranous absorption pathway was illustrated in a study in which surgical manipulation of fetal sheep resulted in intramembranous flow as the sole means of AF absorption [",
"    <a class=\"abstract\" href=\"UTD.htm?0/55/888/abstract/37\">",
"     37",
"    </a>",
"    ]. AF inflow by urine production was augmented for six days with an intraamniotic infusion of Ringer's solution. During the period of Ringer's infusion, only one of six fetuses developed hydramnios as intramembranous absorption of AF increased by more than 1000",
"    <span class=\"nowrap\">",
"     mL/day.",
"    </span>",
"    The authors concluded that intramembranous absorption of AF increased to maintain normal AFV in response to an excessive inflow of exogenous fluid.",
"   </p>",
"   <p>",
"    The mechanism whereby intramembranous absorption of water and solutes regulates AFV and maintains homeostasis was evaluated in a series of studies on ovine fetuses [",
"    <a class=\"abstract\" href=\"UTD.htm?0/55/888/abstract/26,38-43\">",
"     26,38-43",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In one experiment, ovine fetuses exposed to four days of hypoxia increased urine output while maintaining normal AFV [",
"      <a class=\"abstract\" href=\"UTD.htm?0/55/888/abstract/40\">",
"       40",
"      </a>",
"      ]. Since hypoxia is a known inhibitor of fetal swallowing, the authors speculated that intramembranous absorption of AF must have increased. This hypothesis was confirmed in a subsequent study [",
"      <a class=\"abstract\" href=\"UTD.htm?0/55/888/abstract/41\">",
"       41",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Another study evaluated the effects of esophageal ligation on AFV and urinary flow in fetal sheep [",
"      <a class=\"abstract\" href=\"UTD.htm?0/55/888/abstract/38\">",
"       38",
"      </a>",
"      ]. Despite the absence of fetal swallowing, polyhydramnios did not occur and AFV actually decreased by 60 percent. The authors concluded that intramembranous absorption increased to two to three times normal levels to prevent polyhydramnios. The mechanisms increasing intramembranous absorption remain in doubt. The authors suggested that fetal urine",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      lung secretions may contain factors, such as VEGF, that increase intramembranous permeability. Their subsequent experiments, however, found no effect of lung secretions on the rate of intramembranous absorption [",
"      <a class=\"abstract\" href=\"UTD.htm?0/55/888/abstract/26\">",
"       26",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      A subsequent investigation comparing hypoxic to nonhypoxic ovine fetuses showed that hypoxia induced a two- to four-fold increase in VEGF messenger RNA expression in fetal membranes (amnion, chorion) and placenta that was associated with increased intramembranous absorption [",
"      <a class=\"abstract\" href=\"UTD.htm?0/55/888/abstract/39\">",
"       39",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Intravascular infusion of large volumes of saline into ovine fetuses resulted in large increases in urinary flow and intramembranous absorption, as well as a two- to four-fold increase in VEGF messenger RNA in the amnion, chorion, and placenta [",
"      <a class=\"abstract\" href=\"UTD.htm?0/55/888/abstract/42\">",
"       42",
"      </a>",
"      ]. AFV rose only slightly. These observations suggest that intramembranous absorption and AFV homeostasis may be regulated by alterations in VEGF gene expression.",
"     </li>",
"     <li>",
"      An ovine model showed that intramembranous solute fluxes appeared to be mediated primarily by bulk flow and passive diffusion, not by passive osmosis [",
"      <a class=\"abstract\" href=\"UTD.htm?0/55/888/abstract/43,44\">",
"       43,44",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Other studies suggest that intramembranous absorption, and therefore AFV, may be associated with changes in the expression of aquaporin water channels (AQPs) [",
"    <a class=\"abstract\" href=\"UTD.htm?0/55/888/abstract/45-47\">",
"     45-47",
"    </a>",
"    ] in the placenta and fetal membranes. AQPs are a family of cell membrane water channels found ubiquitously. Thirteen AQPs are currently known; AQP 1, 3, 8, 9 and 11 have been described in the placenta and fetal membranes of humans, sheep, and mice [",
"    <a class=\"abstract\" href=\"UTD.htm?0/55/888/abstract/47-49\">",
"     47-49",
"    </a>",
"    ]. In the kidney, AQPs regulate the volume and concentration of urine, and there is evidence linking AQPs in fetal membranes and placenta to AFV:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In wild-type mice, expression of AQP 1 in the fetal membranes is negatively correlated with AFV [",
"      <a class=\"abstract\" href=\"UTD.htm?0/55/888/abstract/47\">",
"       47",
"      </a>",
"      ], and mice lacking AQP 1 [",
"      <a class=\"abstract\" href=\"UTD.htm?0/55/888/abstract/46\">",
"       46",
"      </a>",
"      ] or 8 [",
"      <a class=\"abstract\" href=\"UTD.htm?0/55/888/abstract/50\">",
"       50",
"      </a>",
"      ] (knockout mice) demonstrate increased AFV supporting the theory that intramembranous flow occurs through, and is regulated by, these channels. Mice with oligohydramnios due to a defect in the prostaglandin F2&alpha; receptor demonstrate reduced membrane AQP 8 [",
"      <a class=\"abstract\" href=\"UTD.htm?0/55/888/abstract/51\">",
"       51",
"      </a>",
"      ], suggesting that AQP expression may be changed as a compensatory response to AFV abnormalities.",
"     </li>",
"     <li>",
"      Human studies have largely involved patients with idiopathic abnormalities in AFV. One report found an increased expression of aquaporin 8 in the placenta and membranes of human fetuses with polyhydramnios [",
"      <a class=\"abstract\" href=\"UTD.htm?0/55/888/abstract/52\">",
"       52",
"      </a>",
"      ]. Similarly, another group found expression of AQP 8 and 9 to be increased in the amnion and decreased in the placenta in patients with idiopathic polyhydramnios [",
"      <a class=\"abstract\" href=\"UTD.htm?0/55/888/abstract/53\">",
"       53",
"      </a>",
"      ]. Fetuses with oligohydramnios demonstrated decreased expression of aquaporins 1 and 3 in the membranes, and increased aquaporin 3 in the placenta [",
"      <a class=\"abstract\" href=\"UTD.htm?0/55/888/abstract/54\">",
"       54",
"      </a>",
"      ]. All of these findings have been interpreted as compensatory responses tending to correct the AFV abnormality.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The evidence indicates the potential for alteration in intramembranous flow when AFV abnormalities are present. The signal for this alteration is unknown, and it is not clear whether the AFV is actively regulated by the fetus.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     NORMAL AMNIOTIC FLUID VOLUME ACROSS GESTATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are surprisingly few studies that have measured AFV across gestation, however, the available data describe a characteristic pattern of AFV change (",
"    <a class=\"graphic graphic_figure graphicRef59704 \" href=\"UTD.htm?35/11/36030\">",
"     figure 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a review of 705 normal pregnancies from 12 different studies between 1962 and 1977, AFV was observed to increase progressively from eight weeks of gestation, peak at 34 weeks (at over 800 mL), and decline thereafter [",
"      <a class=\"abstract\" href=\"UTD.htm?0/55/888/abstract/55\">",
"       55",
"      </a>",
"      ]. The largest variability in AFV occurred in the third trimester, probably due to greater variation in fetal urination and swallowing later in pregnancy. The use of several different dye-dilution techniques and failure to subtract blood contamination from the collections of AF at the time of hysterotomy were limitations of this analysis.",
"     </li>",
"     <li>",
"      A subsequent report of 144 pregnancies performed all of the fluid evaluations using the same dye-dilution technique and a single laboratory for the calculation of the AFV [",
"      <a class=\"abstract\" href=\"UTD.htm?0/55/888/abstract/56\">",
"       56",
"      </a>",
"      ]. AFV increased well into the third trimester of pregnancy, with the most significant increase after 30 weeks and until term.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Both of these studies found that AFV at 36 weeks of gestation was approximately 800 mL, but they differed as to whether the volume remained stable [",
"    <a class=\"abstract\" href=\"UTD.htm?0/55/888/abstract/56\">",
"     56",
"    </a>",
"    ] or decreased [",
"    <a class=\"abstract\" href=\"UTD.htm?0/55/888/abstract/55\">",
"     55",
"    </a>",
"    ] at term. Potential selection bias, methodologic differences, and limited numbers of patients studied beyond 36 weeks of gestation prevent a firm conclusion regarding the normal change in AFV between 36 and 40 weeks. Nevertheless, beyond 40 weeks it is likely that mean AFV decreases, with a marked reduction in postterm patients.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Amniotic fluid (AF) is crucial to normal fetal growth and development. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In the second half of pregnancy, AF is produced by the fetus as urine and lung liquid, and resorbed by fetal swallowing. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Late gestation'",
"      </a>",
"      above.) An additional pathway for AF resorption is the intramembranous pathway: across the amnion into fetal vessels on the surface of the placenta. The rate of fluid resorption through the intramembranous pathway changes to maintain normal amniotic fluid volume (AVF) in experimental models; mechanisms for this change are speculative. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Intramembranous flow'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      AF volume increases in human gestation until 34 to 36 weeks of gestation. Subsequently, until term, fluid volumes do not increase and may decrease. (See",
"      <a class=\"local\" href=\"#H16\">",
"       'Normal amniotic fluid volume across gestation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Variations in fetal homeostasis, caused by a variety of fetal and maternal conditions, affect the volume of AF by alterations in fetal urine production, swallowing, and (possibly) lung liquid secretion. Thus, AFV is a passive reflector of the fetal condition. (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Regulation of amniotic fluid volume'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/55/888/abstract/1\">",
"      Brace RA. Physiology of amniotic fluid volume regulation. Clin Obstet Gynecol 1997; 40:280.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/55/888/abstract/2\">",
"      Casey BM, McIntire DD, Bloom SL, et al. Pregnancy outcomes after antepartum diagnosis of oligohydramnios at or beyond 34 weeks' gestation. Am J Obstet Gynecol 2000; 182:909.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/55/888/abstract/3\">",
"      Golan A, Wolman I, Sagi J, et al. Persistence of polyhydramnios during pregnancy--its significance and correlation with maternal and fetal complications. Gynecol Obstet Invest 1994; 37:18.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/55/888/abstract/4\">",
"      Gulbis B, Jauniaux E, Cotton F, Stordeur P. Protein and enzyme patterns in the fluid cavities of the first trimester gestational sac: relevance to the absorptive role of secondary yolk sac. Mol Hum Reprod 1998; 4:857.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/55/888/abstract/5\">",
"      Campbell J, Wathen N, Perry G, et al. The coelomic cavity: an important site of materno-fetal nutrient exchange in the first trimester of pregnancy. Br J Obstet Gynaecol 1993; 100:765.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/55/888/abstract/6\">",
"      Campbell J, Wathen N, Macintosh M, et al. Biochemical composition of amniotic fluid and extraembryonic coelomic fluid in the first trimester of pregnancy. Br J Obstet Gynaecol 1992; 99:563.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/55/888/abstract/7\">",
"      Abramovich DR. Fetal factors influencing the volume and composition of liquor amnii. J Obstet Gynaecol Br Commonw 1970; 77:865.",
"     </a>",
"    </li>",
"    <li>",
"     Abramovich, DR. The volume of amniotic fluid and its regulating factors. In: Amniotic Fluid &mdash; Research and Clinical Applications, 2nd ed, Fairweather, DV, Eskes TK (Eds), Excerpta Medica 1978. p.31.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/55/888/abstract/9\">",
"      Gilbert WM, Brace RA. The missing link in amniotic fluid volume regulation: intramembranous absorption. Obstet Gynecol 1989; 74:748.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/55/888/abstract/10\">",
"      Brace RA. Progress toward understanding the regulation of amniotic fluid volume: water and solute fluxes in and through the fetal membranes. Placenta 1995; 16:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/55/888/abstract/11\">",
"      Wang S, Kallichanda N, Song W, et al. Expression of aquaporin-8 in human placenta and chorioamniotic membranes: evidence of molecular mechanism for intramembranous amniotic fluid resorption. Am J Obstet Gynecol 2001; 185:1226.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/55/888/abstract/12\">",
"      Hanson RS, Powrie RO, Larson L. Diabetes insipidus in pregnancy: a treatable cause of oligohydramnios. Obstet Gynecol 1997; 89:816.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/55/888/abstract/13\">",
"      Ross MG, Nijland MJ, Kullama LK. 1-Deamino-[8-D-arginine] vasopressin-induced maternal plasma hypoosmolality increases ovine amniotic fluid volume. Am J Obstet Gynecol 1996; 174:1118.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/55/888/abstract/14\">",
"      Wladimiroff JW, Campbell S. Fetal urine-production rates in normal and complicated pregnancy. Lancet 1974; 1:151.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/55/888/abstract/15\">",
"      Rabinowitz R, Peters MT, Vyas S, et al. Measurement of fetal urine production in normal pregnancy by real-time ultrasonography. Am J Obstet Gynecol 1989; 161:1264.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/55/888/abstract/16\">",
"      Hedriana HL, Moore TR. Accuracy limits of ultrasonographic estimation of human fetal urinary flow rate. Am J Obstet Gynecol 1994; 171:989.",
"     </a>",
"    </li>",
"    <li>",
"     Brace, RA, Ross, MG. Amniotic fluid volume regulation. In: Fetus and Neonate &mdash; Volume 4: Body fluids and kidney function, Brace, RA, Hanson, MA, Rodeck CH (Eds), Cambridge University Press 1998. p.88.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/55/888/abstract/18\">",
"      Hedriana HL. Ultrasound measurement of fetal urine flow. Clin Obstet Gynecol 1997; 40:337.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/55/888/abstract/19\">",
"      Lee SM, Park SK, Shim SS, et al. Measurement of fetal urine production by three-dimensional ultrasonography in normal pregnancy. Ultrasound Obstet Gynecol 2007; 30:281.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/55/888/abstract/20\">",
"      Roberts TJ, Nijland MJ, Curran M, Ross MG. Maternal 1-deamino-8-D-arginine-vasopressin-induced sequential decreases in plasma sodium concentration: ovine fetal renal responses. Am J Obstet Gynecol 1999; 180:82.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/55/888/abstract/21\">",
"      &Uuml;lker K, &Ccedil;e&ccedil;en K, Temur ��, et al. Effects of the maternal position and rest on the fetal urine production rate: a prospective study conducted by 3-dimensional sonography using the rotational technique (virtual organ computer-aided analysis). J Ultrasound Med 2011; 30:481.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/55/888/abstract/22\">",
"      Stigter RH, Mulder EJ, Bruinse HW, Visser GH. Fetal urine production in late pregnancy. ISRN Obstet Gynecol 2011; 2011:345431.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/55/888/abstract/23\">",
"      Touboul C, Boulvain M, Picone O, et al. Normal fetal urine production rate estimated with 3-dimensional ultrasonography using the rotational technique (virtual organ computer-aided analysis). Am J Obstet Gynecol 2008; 199:57.e1.",
"     </a>",
"    </li>",
"    <li>",
"     Harding, R. Development of the respiratory system. In: Textbook of Fetal Physiology, Thorburn, GD, Harding, R (Eds), Oxford Medical Publications, 1994. p.140.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/55/888/abstract/25\">",
"      Brace RA, Wlodek ME, Cock ML, Harding R. Swallowing of lung liquid and amniotic fluid by the ovine fetus under normoxic and hypoxic conditions. Am J Obstet Gynecol 1994; 171:764.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/55/888/abstract/26\">",
"      Jellyman JK, Cheung CY, Brace RA. Amniotic fluid volume responses to esophageal ligation in fetal sheep: contribution of lung liquid. Am J Obstet Gynecol 2009; 200:313.e1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/55/888/abstract/27\">",
"      Grassi R, Farina R, Floriani I, et al. Assessment of fetal swallowing with gray-scale and color Doppler sonography. AJR Am J Roentgenol 2005; 185:1322.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/55/888/abstract/28\">",
"      Miller JL, Sonies BC, Macedonia C. Emergence of oropharyngeal, laryngeal and swallowing activity in the developing fetal upper aerodigestive tract: an ultrasound evaluation. Early Hum Dev 2003; 71:61.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/55/888/abstract/29\">",
"      Ross MG, Nijland MJ. Fetal swallowing: relation to amniotic fluid regulation. Clin Obstet Gynecol 1997; 40:352.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/55/888/abstract/30\">",
"      Jang PR, Brace RA. Amniotic fluid composition changes during urine drainage and tracheoesophageal occlusion in fetal sheep. Am J Obstet Gynecol 1992; 167:1732.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/55/888/abstract/31\">",
"      Kullama LK, Nijland MJ, Ervin MG, Ross MG. Intraamniotic deamino(D-Arg8)-vasopressin: prolonged effects on ovine fetal urine flow and swallowing. Am J Obstet Gynecol 1996; 174:78.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/55/888/abstract/32\">",
"      Wilson SM, Olver RE, Walters DV. Developmental regulation of lumenal lung fluid and electrolyte transport. Respir Physiol Neurobiol 2007; 159:247.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/55/888/abstract/33\">",
"      Bock JL. Metabolic profiling of amniotic fluid by proton nuclear magnetic resonance spectroscopy: correlation with fetal maturation and other clinical variables. Clin Chem 1994; 40:56.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/55/888/abstract/34\">",
"      Yoshimura S, Masuzaki H, Gotoh H, Ishimaru T. Fetal redistribution of blood flow and amniotic fluid volume in growth-retarded fetuses. Early Hum Dev 1997; 47:297.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/55/888/abstract/35\">",
"      Kimble RM, Harding JE, Kolbe A. Does gut atresia cause polyhydramnios? Pediatr Surg Int 1998; 13:115.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/55/888/abstract/36\">",
"      Moore TR. Amniotic fluid dynamics reflect fetal and maternal health and disease. Obstet Gynecol 2010; 116:759.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/55/888/abstract/37\">",
"      Faber JJ, Anderson DF. Regulatory response of intramembranous absorption of amniotic fluid to infusion of exogenous fluid in sheep. Am J Physiol 1999; 277:R236.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/55/888/abstract/38\">",
"      Matsumoto LC, Cheung CY, Brace RA. Effect of esophageal ligation on amniotic fluid volume and urinary flow rate in fetal sheep. Am J Obstet Gynecol 2000; 182:699.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/55/888/abstract/39\">",
"      Matsumoto LC, Bogic L, Brace RA, Cheung CY. Prolonged hypoxia upregulates vascular endothelial growth factor messenger RNA expression in ovine fetal membranes and placenta. Am J Obstet Gynecol 2002; 186:303.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/55/888/abstract/40\">",
"      Matsumoto LC, Cheung CY, Brace RA. Increased urinary flow without development of polyhydramnios in response to prolonged hypoxia in the ovine fetus. Am J Obstet Gynecol 2001; 184:1008.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/55/888/abstract/41\">",
"      Thurlow RW, Brace RA. Swallowing, urine flow, and amniotic fluid volume responses to prolonged hypoxia in the ovine fetus. Am J Obstet Gynecol 2003; 189:601.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/55/888/abstract/42\">",
"      Daneshmand SS, Cheung CY, Brace RA. Regulation of amniotic fluid volume by intramembranous absorption in sheep: role of passive permeability and vascular endothelial growth factor. Am J Obstet Gynecol 2003; 188:786.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/55/888/abstract/43\">",
"      Smith RP, Miller SL, Igosheva N, et al. Cardiovascular and endocrine responses to cutaneous electrical stimulation after fentanyl in the ovine fetus. Am J Obstet Gynecol 2004; 190:836.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/55/888/abstract/44\">",
"      Brace RA, Vermin ML, Huijssoon E. Regulation of amniotic fluid volume: intramembranous solute and volume fluxes in late gestation fetal sheep. Am J Obstet Gynecol 2004; 191:837.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/55/888/abstract/45\">",
"      Wang S, Chen J, Beall M, et al. Expression of aquaporin 9 in human chorioamniotic membranes and placenta. Am J Obstet Gynecol 2004; 191:2160.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/55/888/abstract/46\">",
"      Mann SE, Ricke EA, Torres EA, Taylor RN. A novel model of polyhydramnios: amniotic fluid volume is increased in aquaporin 1 knockout mice. Am J Obstet Gynecol 2005; 192:2041.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/55/888/abstract/47\">",
"      Beall MH, Wang S, Yang B, et al. Placental and membrane aquaporin water channels: correlation with amniotic fluid volume and composition. Placenta 2007; 28:421.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/55/888/abstract/48\">",
"      Prat C, Blanchon L, Borel V, et al. Ontogeny of aquaporins in human fetal membranes. Biol Reprod 2012; 86:48.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/55/888/abstract/49\">",
"      Liu H, Zheng Z, Wintour EM. Aquaporins and fetal fluid balance. Placenta 2008; 29:840.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/55/888/abstract/50\">",
"      Sha XY, Xiong ZF, Liu HS, et al. Pregnant phenotype in aquaporin 8-deficient mice. Acta Pharmacol Sin 2011; 32:840.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/55/888/abstract/51\">",
"      Shioji M, Fukuda H, Kanzaki T, et al. Reduction of aquaporin-8 on fetal membranes under oligohydramnios in mice lacking prostaglandin F2 alpha receptor. J Obstet Gynaecol Res 2006; 32:373.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/55/888/abstract/52\">",
"      Huang J, Qi HB. [Expression of aquaporin 8 in human fetal membrane and placenta of idiopathic polyhydramnios]. Zhonghua Fu Chan Ke Za Zhi 2009; 44:19.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/55/888/abstract/53\">",
"      Zhu X, Jiang S, Hu Y, et al. The expression of aquaporin 8 and aquaporin 9 in fetal membranes and placenta in term pregnancies complicated by idiopathic polyhydramnios. Early Hum Dev 2010; 86:657.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/55/888/abstract/54\">",
"      Zhu XQ, Jiang SS, Zhu XJ, et al. Expression of aquaporin 1 and aquaporin 3 in fetal membranes and placenta in human term pregnancies with oligohydramnios. Placenta 2009; 30:670.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/55/888/abstract/55\">",
"      Brace RA, Wolf EJ. Normal amniotic fluid volume changes throughout pregnancy. Am J Obstet Gynecol 1989; 161:382.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/55/888/abstract/56\">",
"      Magann EF, Bass JD, Chauhan SP, et al. Amniotic fluid volume in normal singleton pregnancies. Obstet Gynecol 1997; 90:524.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 2283 Version 7.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1003-210.101.131.232-6DA085BC69-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f0_55_888=[""].join("\n");
var outline_f0_55_888=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H17\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      SOURCES OF AMNIOTIC FLUID",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Early gestation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      - Coelomic fluid",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      - Amniotic fluid",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Mid gestation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Late gestation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Fetal urination",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Fetal lung secretions",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Fetal swallowing",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Intramembranous flow",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Oral-nasal secretions and transmembranous flow",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      AMNIOTIC FLUID OSMOLALITY, SODIUM, AND CHLORIDE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      REGULATION OF AMNIOTIC FLUID VOLUME",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Mechanisms",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      NORMAL AMNIOTIC FLUID VOLUME ACROSS GESTATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"OBGYN/2283\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"OBGYN/2283|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?35/11/36030\" title=\"figure 1\">",
"      Normal amniotic fluid volume",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f0_55_889="RA MTP erosions x-ray";
var content_f0_55_889=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RADIOL%2F85831%7ERADIOL%2F85820&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RADIOL%2F85831%7ERADIOL%2F85820&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 596px\">",
"   <div class=\"ttl\">",
"    Plain radiograph of metatarsophalangeal joint space narrowing and erosions in rheumatoid arthritis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 576px; height: 432px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The radiograph of the left foot in the AP projection demonstrates an erosion in the periarticular, marginal \"bare\" area of the joint of the 5th&nbsp;MTP joint and more subtle erosions at the 1st, 2nd, 3rd, and 4th MTPs&nbsp;(white arrows), characteristic of rheumatoid arthritis. Also present is joint space narrowing of the 1st and 2nd MTP joints (orange arrows).",
"    <div class=\"footnotes\">",
"     MTP: metatarsophalangeal",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Richard Waite, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Plain radiograph of normal left foot",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 379px; height: 597px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The normal radiograph&nbsp;of the left foot is from a 53-year-old female. The foot is shown in the AP (A), oblique (B), and lateral projections (C).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f0_55_889=[""].join("\n");
var outline_f0_55_889=null;
var title_f0_55_890="Overview of sudden cardiac arrest and sudden cardiac death";
var content_f0_55_890=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"5\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Overview of sudden cardiac arrest and sudden cardiac death",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?0/55/890/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?0/55/890/contributors\">",
"     David S Siscovick, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?0/55/890/contributors\">",
"     Philip J Podrid, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?0/55/890/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?0/55/890/contributors\">",
"     Brian Olshansky, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?0/55/890/contributors\">",
"     Scott Manaker, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?0/55/890/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?0/55/890/contributors\">",
"     Brian C Downey, MD, FACC",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?0/55/890/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jan 3, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Sudden cardiac arrest (SCA) and sudden cardiac death (SCD) refer to the sudden cessation of cardiac activity with hemodynamic collapse, typically due to sustained ventricular",
"    <span class=\"nowrap\">",
"     tachycardia/ventricular",
"    </span>",
"    fibrillation. These events mostly occur in patients with structural heart disease (that may not have been previously diagnosed), particularly coronary heart disease. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/54/16233?source=see_link\">",
"     \"Pathophysiology and etiology of sudden cardiac arrest\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The event is referred to as SCA (or aborted SCD) if an intervention (eg, defibrillation) or spontaneous reversion restores circulation, and the event is called SCD if the patient dies [",
"    <a class=\"abstract\" href=\"UTD.htm?0/55/890/abstract/1\">",
"     1",
"    </a>",
"    ]. However, the use of SCD to describe both fatal and nonfatal cardiac arrest persists by convention.",
"   </p>",
"   <p>",
"    The specific causes of SCA vary with the population studied and patient age (",
"    <a class=\"graphic graphic_table graphicRef62184 \" href=\"UTD.htm?16/52/17228\">",
"     table 1",
"    </a>",
"    ). SCA most commonly results from hemodynamic collapse due to ventricular fibrillation (VF) in the setting of structural heart disease (",
"    <a class=\"graphic graphic_waveform graphicRef80454 \" href=\"UTD.htm?29/47/30455\">",
"     waveform 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?0/55/890/abstract/2\">",
"     2",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/54/16233?source=see_link\">",
"     \"Pathophysiology and etiology of sudden cardiac arrest\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The outcome following SCA depends upon numerous factors including the underlying cause and the rapidity of resuscitation. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/24/8585?source=see_link\">",
"     \"Supportive data for advanced cardiac life support in adults with sudden cardiac arrest\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/21/30041?source=see_link\">",
"     \"Outcome of sudden cardiac arrest\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Most individuals suffering from SCA become unconscious within seconds to minutes as a result of insufficient cerebral blood flow. There are usually no premonitory symptoms. If symptoms are present, they are nonspecific and include chest discomfort, palpitations, shortness of breath, and weakness.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     DEFINITIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Various criteria have been used to define SCA and SCD in the medical literature [",
"    <a class=\"abstract\" href=\"UTD.htm?0/55/890/abstract/3\">",
"     3",
"    </a>",
"    ]. Difficulties in deriving a specific definition include the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Events are witnessed in only two-thirds of cases, making the diagnosis difficult to establish in many instances.",
"     </li>",
"     <li>",
"      It is not possible to restrict the definition of SCA to documented cases of VF since the cardiac rhythm at clinical presentation is unknown in many cases.",
"     </li>",
"     <li>",
"      The duration of symptoms prior to SCA generally defines the suddenness of death. However, the duration of symptoms is unknown in approximately one-third of cases.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    For these reasons, operational criteria for SCA and SCD have been proposed that do not rely upon the cardiac rhythm at the time of the event. The criteria focus on the out-of-hospital occurrence of a presumed sudden pulseless condition and the",
"    <strong>",
"     absence",
"    </strong>",
"    of evidence of a noncardiac condition (eg, central airway obstruction, intracranial hemorrhage, pulmonary embolism) as the cause of cardiac arrest.",
"   </p>",
"   <p>",
"    The 2006 American College of",
"    <span class=\"nowrap\">",
"     Cardiology/American",
"    </span>",
"    Heart",
"    <span class=\"nowrap\">",
"     Association/Heart",
"    </span>",
"    Rhythm Society",
"    <span class=\"nowrap\">",
"     (ACC/AHA/HRS)",
"    </span>",
"    to establish data standards for electrophysiology included definitions to guide documentation in research and clinical practice.",
"   </p>",
"   <p>",
"    The following definitions of SCA and SCD were presented:",
"   </p>",
"   <p>",
"    \"[Sudden] cardiac arrest is the sudden cessation of cardiac activity so that the victim becomes unresponsive, with no normal breathing and no signs of circulation. If corrective measures are not taken rapidly, this condition progresses to sudden death. Cardiac arrest should be used to signify an event as described above, that is reversed, usually by CPR",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    defibrillation or cardioversion, or cardiac pacing. Sudden cardiac death should not be used to describe events that are not fatal.\"",
"   </p>",
"   <p>",
"    Throughout this topic we will use the terms SCA and SCD as defined in the 2006",
"    <span class=\"nowrap\">",
"     ACC/AHA/HRS",
"    </span>",
"    document. However, many continue to use SCD to describe both fatal and nonfatal cardiac arrest.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Death certificate data suggest that SCD accounts for approximately 15 percent of the total mortality in the United States and other industrialized countries [",
"    <a class=\"abstract\" href=\"UTD.htm?0/55/890/abstract/4\">",
"     4",
"    </a>",
"    ]. However, death certificate data may overestimate the prevalence of SCD [",
"    <a class=\"abstract\" href=\"UTD.htm?0/55/890/abstract/5,6\">",
"     5,6",
"    </a>",
"    ]. In a prospective evaluation of deaths in one county in Oregon, SCD was implicated in 5.6 percent of annual mortality [",
"    <a class=\"abstract\" href=\"UTD.htm?0/55/890/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In absolute terms, the estimated number of sudden cardiac deaths in the United States in 1999 was approximately 450,000 [",
"    <a class=\"abstract\" href=\"UTD.htm?0/55/890/abstract/7\">",
"     7",
"    </a>",
"    ]. Despite advances in the treatment of heart disease, the outcome of patients experiencing SCA remains poor, although the prognosis varies significantly according to the initial rhythm. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/21/30041?source=see_link\">",
"     \"Outcome of sudden cardiac arrest\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The risk of experiencing SCA is increased by a number of factors [",
"    <a class=\"abstract\" href=\"UTD.htm?0/55/890/abstract/4,6,8\">",
"     4,6,8",
"    </a>",
"    ]. The incidence increases dramatically with age and with underlying cardiac disease (",
"    <a class=\"graphic graphic_figure graphicRef59028 \" href=\"UTD.htm?18/4/18509\">",
"     figure 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_figure graphicRef52309 \" href=\"UTD.htm?24/42/25261\">",
"     figure 2",
"    </a>",
"    ). In addition, men are two to three times more likely to experience SCA than women (",
"    <a class=\"graphic graphic_figure graphicRef59028 \" href=\"UTD.htm?18/4/18509\">",
"     figure 1",
"    </a>",
"    ). Among 161,808 post-menopausal women who participated in the Women's Health Initiative and were followed for an average of 10.8 years, the incidence rate of SCD was 2.4 per 10,000",
"    <span class=\"nowrap\">",
"     women/year,",
"    </span>",
"    and nearly one-half of women who experienced SCD did not have prior clinically-recognized coronary heart disease [",
"    <a class=\"abstract\" href=\"UTD.htm?0/55/890/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The magnitude of the influence of underlying cardiac disease on the risk of SCA is illustrated by the following observations:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The risk of SCA is increased six- to ten-fold in the presence of clinically recognized heart disease, and two- to four-fold in the presence of coronary heart disease (CHD) risk factors [",
"      <a class=\"abstract\" href=\"UTD.htm?0/55/890/abstract/6,10\">",
"       6,10",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      SCD is the mechanism of death in over 60 percent of patients with known CHD [",
"      <a class=\"abstract\" href=\"UTD.htm?0/55/890/abstract/4,7,11\">",
"       4,7,11",
"      </a>",
"      ]. In addition, SCA is the",
"      <strong>",
"       initial",
"      </strong>",
"      clinical manifestation of CHD in approximately15 percent [",
"      <a class=\"abstract\" href=\"UTD.htm?0/55/890/abstract/12\">",
"       12",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?43/20/44361?source=see_link&amp;anchor=H23#H23\">",
"       \"Epidemiology of coronary heart disease\", section on 'Sudden cardiac death'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     ETIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;SCA usually occurs in people with some form of underlying structural heart disease, most notably CHD (",
"    <a class=\"graphic graphic_table graphicRef62184 \" href=\"UTD.htm?16/52/17228\">",
"     table 1",
"    </a>",
"    ). The etiologies of SCA are discussed in detail separately, but will be briefly reviewed here. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/54/16233?source=see_link\">",
"     \"Pathophysiology and etiology of sudden cardiac arrest\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Coronary heart disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;As much as 70 percent of SCAs have been attributed to CHD. Among patients with CHD, SCA can occur both during an acute coronary syndrome (ACS) and in the setting of chronic, otherwise stable CHD (often such patients have had prior myocardial damage and scar that serves as a substrate for SCA). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/20/44361?source=see_link\">",
"     \"Epidemiology of coronary heart disease\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/10/30890?source=see_link\">",
"     \"Clinical features and treatment of ventricular arrhythmias during acute myocardial infarction\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/24/20874?source=see_link\">",
"     \"Incidence of and risk stratification for sudden cardiac death after acute myocardial infarction\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The arrhythmic mechanisms and the implications for SCA survivors are different in these two settings. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/21/30041?source=see_link\">",
"     \"Outcome of sudden cardiac arrest\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Other structural heart disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Other forms of structural heart disease, both acquired and hereditary, account for approximately 10 percent of cases of out-of-hospital SCA. Examples of such disorders include the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Heart failure and cardiomyopathy in which SCD is responsible for approximately one-third of deaths. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?20/47/21241?source=see_link\">",
"       \"Ventricular arrhythmias in heart failure and cardiomyopathy\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Left ventricular hypertrophy due to hypertension or other causes. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?1/23/1401?source=see_link\">",
"       \"Left ventricular hypertrophy and arrhythmia\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Myocarditis. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?26/16/26889?source=see_link&amp;anchor=H8#H8\">",
"       \"Clinical manifestations and diagnosis of myocarditis in adults\", section on 'Clinicopathologic classification'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Hypertrophic cardiomyopathy. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?22/3/22586?source=see_link\">",
"       \"Ventricular arrhythmias and sudden cardiac arrest in hypertrophic cardiomyopathy\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Arrhythmogenic right ventricular cardiomyopathy. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?22/62/23528?source=see_link\">",
"       \"Genetics and pathogenesis of arrhythmogenic right ventricular cardiomyopathy\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Congenital coronary artery anomalies. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?13/56/14218?source=see_link\">",
"       \"Congenital and pediatric coronary artery abnormalities\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Mitral valve prolapse. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?6/31/6649?source=see_link\">",
"       \"Natural history of chronic mitral regurgitation in mitral valve prolapse and flail mitral leaflet\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Absence of structural heart disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;In different reports, approximately 10 to 12 percent of cases of SCA among subjects under age 45 occur in the absence of structural heart disease [",
"    <a class=\"abstract\" href=\"UTD.htm?0/55/890/abstract/13,14\">",
"     13,14",
"    </a>",
"    ], while a lower value of about 5 percent has been described when older patients are included [",
"    <a class=\"abstract\" href=\"UTD.htm?0/55/890/abstract/15,16\">",
"     15,16",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/12/15559?source=see_link\">",
"     \"Sudden cardiac arrest in the absence of apparent structural heart disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    This can occur in a variety of settings:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Brugada syndrome. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?27/37/28250?source=see_link\">",
"       \"Brugada syndrome\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Idiopathic VF, also called primary electrical disease. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?15/12/15559?source=see_link&amp;anchor=H11#H11\">",
"       \"Sudden cardiac arrest in the absence of apparent structural heart disease\", section on 'Idiopathic VF'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Congenital or acquired long QT syndrome (",
"      <a class=\"graphic graphic_table graphicRef57431 \" href=\"UTD.htm?2/48/2830\">",
"       table 2",
"      </a>",
"      ). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?2/9/2202?source=see_link\">",
"       \"Clinical features of congenital long QT syndrome\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?22/55/23418?source=see_link\">",
"       \"Acquired long QT syndrome\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Arrhythmogenic right ventricular cardiomyopathy. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?31/22/32106?source=see_link\">",
"       \"Clinical manifestations and diagnosis of arrhythmogenic right ventricular cardiomyopathy\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Familial polymorphic ventricular tachycardia, also called \"catecholaminergic polymorphic VT\". (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?36/48/37641?source=see_link\">",
"       \"Catecholaminergic polymorphic ventricular tachycardia and other polymorphic ventricular tachycardias with a normal QT interval\"",
"      </a>",
"      .).",
"     </li>",
"     <li>",
"      Familial SCD of uncertain cause.",
"     </li>",
"     <li>",
"      Wolff-Parkinson-White syndrome. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?16/61/17370?source=see_link&amp;anchor=H8471569#H8471569\">",
"       \"Epidemiology, clinical manifestations, and diagnosis of the Wolff-Parkinson-White syndrome\", section on 'Ventricular fibrillation and sudden death'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Acute triggers",
"    </span>",
"    &nbsp;&mdash;&nbsp;In addition to the presence of the above underlying disorders, superimposed triggers for SCA appear to play a major role in the pathogenesis of this disorder. These include ischemia, electrolyte disturbances (particularly hypokalemia and hypomagnesemia), the proarrhythmic effect of some antiarrhythmic drugs, autonomic nervous system activation, and psychosocial factors. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/24/4490?source=see_link&amp;anchor=H4#H4\">",
"     \"Evaluation of the survivor of sudden cardiac arrest\", section on 'Transient or reversible causes'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In addition, SCA can result from commotio cordis in which VF is precipitated by direct trauma over precordium. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/12/15559?source=see_link&amp;anchor=H10#H10\">",
"     \"Sudden cardiac arrest in the absence of apparent structural heart disease\", section on 'Commotio cordis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     RISK FACTORS",
"    </span>",
"    &nbsp;&mdash;&nbsp;A number of clinical characteristics and other factors are associated with an increased risk of SCA among persons without prior clinically recognized heart disease [",
"    <a class=\"abstract\" href=\"UTD.htm?0/55/890/abstract/17-22\">",
"     17-22",
"    </a>",
"    ]. Most risk factors for CHD are also risk factors for SCA. These include dyslipidemia, hypertension, cigarette smoking, physical inactivity, obesity, diabetes mellitus, and a family history of premature CHD or myocardial infarction (",
"    <a class=\"graphic graphic_figure graphicRef55353 \" href=\"UTD.htm?24/31/25086\">",
"     figure 3",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?0/55/890/abstract/9,17-19,23,24\">",
"     9,17-19,23,24",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/59/39866?source=see_link\">",
"     \"Overview of the risk equivalents and established risk factors for cardiovascular disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Cigarette smoking",
"    </span>",
"    &nbsp;&mdash;&nbsp;Current cigarette smoking and the number of cigarettes smoked per day among current smokers are strongly related to the risk of SCA in patients with CHD. As an example, among 101,018 women followed for 30 years in the Nurses' Health Study, current smokers had a significantly greater risk of SCD than women who had never smoked (adjusted hazard ratio 2.44, 95% CI 1.80-3.31), and there was an increased risk even among those women who smoked 1 to 14 cigarettes per day (adjusted hazard ratio 1.84, 95% CI 1.16-2.92) [",
"    <a class=\"abstract\" href=\"UTD.htm?0/55/890/abstract/25\">",
"     25",
"    </a>",
"    ]. For women in this study who stopped smoking, the risk of SCD declined over time in a linear fashion; these women had the same risk of SCD as never smokers 20 years after quitting [",
"    <a class=\"abstract\" href=\"UTD.htm?0/55/890/abstract/25\">",
"     25",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Based upon the observations that the risk of SCA is particularly high among current smokers and declines rapidly after stopping smoking, smoking cessation should be viewed as a critical component of efforts to reduce the risk of SCA as well as a multitude of other complications. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/28/1482?source=see_link\">",
"     \"Cardiovascular risk of smoking and benefits of smoking cessation\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/11/34997?source=see_link\">",
"     \"Patterns of tobacco use\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Exercise",
"    </span>",
"    &nbsp;&mdash;&nbsp;The risk of SCA is transiently increased during and up to 30 minutes after strenuous exercise compared to other times [",
"    <a class=\"abstract\" href=\"UTD.htm?0/55/890/abstract/19,26\">",
"     19,26",
"    </a>",
"    ]. However, the actual risk during any one episode of vigorous exercise is very low (1 per 1.51 million episodes of exercise) [",
"    <a class=\"abstract\" href=\"UTD.htm?0/55/890/abstract/26\">",
"     26",
"    </a>",
"    ]. Furthermore, the magnitude of the transient increase in risk during acute exercise is lower among men who are regular exercisers compared with men for whom exercise is unusual [",
"    <a class=\"abstract\" href=\"UTD.htm?0/55/890/abstract/19,26\">",
"     19,26",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/46/28394?source=see_link\">",
"     \"Overview of the benefits and risks of exercise\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The small transient increase in risk during exercise is",
"    <strong>",
"     outweighed",
"    </strong>",
"    by a reduction in the risk of SCA at other times [",
"    <a class=\"abstract\" href=\"UTD.htm?0/55/890/abstract/17,27\">",
"     17,27",
"    </a>",
"    ]. Regular exercise is associated with a lower resting heart rate and increased heart rate variability, characteristics associated with a reduced risk of SCD (",
"    <a class=\"graphic graphic_table graphicRef51658 \" href=\"UTD.htm?38/50/39723\">",
"     table 3",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/28/14793?source=see_link\">",
"     \"Exercise and fitness in the prevention of cardiovascular disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    One exception to the lower overall risk associated with intensive exercise occurs in patients with certain, often unrecognized underlying heart diseases. Examples include hypertrophic cardiomyopathy, anomalous coronary artery of wrong sinus origin, myocarditis, and arrhythmogenic right ventricular cardiomyopathy [",
"    <a class=\"abstract\" href=\"UTD.htm?0/55/890/abstract/28,29\">",
"     28,29",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/36/13898?source=see_link\">",
"     \"Risk of sudden cardiac death in athletes\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Family history of SCA",
"    </span>",
"    &nbsp;&mdash;&nbsp;A family history of SCA, either alone or with myocardial infarction, is associated with a 1.5 to 1.8-fold increased risk of SCA [",
"    <a class=\"abstract\" href=\"UTD.htm?0/55/890/abstract/18,24\">",
"     18,24",
"    </a>",
"    ]. The increase in risk is not explained by traditional risk factors that tend to aggregate in families, such as hypercholesterolemia, hypertension, diabetes mellitus, and obesity.",
"   </p>",
"   <p>",
"    The magnitude of the increase in risk associated with the presence of a family history is modest compared to the two- to five-fold increase in risk associated with other modifiable risk factors such as physical inactivity and current cigarette smoking. Few studies have examined potential gene-environment interactions related to the risk of SCD. Nevertheless, it is likely that interactions of mutations or polymorphisms in specific genes and environmental factors influence this risk.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Serum CRP",
"    </span>",
"    &nbsp;&mdash;&nbsp;Chronic inflammation, as manifested in part by higher serum concentrations of C-reactive protein (CRP), has been implicated as a risk factor for a variety of cardiovascular diseases (including acute coronary syndromes, stroke, and the efficacy of lipid lowering with statins). Elevated serum CRP is also associated with an increased risk of SCA [",
"    <a class=\"abstract\" href=\"UTD.htm?0/55/890/abstract/30\">",
"     30",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/0/27658?source=see_link\">",
"     \"C-reactive protein in cardiovascular disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Excess alcohol intake",
"    </span>",
"    &nbsp;&mdash;&nbsp;Moderate alcohol intake (eg, one to two drinks per day, and avoidance of binge drinking) may decrease the risk of SCD [",
"    <a class=\"abstract\" href=\"UTD.htm?0/55/890/abstract/31\">",
"     31",
"    </a>",
"    ]. In comparison, heavy alcohol consumption (six or more drinks per day) or binge drinking",
"    <strong>",
"     increases",
"    </strong>",
"    the risk for SCD [",
"    <a class=\"abstract\" href=\"UTD.htm?0/55/890/abstract/31,32\">",
"     31,32",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/33/31258?source=see_link\">",
"     \"Cardiovascular benefits and risks of moderate alcohol consumption\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Psychosocial factors",
"    </span>",
"    &nbsp;&mdash;&nbsp;Clinical observations have suggested a possible relation between acutely stressful situations and the risk of SCA. Major disasters, such as earthquakes and war, result in a rapid transient increase in the rate of SCA in populations [",
"    <a class=\"abstract\" href=\"UTD.htm?0/55/890/abstract/20,21\">",
"     20,21",
"    </a>",
"    ]. The level of educational attainment and social support from others may alter the risk associated with stressful life events. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/15/23800?source=see_link\">",
"     \"Psychosocial factors in sudden cardiac arrest\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Caffeine",
"    </span>",
"    &nbsp;&mdash;&nbsp;Excessive caffeine intake has been investigated as a potential risk factor for SCA [",
"    <a class=\"abstract\" href=\"UTD.htm?0/55/890/abstract/33\">",
"     33",
"    </a>",
"    ]. In the limited data available, no significant association between caffeine intake and SCA have been found.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Fatty acids",
"    </span>",
"    &nbsp;&mdash;&nbsp;Elevated plasma nonesterified fatty acid (free fatty acid) concentrations are associated with ventricular arrhythmias and SCD after a myocardial infarction and, after adjustment for confounding factors, in the general population [",
"    <a class=\"abstract\" href=\"UTD.htm?0/55/890/abstract/34\">",
"     34",
"    </a>",
"    ]. In addition, cardiac arrest survivors without prior clinically recognized heart disease may have, when compared to controls, higher concentrations of total trans-fatty acids and of trans isomers of linoleic acid in red blood cell membranes [",
"    <a class=\"abstract\" href=\"UTD.htm?0/55/890/abstract/35\">",
"     35",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/34/2601?source=see_link\">",
"     \"Dietary fat\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In contrast, a higher intake and higher levels of long-chain n-3 polyunsaturated fatty acids (eicosapentaenoic acid and docosahexaenoic acid) in plasma and the red blood cell membrane are associated with a",
"    <strong>",
"     lower",
"    </strong>",
"    risk of SCD [",
"    <a class=\"abstract\" href=\"UTD.htm?0/55/890/abstract/22,36-38\">",
"     22,36-38",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H25\">",
"     'Fish intake and fish oil'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h1\">",
"     MANAGEMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The acute management of cardiac arrest is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/28/35274?source=see_link\">",
"     \"Post-cardiac arrest management in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Management issues for survivors of SCA include the following:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Identification and treatment of acute reversible causes",
"     </li>",
"     <li>",
"      Evaluation for structural heart disease",
"     </li>",
"     <li>",
"      In patients without obvious arrhythmic triggers or cardiac structural abnormalities, an evaluation for primary electrical diseases",
"     </li>",
"     <li>",
"      Neurologic and psychologic assessment",
"     </li>",
"     <li>",
"      In selected patients with a suspected or confirmed heritable syndrome, evaluation of family members",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    These issues are discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/24/4490?source=see_link\">",
"     \"Evaluation of the survivor of sudden cardiac arrest\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h1\">",
"     PRIMARY PREVENTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The optimal approach to the primary prevention of SCA varies among the following categories:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The general population.",
"     </li>",
"     <li>",
"      Patients surviving an acute myocardial infarction. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?20/24/20874?source=see_link\">",
"       \"Incidence of and risk stratification for sudden cardiac death after acute myocardial infarction\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Patients with heart failure and cardiomyopathy. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?20/47/21241?source=see_link\">",
"       \"Ventricular arrhythmias in heart failure and cardiomyopathy\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Patients with one of the congenital disorders associated with an increased risk of SCA (eg, Brugada syndrome, congenital long QT syndrome, WPW).",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     General population",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are two approaches to reduce the risk of SCA in the general population:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Screening and risk stratification to identify individuals who may benefit from specific interventions (eg, stress testing, screening ECGs).",
"     </li>",
"     <li>",
"      Interventions that may be expected to reduce SCA risk in any individual (eg, smoking cessation or other lifestyle modifications). Such interventions generally target the underlying disorders that predispose to SCA.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h3\">",
"     Screening and risk stratification",
"    </span>",
"    &nbsp;&mdash;&nbsp;Among populations already known to be at an elevated risk of SCA (eg, patients with a prior myocardial infarction), further risk stratification with a variety of tests can identify subgroups that benefit from specific therapies, such as an ICD. (See",
"    <a class=\"local\" href=\"#H26\">",
"     'Post myocardial infarction'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    However, in the general population without known cardiovascular disease, there is no evidence that routine screening with any test (eg, 12-lead electrocardiography, exercise stress testing, or Holter monitoring) effectively identifies populations at an increased risk of SCA.",
"   </p>",
"   <p>",
"    With regard to risk stratification of the general population, we suggest the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Screening for risk factors for cardiovascular disease according to standard guidelines. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?32/29/33241?source=see_link\">",
"       \"Screening guidelines for dyslipidemia\"",
"      </a>",
"      .) The USPSTF clinical practice guideline for screening for high blood pressure, as well as other USPSTF guidelines, can be accessed through the website for the Agency for Healthcare Research and Quality at",
"      <a class=\"external\" href=\"file://www.ahrq.gov/clinic/uspstfix.htm\">",
"       www.ahrq.gov/clinic/uspstfix.htm",
"      </a>",
"      .",
"     </li>",
"     <li>",
"      Screening for CHD as appropriate in selected patients, according to standard guidelines. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?25/50/26409?source=see_link\">",
"       \"Screening for coronary heart disease\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Routine additional testing for the purpose of SCA risk stratification is not recommended.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    An issue that merits special consideration is the pre-participation evaluation of athletes. This is a complex issue and there are conflicting opinions regarding the appropriate nature of a screening evaluation. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/37/31318?source=see_link\">",
"     \"Screening to prevent sudden cardiac death in athletes\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h3\">",
"     Risk factor reduction",
"    </span>",
"    &nbsp;&mdash;&nbsp;Many of the traditional risk factors associated with the development of CHD are also associated with SCA. (See",
"    <a class=\"local\" href=\"#H9\">",
"     'Risk factors'",
"    </a>",
"    above and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/28/5576?source=see_link\">",
"     \"Overview of primary prevention of coronary heart disease and stroke\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Thus, management of these risk factors may reduce the incidence of SCA in the general public. Such interventions include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Effective treatment of hypercholesterolemia",
"     </li>",
"     <li>",
"      Effective treatment of hypertension",
"     </li>",
"     <li>",
"      Adoption of a heart-healthy diet",
"     </li>",
"     <li>",
"      Regular exercise",
"     </li>",
"     <li>",
"      Smoking cessation",
"     </li>",
"     <li>",
"      Moderation of alcohol consumption",
"     </li>",
"     <li>",
"      Effective treatment of diabetes",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    These interventions are generally in agreement with guidelines published in 2001 by a task force of the European Society of Cardiology [",
"    <a class=\"abstract\" href=\"UTD.htm?0/55/890/abstract/39\">",
"     39",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    There is no definitive evidence that risk factor reduction in the general population lowers the rate of SCA. However, a number of studies have demonstrated that interventions to treat risk factors can lower total cardiovascular and coronary mortality. Since the majority of CHD mortality is due to SCD, these results suggest that interventions to reduce risk factors will reduce SCA rates as well. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/28/5576?source=see_link\">",
"     \"Overview of primary prevention of coronary heart disease and stroke\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    As an example, a multifactorial, controlled, randomized trial from the Belgian component of the World Health Organization evaluated the effect of efforts aimed at reducing serum cholesterol (via dietary changes), increasing physical activity, and controlling smoking, hypertension, and weight (in those who were overweight) on risk factors and mortality [",
"    <a class=\"abstract\" href=\"UTD.htm?0/55/890/abstract/40\">",
"     40",
"    </a>",
"    ]. Compared to the control group, the intervention group had significant reductions in the incidence of CHD and coronary mortality.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h3\">",
"     Moderate alcohol intake",
"    </span>",
"    &nbsp;&mdash;&nbsp;Excess alcohol intake increases the risk of SCA, while light-to-moderate alcohol consumption (ie, &le;2 drinks per day) reduces the risk of coronary heart disease and cardiovascular mortality [",
"    <a class=\"abstract\" href=\"UTD.htm?0/55/890/abstract/31,32\">",
"     31,32",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H14\">",
"     'Excess alcohol intake'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    It is reasonable to expect that moderate alcohol intake will also reduce SCA. This effect was documented by the Physicians Health Study, which evaluated 21,537 men who were free of known cardiovascular disease [",
"    <a class=\"abstract\" href=\"UTD.htm?0/55/890/abstract/31\">",
"     31",
"    </a>",
"    ]. Compared to men who rarely or never drank, those who had two to four drinks per week or five to six drinks per week had a significantly reduced risk for SCD (relative risks 0.40 and 0.21, respectively); the risk approached unity at &ge;2 drinks per day. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/33/31258?source=see_link\">",
"     \"Cardiovascular benefits and risks of moderate alcohol consumption\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h3\">",
"     Regular exercise",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are no data from long-term exercise intervention trials among apparently healthy persons that focus upon major disease end points. Nevertheless, regular exercise should be encouraged for the primary prevention of CHD and SCA. Although there is a small transient increase in risk during and shortly after strenuous exercise, there is an overall reduction in SCD among exercisers compared with sedentary men [",
"    <a class=\"abstract\" href=\"UTD.htm?0/55/890/abstract/17,19,27,41\">",
"     17,19,27,41",
"    </a>",
"    ]. It is unclear if more exercise (higher intensity or longer duration) is better than less (non-strenuous physical activity, such as walking for exercise 30 minutes most days). (See",
"    <a class=\"local\" href=\"#H11\">",
"     'Exercise'",
"    </a>",
"    above and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/46/28394?source=see_link\">",
"     \"Overview of the benefits and risks of exercise\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/28/14793?source=see_link\">",
"     \"Exercise and fitness in the prevention of cardiovascular disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Patients should be advised to pay attention to potential symptoms of CHD, even if they have engaged in regular exercise without limitations for an extended period of time. In addition, patients with known heart disease should be encouraged to engage in regular exercise in a supervised setting such as a cardiac rehabilitation program. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/43/31417?source=see_link\">",
"     \"Components of cardiac rehabilitation and exercise prescription\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h3\">",
"     Fish intake and fish oil",
"    </span>",
"    &nbsp;&mdash;&nbsp;In observational studies of populations at low cardiovascular risk, greater dietary fatty fish intake was associated with lower cardiac mortality [",
"    <a class=\"abstract\" href=\"UTD.htm?0/55/890/abstract/22,37,38,42,43\">",
"     22,37,38,42,43",
"    </a>",
"    ]. This benefit is due in part to a reduced risk of SCD (",
"    <a class=\"graphic graphic_figure graphicRef81322 \" href=\"UTD.htm?6/61/7134\">",
"     figure 4",
"    </a>",
"    ). Based upon these results, subsequent randomized trials evaluated the benefit of fish oil supplements in various high-risk populations [",
"    <a class=\"abstract\" href=\"UTD.htm?0/55/890/abstract/44,45\">",
"     44,45",
"    </a>",
"    ]. These issues are discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/51/28474?source=see_link&amp;anchor=H2#H2\">",
"     \"Lipid lowering with diet or dietary supplements\", section on 'Fish oil and omega-3 fatty acids'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/23/43385?source=see_link&amp;anchor=H17#H17\">",
"     \"Role of implantable cardioverter-defibrillators for the secondary prevention of sudden cardiac death\", section on 'Fish oil'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    For most individuals, there is little evidence that the pharmacologic doses of n-3 polyunsaturated fatty acids found in fish oil supplements (approximately 10 to 20 times the nutritional dose from fish) provide more protection than the intake of one to two servings of fatty fish (eg, salmon) per week. The pharmacologic use of fish oils supplements should be restricted to patients with refractory hypertriglyceridemia and, in such patients, the periodic monitoring of apolipoprotein B levels is recommended. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/57/31641?source=see_link\">",
"     \"Healthy diet in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/47/35578?source=see_link&amp;anchor=H18#H18\">",
"     \"Approach to the patient with hypertriglyceridemia\", section on 'Pharmacologic therapy (including fish oil)'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h2\">",
"     Post myocardial infarction",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients who have had an MI are at an increased risk of SCA. However, among post-MI patients, this risk varies significantly according to a number of factors.",
"   </p>",
"   <p>",
"    The approach to the prevention of SCA in such patients includes the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Standard medical therapies. Both beta blockers and ACE inhibitors (or angiotensin II receptor blockers) reduce overall mortality after an MI and are routinely administered. These agents also lower the incidence of SCD. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?14/62/15338?source=see_link&amp;anchor=H2#H2\">",
"       \"Role of implantable cardioverter-defibrillators for the primary prevention of sudden cardiac death after myocardial infarction\", section on 'Medical therapy'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Risk stratification to identify those patients at the highest risk of SCA. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?20/24/20874?source=see_link\">",
"       \"Incidence of and risk stratification for sudden cardiac death after acute myocardial infarction\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      ICD implantation in selected patients. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?14/62/15338?source=see_link\">",
"       \"Role of implantable cardioverter-defibrillators for the primary prevention of sudden cardiac death after myocardial infarction\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h2\">",
"     Heart failure and cardiomyopathy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with heart failure and left ventricular systolic dysfunction, regardless of the etiology, are at an increased risk of SCA. Primary prevention with an ICD is recommended in selected patients with either ischemic or nonischemic cardiomyopathy. The supporting data are discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/55/19322?source=see_link&amp;anchor=H13#H13\">",
"     \"Secondary and primary prevention of sudden cardiac death in heart failure and cardiomyopathy\", section on 'Primary prevention of SCD'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In addition, as with patients with CHD, standard medical therapies for HF (beta blockers, ACE inhibitors or angiotensin II receptor blockers, and aldosterone inhibitors such as",
"    <a class=\"drug drug_general\" href=\"UTD.htm?17/22/17767?source=see_link\">",
"     spironolactone",
"    </a>",
"    or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?4/58/5031?source=see_link\">",
"     eplerenone",
"    </a>",
"    ) may lower the risk of SCA. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/47/21241?source=see_link&amp;anchor=H12#H12\">",
"     \"Ventricular arrhythmias in heart failure and cardiomyopathy\", section on 'Effect of HF therapy on ventricular arrhythmia'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h2\">",
"     Counseling patients and families",
"    </span>",
"    &nbsp;&mdash;&nbsp;Given the mounting evidence related to the primary prevention of SCA, it now is clear that primary care clinicians can influence the occurrence of these events. As discussed above, there are clinical recommendations for those at risk of SCA that are likely to reduce risk. (See",
"    <a class=\"local\" href=\"#H22\">",
"     'Risk factor reduction'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29\">",
"    <span class=\"h1\">",
"     SECONDARY PREVENTION",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30\">",
"    <span class=\"h2\">",
"     ICD therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;An implantable cardioverter-defibrillator (ICD) is the preferred therapeutic modality in most survivors of SCA. The ICD does not prevent the recurrence of malignant ventricular arrhythmias, but it effectively terminates these arrhythmias when they do recur. The role of the ICD in survivors of SCA is presented separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/23/43385?source=see_link\">",
"     \"Role of implantable cardioverter-defibrillators for the secondary prevention of sudden cardiac death\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    ICD patients who have frequent arrhythmia recurrences and device discharges may benefit from adjunctive therapies, such as antiarrhythmic drugs or catheter ablation. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/23/43385?source=see_link&amp;anchor=H12#H12\">",
"     \"Role of implantable cardioverter-defibrillators for the secondary prevention of sudden cardiac death\", section on 'Adjunctive therapy'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/23/3448?source=see_link&amp;anchor=H7#H7\">",
"     \"Pharmacologic therapy in survivors of sudden cardiac arrest\", section on 'Adjunctive therapy in patients with an ICD'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/52/13129?source=see_link\">",
"     \"Catheter ablation for ventricular arrhythmias\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H31\">",
"    <span class=\"h2\">",
"     Antiarrhythmic drugs",
"    </span>",
"    &nbsp;&mdash;&nbsp;Antiarrhythmic drugs are less effective than an ICD for secondary prevention of SCD. Thus, their use in this setting is limited to the adjunctive role described above, or in patients who do not want or are not candidates for an ICD (eg, due to marked comorbidities or end-stage heart failure that make death likely). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/23/3448?source=see_link\">",
"     \"Pharmacologic therapy in survivors of sudden cardiac arrest\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, \"The Basics\" and \"Beyond the Basics.\" The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on \"patient info\" and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?33/39/34419?source=see_link\">",
"       \"Patient information: Sudden cardiac arrest (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H32\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The following summary and recommendations address general issues related to sudden cardiac arrest (SCA) and sudden cardiac death (SCD).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H33\">",
"    <span class=\"h2\">",
"     General information",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      SCA and SCD refer to the sudden cessation of cardiac activity with hemodynamic collapse. Events that are successfully treated with patient survival are referred to as SCA, while those that lead to death are referred to as SCD. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Definitions'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      SCD is common, accounting for up to 15 percent of total mortality in industrialized countries, based upon review of death certificate data. Smaller prospective studies, however, have suggested a lower incidence. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Epidemiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      SCA is most commonly due to ventricular tachyarrhythmias (ie, ventricular fibrillation or ventricular tachycardia). The risk of such arrhythmic events is increased in patients with coronary heart disease or other forms of structural heart disease. In patients with hearts that appear structurally normal, relatively uncommon primary arrhythmia syndromes can cause SCA. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Etiology'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?15/12/15559?source=see_link\">",
"       \"Sudden cardiac arrest in the absence of apparent structural heart disease\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      The risk factors for SCA are similar to those for coronary heart disease. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Risk factors'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H34\">",
"    <span class=\"h2\">",
"     Primary prevention",
"    </span>",
"    &nbsp;&mdash;&nbsp;The approach to primary prevention of SCD varies according to a patient's clinical profile.",
"   </p>",
"   <p>",
"    For the general population without known cardiac disease:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Apart from standard screening and management of risk factors for CHD (eg, measurement of lipids and BP), in patients without known cardiac disease we recommend no additional screening tests or treatment for the purpose of primary prevention of SCD (",
"      <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"       Grade 1B",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H20\">",
"       'General population'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Preparticipation screening of athletes for the purpose of preventing SCD is a unique issue that is discussed in detail separately. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?30/37/31318?source=see_link\">",
"       \"Screening to prevent sudden cardiac death in athletes\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Patients with known cardiac disease (eg, prior MI, cardiomyopathy, or heart failure) are at an increased risk of SCA. (See",
"    <a class=\"local\" href=\"#H26\">",
"     'Post myocardial infarction'",
"    </a>",
"    above and",
"    <a class=\"local\" href=\"#H27\">",
"     'Heart failure and cardiomyopathy'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    The approach to the primary prevention of SCA in such patients includes the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Standard medical therapies that lower the incidence of SCA. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?14/62/15338?source=see_link&amp;anchor=H2#H2\">",
"       \"Role of implantable cardioverter-defibrillators for the primary prevention of sudden cardiac death after myocardial infarction\", section on 'Medical therapy'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?20/47/21241?source=see_link&amp;anchor=H12#H12\">",
"       \"Ventricular arrhythmias in heart failure and cardiomyopathy\", section on 'Effect of HF therapy on ventricular arrhythmia'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Testing for the purpose of SCA risk stratification in selected subgroups. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?20/24/20874?source=see_link\">",
"       \"Incidence of and risk stratification for sudden cardiac death after acute myocardial infarction\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      ICD implantation in selected patients. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?14/62/15338?source=see_link\">",
"       \"Role of implantable cardioverter-defibrillators for the primary prevention of sudden cardiac death after myocardial infarction\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?20/47/21241?source=see_link&amp;anchor=H21#H21\">",
"       \"Ventricular arrhythmias in heart failure and cardiomyopathy\", section on 'Prevention of SCD'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H35\">",
"    <span class=\"h2\">",
"     Management and secondary prevention",
"    </span>",
"    &nbsp;&mdash;&nbsp;The management of SCA includes acute treatment of the arrest, and for SCA survivors, a comprehensive evaluation and secondary prevention.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The acute management of SCA involves standard cardiopulmonary resuscitation protocols. These issues are discussed in detail separately. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?13/33/13850?source=see_link\">",
"       \"Advanced cardiac life support (ACLS) in adults\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Management of survivors of SCA includes the identification and treatment of acute reversible causes, evaluation for structural heart disease",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      primary electrical diseases, neurologic and psychologic assessment, and evaluation of family members in selected cases. These issues are discussed in detail separately. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?4/24/4490?source=see_link\">",
"       \"Evaluation of the survivor of sudden cardiac arrest\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Secondary prevention of SCD, usually with an ICD, is appropriate for most SCA survivors. This issue is discussed in detail separately. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?42/23/43385?source=see_link\">",
"       \"Role of implantable cardioverter-defibrillators for the secondary prevention of sudden cardiac death\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/55/890/abstract/1\">",
"      American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (ACC/AHA/HRS Writing Committee to Develop Data Standards on Electrophysiology), Buxton AE, Calkins H, et al. ACC/AHA/HRS 2006 key data elements and definitions for electrophysiological studies and procedures: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (ACC/AHA/HRS Writing Committee to Develop Data Standards on Electrophysiology). Circulation 2006; 114:2534.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/55/890/abstract/2\">",
"      Demirovic J, Myerburg RJ. Epidemiology of sudden coronary death: an overview. Prog Cardiovasc Dis 1994; 37:39.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/55/890/abstract/3\">",
"      Siscovick DS. Challenges in cardiac arrest research: data collection to assess outcomes. Ann Emerg Med 1993; 22:92.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/55/890/abstract/4\">",
"      Zheng ZJ, Croft JB, Giles WH, Mensah GA. Sudden cardiac death in the United States, 1989 to 1998. Circulation 2001; 104:2158.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/55/890/abstract/5\">",
"      Chugh SS, Jui J, Gunson K, et al. Current burden of sudden cardiac death: multiple source surveillance versus retrospective death certificate-based review in a large U.S. community. J Am Coll Cardiol 2004; 44:1268.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/55/890/abstract/6\">",
"      Rea TD, Pearce RM, Raghunathan TE, et al. Incidence of out-of-hospital cardiac arrest. Am J Cardiol 2004; 93:1455.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/55/890/abstract/7\">",
"      Centers for Disease Control and Prevention (CDC). State-specific mortality from sudden cardiac death--United States, 1999. MMWR Morb Mortal Wkly Rep 2002; 51:123.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/55/890/abstract/8\">",
"      Kannel WB, Wilson PW, D'Agostino RB, Cobb J. Sudden coronary death in women. Am Heart J 1998; 136:205.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/55/890/abstract/9\">",
"      Bertoia ML, Allison MA, Manson JE, et al. Risk factors for sudden cardiac death in post-menopausal women. J Am Coll Cardiol 2012; 60:2674.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/55/890/abstract/10\">",
"      Kuller LH. Sudden death--definition and epidemiologic considerations. Prog Cardiovasc Dis 1980; 23:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/55/890/abstract/11\">",
"      Gillum RF. Sudden coronary death in the United States: 1980-1985. Circulation 1989; 79:756.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/55/890/abstract/12\">",
"      Kannel WB, Doyle JT, McNamara PM, et al. Precursors of sudden coronary death. Factors related to the incidence of sudden death. Circulation 1975; 51:606.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/55/890/abstract/13\">",
"      Drory Y, Turetz Y, Hiss Y, et al. Sudden unexpected death in persons less than 40 years of age. Am J Cardiol 1991; 68:1388.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/55/890/abstract/14\">",
"      Topaz O, Edwards JE. Pathologic features of sudden death in children, adolescents, and young adults. Chest 1985; 87:476.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/55/890/abstract/15\">",
"      Chugh SS, Kelly KL, Titus JL. Sudden cardiac death with apparently normal heart. Circulation 2000; 102:649.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/55/890/abstract/16\">",
"      Survivors of out-of-hospital cardiac arrest with apparently normal heart. Need for definition and standardized clinical evaluation. Consensus Statement of the Joint Steering Committees of the Unexplained Cardiac Arrest Registry of Europe and of the Idiopathic Ventricular Fibrillation Registry of the United States. Circulation 1997; 95:265.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/55/890/abstract/17\">",
"      Siscovick DS, Weiss NS, Hallstrom AP, et al. Physical activity and primary cardiac arrest. JAMA 1982; 248:3113.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/55/890/abstract/18\">",
"      Friedlander Y, Siscovick DS, Weinmann S, et al. Family history as a risk factor for primary cardiac arrest. Circulation 1998; 97:155.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/55/890/abstract/19\">",
"      Siscovick DS, Weiss NS, Fletcher RH, Lasky T. The incidence of primary cardiac arrest during vigorous exercise. N Engl J Med 1984; 311:874.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/55/890/abstract/20\">",
"      Trichopoulos D, Katsouyanni K, Zavitsanos X, et al. Psychological stress and fatal heart attack: the Athens (1981) earthquake natural experiment. Lancet 1983; 1:441.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/55/890/abstract/21\">",
"      Kark JD, Goldman S, Epstein L. Iraqi missile attacks on Israel. The association of mortality with a life-threatening stressor. JAMA 1995; 273:1208.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/55/890/abstract/22\">",
"      Siscovick DS, Raghunathan TE, King I, et al. Dietary intake and cell membrane levels of long-chain n-3 polyunsaturated fatty acids and the risk of primary cardiac arrest. JAMA 1995; 274:1363.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/55/890/abstract/23\">",
"      Kannel WB, Thomas HE Jr. Sudden coronary death: the Framingham Study. Ann N Y Acad Sci 1982; 382:3.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/55/890/abstract/24\">",
"      Jouven X, Desnos M, Guerot C, Ducimeti&egrave;re P. Predicting sudden death in the population: the Paris Prospective Study I. Circulation 1999; 99:1978.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/55/890/abstract/25\">",
"      Sandhu RK, Jimenez MC, Chiuve SE, et al. Smoking, smoking cessation, and risk of sudden cardiac death in women. Circ Arrhythm Electrophysiol 2012; 5:1091.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/55/890/abstract/26\">",
"      Albert CM, Mittleman MA, Chae CU, et al. Triggering of sudden death from cardiac causes by vigorous exertion. N Engl J Med 2000; 343:1355.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/55/890/abstract/27\">",
"      Lemaitre RN, Siscovick DS, Raghunathan TE, et al. Leisure-time physical activity and the risk of primary cardiac arrest. Arch Intern Med 1999; 159:686.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/55/890/abstract/28\">",
"      Maron BJ, Carney KP, Lever HM, et al. Relationship of race to sudden cardiac death in competitive athletes with hypertrophic cardiomyopathy. J Am Coll Cardiol 2003; 41:974.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/55/890/abstract/29\">",
"      Corrado D, Basso C, Schiavon M, Thiene G. Screening for hypertrophic cardiomyopathy in young athletes. N Engl J Med 1998; 339:364.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/55/890/abstract/30\">",
"      Albert CM, Ma J, Rifai N, et al. Prospective study of C-reactive protein, homocysteine, and plasma lipid levels as predictors of sudden cardiac death. Circulation 2002; 105:2595.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/55/890/abstract/31\">",
"      Albert CM, Manson JE, Cook NR, et al. Moderate alcohol consumption and the risk of sudden cardiac death among US male physicians. Circulation 1999; 100:944.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/55/890/abstract/32\">",
"      Wannamethee G, Shaper AG. Alcohol and sudden cardiac death. Br Heart J 1992; 68:443.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/55/890/abstract/33\">",
"      Weinmann S, Siscovick DS, Raghunathan TE, et al. Caffeine intake in relation to the risk of primary cardiac arrest. Epidemiology 1997; 8:505.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/55/890/abstract/34\">",
"      Jouven X, Charles MA, Desnos M, Ducimeti&egrave;re P. Circulating nonesterified fatty acid level as a predictive risk factor for sudden death in the population. Circulation 2001; 104:756.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/55/890/abstract/35\">",
"      Lemaitre RN, King IB, Raghunathan TE, et al. Cell membrane trans-fatty acids and the risk of primary cardiac arrest. Circulation 2002; 105:697.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/55/890/abstract/36\">",
"      Harper CR, Jacobson TA. The fats of life: the role of omega-3 fatty acids in the prevention of coronary heart disease. Arch Intern Med 2001; 161:2185.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/55/890/abstract/37\">",
"      Albert CM, Campos H, Stampfer MJ, et al. Blood levels of long-chain n-3 fatty acids and the risk of sudden death. N Engl J Med 2002; 346:1113.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/55/890/abstract/38\">",
"      Daviglus ML, Stamler J, Orencia AJ, et al. Fish consumption and the 30-year risk of fatal myocardial infarction. N Engl J Med 1997; 336:1046.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/55/890/abstract/39\">",
"      Priori SG, Aliot E, Blomstrom-Lundqvist C, et al. Task Force on Sudden Cardiac Death of the European Society of Cardiology. Eur Heart J 2001; 22:1374.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/55/890/abstract/40\">",
"      De Backer G, Kornitzer M, Dramaix M, et al. The Belgian Heart Disease Prevention Project: 10-year mortality follow-up. Eur Heart J 1988; 9:238.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/55/890/abstract/41\">",
"      Shephard RJ, Balady GJ. Exercise as cardiovascular therapy. Circulation 1999; 99:963.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/55/890/abstract/42\">",
"      Kromhout D, Bosschieter EB, de Lezenne Coulander C. The inverse relation between fish consumption and 20-year mortality from coronary heart disease. N Engl J Med 1985; 312:1205.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/55/890/abstract/43\">",
"      Albert CM, Hennekens CH, O'Donnell CJ, et al. Fish consumption and risk of sudden cardiac death. JAMA 1998; 279:23.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/55/890/abstract/44\">",
"      Marchioli R, Barzi F, Bomba E, et al. Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-Prevenzione. Circulation 2002; 105:1897.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/55/890/abstract/45\">",
"      Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico. Lancet 1999; 354:447.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 963 Version 9.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1103-200.150.3.100-7D04F74F15-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f0_55_890=[""].join("\n");
var outline_f0_55_890=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H32\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      DEFINITIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      ETIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Coronary heart disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Other structural heart disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Absence of structural heart disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Acute triggers",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      RISK FACTORS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Cigarette smoking",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Exercise",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Family history of SCA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Serum CRP",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Excess alcohol intake",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Psychosocial factors",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Caffeine",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Fatty acids",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      MANAGEMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      PRIMARY PREVENTION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      General population",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      - Screening and risk stratification",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      - Risk factor reduction",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      - Moderate alcohol intake",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      - Regular exercise",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      - Fish intake and fish oil",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      Post myocardial infarction",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      Heart failure and cardiomyopathy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      Counseling patients and families",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H29\">",
"      SECONDARY PREVENTION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H30\">",
"      ICD therapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H31\">",
"      Antiarrhythmic drugs",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H32\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H33\">",
"      General information",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H34\">",
"      Primary prevention",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H35\">",
"      Management and secondary prevention",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"CARD/963\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"CARD/963|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?18/4/18509\" title=\"figure 1\">",
"      Incidence of sudden death in men and women increases with age",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?24/42/25261\" title=\"figure 2\">",
"      SCD and clinical manifestations",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?24/31/25086\" title=\"figure 3\">",
"      Number of risk factors and CVD risk",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?6/61/7134\" title=\"figure 4\">",
"      Fish intake and sudden death",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"CARD/963|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/52/17228\" title=\"table 1\">",
"      Major causes of sudden death",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?2/48/2830\" title=\"table 2\">",
"      Causes of long QT syndrome",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?38/50/39723\" title=\"table 3\">",
"      Mechanism exercise on mortality",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"CARD/963|Waveform\">",
"      <a href=\"#\" title=\"WAVEFORMS\">",
"       WAVEFORMS",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_waveform\" href=\"UTD.htm?29/47/30455\" title=\"waveform 1\">",
"      ECG Ventricular fibrillation tutorial",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/55/23418?source=related_link\">",
"      Acquired long QT syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/33/13850?source=related_link\">",
"      Advanced cardiac life support (ACLS) in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/47/35578?source=related_link\">",
"      Approach to the patient with hypertriglyceridemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/37/28250?source=related_link\">",
"      Brugada syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/0/27658?source=related_link\">",
"      C-reactive protein in cardiovascular disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/33/31258?source=related_link\">",
"      Cardiovascular benefits and risks of moderate alcohol consumption",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/28/1482?source=related_link\">",
"      Cardiovascular risk of smoking and benefits of smoking cessation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/48/37641?source=related_link\">",
"      Catecholaminergic polymorphic ventricular tachycardia and other polymorphic ventricular tachycardias with a normal QT interval",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/52/13129?source=related_link\">",
"      Catheter ablation for ventricular arrhythmias",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/10/30890?source=related_link\">",
"      Clinical features and treatment of ventricular arrhythmias during acute myocardial infarction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?2/9/2202?source=related_link\">",
"      Clinical features of congenital long QT syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/22/32106?source=related_link\">",
"      Clinical manifestations and diagnosis of arrhythmogenic right ventricular cardiomyopathy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/16/26889?source=related_link\">",
"      Clinical manifestations and diagnosis of myocarditis in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/43/31417?source=related_link\">",
"      Components of cardiac rehabilitation and exercise prescription",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/56/14218?source=related_link\">",
"      Congenital and pediatric coronary artery abnormalities",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?2/34/2601?source=related_link\">",
"      Dietary fat",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/20/44361?source=related_link\">",
"      Epidemiology of coronary heart disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/61/17370?source=related_link\">",
"      Epidemiology, clinical manifestations, and diagnosis of the Wolff-Parkinson-White syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/24/4490?source=related_link\">",
"      Evaluation of the survivor of sudden cardiac arrest",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/28/14793?source=related_link\">",
"      Exercise and fitness in the prevention of cardiovascular disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/62/23528?source=related_link\">",
"      Genetics and pathogenesis of arrhythmogenic right ventricular cardiomyopathy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/57/31641?source=related_link\">",
"      Healthy diet in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/24/20874?source=related_link\">",
"      Incidence of and risk stratification for sudden cardiac death after acute myocardial infarction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/23/1401?source=related_link\">",
"      Left ventricular hypertrophy and arrhythmia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/51/28474?source=related_link\">",
"      Lipid lowering with diet or dietary supplements",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/31/6649?source=related_link\">",
"      Natural history of chronic mitral regurgitation in mitral valve prolapse and flail mitral leaflet",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/21/30041?source=related_link\">",
"      Outcome of sudden cardiac arrest",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/28/5576?source=related_link\">",
"      Overview of primary prevention of coronary heart disease and stroke",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/46/28394?source=related_link\">",
"      Overview of the benefits and risks of exercise",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/59/39866?source=related_link\">",
"      Overview of the risk equivalents and established risk factors for cardiovascular disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/54/16233?source=related_link\">",
"      Pathophysiology and etiology of sudden cardiac arrest",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?33/39/34419?source=related_link\">",
"      Patient information: Sudden cardiac arrest (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/11/34997?source=related_link\">",
"      Patterns of tobacco use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/23/3448?source=related_link\">",
"      Pharmacologic therapy in survivors of sudden cardiac arrest",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/28/35274?source=related_link\">",
"      Post-cardiac arrest management in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/15/23800?source=related_link\">",
"      Psychosocial factors in sudden cardiac arrest",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/36/13898?source=related_link\">",
"      Risk of sudden cardiac death in athletes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/62/15338?source=related_link\">",
"      Role of implantable cardioverter-defibrillators for the primary prevention of sudden cardiac death after myocardial infarction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/23/43385?source=related_link\">",
"      Role of implantable cardioverter-defibrillators for the secondary prevention of sudden cardiac death",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/50/26409?source=related_link\">",
"      Screening for coronary heart disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/29/33241?source=related_link\">",
"      Screening guidelines for dyslipidemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/37/31318?source=related_link\">",
"      Screening to prevent sudden cardiac death in athletes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/55/19322?source=related_link\">",
"      Secondary and primary prevention of sudden cardiac death in heart failure and cardiomyopathy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/12/15559?source=related_link\">",
"      Sudden cardiac arrest in the absence of apparent structural heart disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/24/8585?source=related_link\">",
"      Supportive data for advanced cardiac life support in adults with sudden cardiac arrest",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/3/22586?source=related_link\">",
"      Ventricular arrhythmias and sudden cardiac arrest in hypertrophic cardiomyopathy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/47/21241?source=related_link\">",
"      Ventricular arrhythmias in heart failure and cardiomyopathy",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f0_55_891="Interstitial lung diseases that may include a component of OP";
var content_f0_55_891=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F87711&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F87711&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Interstitial lung diseases that may include a component of organizing pneumonia",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td>",
"        Chronic eosinophilic pneumonia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Diffuse alveolar damage",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hypersensitivity pneumonitis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Idiopathic pulmonary fibrosis (minor scattered foci)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Nonspecific interstitial pneumonia",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f0_55_891=[""].join("\n");
var outline_f0_55_891=null;
var title_f0_55_892="Surgical wound classification";
var content_f0_55_892=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F51272&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F51272&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Surgical wound classification",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Class I/Clean",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        An uninfected operative wound in which no inflammation",
"is encountered and the respiratory, alimentary, genital, or uninfected",
"urinary tract is not entered. In addition, clean wounds are primarily",
"closed and, if necessary, drained with closed drainage. Operative",
"incisional wounds that follow nonpenetrating (blunt) trauma should be",
"included in this category if they meet the criteria.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Class",
"II/Clean-Contaminated",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        An operative wound in which the respiratory,",
"alimentary, genital, or urinary tracts are entered under controlled",
"conditions and without unusual contamination. Specifically, operations",
"involving the biliary tract, appendix, vagina, and oropharynx are",
"included in this category, provided no evidence of infection or major",
"break in technique is encountered.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Class",
"III/Contaminated",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Open, fresh, accidental wounds. In addition, operations",
"with major breaks in sterile technique (eg, open cardiac massage) or",
"gross spillage from the gastrointestinal tract, and incisions in which",
"acute, nonpurulent inflammation is encountered are included in this",
"category.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Class",
"IV/Dirty-Infected",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Old traumatic wounds with retained devitalized tissue",
"and those that involve existing clinical infection or perforated",
"viscera. This definition suggests that the organisms causing",
"postoperative infection were present in the operative field before the",
"operation.",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Garner JS. CDC guideline for prevention of surgical wound infections, 1985. Supercedes guideline for prevention of surgical wound infections published in 1982. (Originally published in 1995). Revised. Infect Control 1986; 7:193.",
"     <br>",
"      Simmons BP. Guideline for prevention of surgical wound infections. Infect Control 1982; 3:185.",
"     </br>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f0_55_892=[""].join("\n");
var outline_f0_55_892=null;
var title_f0_55_893="ICD-10 Criteria HKD";
var content_f0_55_893=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F53723&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F53723&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    International classification of disease (10th edition) diagnostic criteria for hyperkinetic disorder",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Inattentive symptoms (at least six)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Often fails to give close attention to details, or makes careless errors in school work, work or other activities.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Often fails to sustain attention in tasks or play activities.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Often appears not to listen to what is being said to him or her.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Often fails to follow through on instructions or to finish",
"school work, chores, or duties in the workplace (not because of",
"oppositional behavior or failure to understand instructions).",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Is often impaired in organizing tasks and activities.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Often avoids or strongly dislikes tasks, such as homework, that require sustained mental effort.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Often loses things necessary for certain tasks and activities, such as school assignments, pencils, books, toys or tools.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Is often easily distracted by external stimuli.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Is often forgetful in the course of daily activities.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Hyperactive symptoms (at least three)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Often fidgets with hands or feet or squirms on seat.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Leaves seat in classroom or in other situations in which remaining seated is expected.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Often runs about or climbs excessively in situations in which it is inappropriate (in adolescents or adults, only feelings of restlessness may be present).",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Is often unduly noisy in playing or has difficulty in engaging quietly in leisure activities.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Exhibits a persistent pattern of excessive motor activity that is not substantially modified by social context or demands.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Impulsivity symptoms",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Often blurts out answers before questions have been completed.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Often fails to wait in lines or await turns in games or group situations.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Often interrupts or intrudes on others (eg butts into others' conversations or games).",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Often talks excessively without appropriate response to social constraints.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Additional criteria",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        At least six inattentive symptoms, three hyperactive symptoms, and one impulsivity symptom, have persisted for at least six months, to a degree that is maladaptive and inconsistent with the developmental level of the child.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Onset of the disorder is no later than the age of seven years.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Criteria should be met for more than one setting (eg, at home and school).",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        The symptoms cause clinically significant distress or impairment in social, academic, or occupational functioning.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        The patient does not meet criteria for pervasive",
"developmental disorders, manic episode, depressive episode, or anxiety",
"disorders.",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Adapted from International Statistical Classification of Diseases and Related Health Problems (ICD-10), 10th edition, American Psychiatric Association, 1992.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f0_55_893=[""].join("\n");
var outline_f0_55_893=null;
var title_f0_55_894="Contents: Peds environmental emergencies";
var content_f0_55_894=[" <script type=\"text/javascript\">",
"  $$.inlineInitCustomer(",
"	false);",
"	var quirksmode = document.compatMode == \"CSS1Compat\";",
"	if (quirksmode) {",
"		$(\"html\").addClass(\"ie-standards\");",
"	}",
" </script>",
" <div id=\"message-wrap\">",
"  <div id=\"message-bg\">",
"  </div>",
"  <iframe id=\"message-bk\">",
"  </iframe>",
"  <dl id=\"message-container\">",
"   <dt id=\"message-title\">",
"   </dt>",
"   <dd id=\"message-body\">",
"   </dd>",
"   <dd id=\"message-controls\">",
"   </dd>",
"  </dl>",
" </div>",
" <div id=\"topPanel\">",
"  <div id=\"header\">",
"   <div id=\"header_container\">",
"    <h2 id=\"logo\">",
"     <a href=\"./toc\">",
"      Wolters Kluwer Health UpToDate",
"     </a>",
"    </h2>",
"    <div id=\"header_right\">",
"     <div id=\"searchpanel\">",
"      <a href=\"/login\" id=\"loginbutton\">",
"       Log in",
"      </a>",
"      <div id=\"cmsSearchBox\">",
"       <div class=\"header-search\">",
"        <form action=\"./search\" id=\"cmssearch\" method=\"get\" name=\"SearchForm\">",
"         <div class=\"header-search-left\">",
"          <input autocomplete=\"off\" class=\"searchfield\" id=\"cmsTxtBox\" name=\"search\" placeholder=\"Search UpToDate\" type=\"text\"/>",
"         </div>",
"         <div class=\"header-search-right\">",
"          <input alt=\"Search\" id=\"cmsSearchSubmit\" src=\"/sites/all/themes/uptodate/images/search_button.png\" type=\"image\"/>",
"         </div>",
"         <div class=\"clear\">",
"         </div>",
"        </form>",
"       </div>",
"      </div>",
"      <div id=\"cms_lang_dropdown\">",
"       <form accept-charset=\"UTF-8\" action=\"/\" id=\"lang-dropdown-form\" method=\"post\">",
"        <div class=\"form-item form-type-select form-item-lang-dropdown-select\">",
"         <select class=\"lang-dropdown-select-element form-select\" id=\"edit-lang-dropdown-select\" name=\"lang_dropdown_select\" style=\"width:100px\">",
"          <option selected=\"selected\" value=\"en\">",
"           English",
"          </option>",
"          <option value=\"ja\">",
"           ���������������������������",
"          </option>",
"         </select>",
"        </div>",
"        <input name=\"lang_dropdown_type\" type=\"hidden\" value=\"language\">",
"         <input name=\"en\" type=\"hidden\" value=\"/\">",
"          <input name=\"ja\" type=\"hidden\" value=\"/ja\">",
"           <noscript>",
"            <div>",
"             <input class=\"form-submit\" id=\"edit-submit\" name=\"op\" type=\"submit\" value=\"Go\"/>",
"            </div>",
"           </noscript>",
"           <input name=\"form_build_id\" type=\"hidden\" value=\"form-on4lUWpxHun_wp6revUkjCG6rK2IBuCGME9Cw0HXeok\">",
"            <input name=\"form_id\" type=\"hidden\" value=\"lang_dropdown_form\">",
"            </input>",
"           </input>",
"          </input>",
"         </input>",
"        </input>",
"       </form>",
"      </div>",
"      <div class=\"clear\">",
"      </div>",
"     </div>",
"     <ul id=\"utility\">",
"      <li class=\"first\">",
"       <a href=\"/home/about-us\">",
"        About Us",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/news-events\">",
"        News &amp; Events",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/contact-us\">",
"        Contact Us",
"       </a>",
"      </li>",
"      <li class=\"last\">",
"       <a href=\"/help\">",
"        Help",
"       </a>",
"      </li>",
"     </ul>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"nav\">",
"    <ul>",
"     <li id=\"productTab\">",
"      <a href=\"/home/product\">",
"       Product",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"editoralTab\">",
"      <a href=\"/home/editorial\">",
"       Editorial",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"whyUptodateTab\">",
"      <a href=\"/home/why-uptodate\">",
"       Why UpToDate",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"supscriptionOptionsTab\">",
"      <a href=\"/home/subscription-options\">",
"       Subscription Options",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"/store\">",
"       Subscribe",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"wkhcsTab\">",
"      <a href=\"/home/wolters-kluwer-health-clinical-solutions\">",
"       Wolters Kluwer Health Clinical Solutions",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"    </ul>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"greyBar\">",
"    <div id=\"greyBarTitle\">",
"     <span class=\"emphasis\">",
"      <a href=\"UTD.htm?3/3/3134\">",
"       Contents",
"      </a>",
"     </span>",
"     <img src=\"./../images/space_arrows.myextg\">",
"      <a href=\"UTD.htm?17/55/18302\">",
"       Pediatrics",
"      </a>",
"      <img src=\"./../images/space_arrows.myextg\">",
"       Peds environmental emergencies",
"      </img>",
"     </img>",
"    </div>",
"    <div id=\"greyBarButtons\">",
"     <div id=\"printGB\">",
"      <a class=\"icontxt\" href=\"?view=print\">",
"       <img align=\"middle\" alt=\"Print this page\" border=\"0\" height=\"20\" src=\"./../images/icn_print.myextg\" width=\"24\"/>",
"      </a>",
"      <a class=\"icontxt\" href=\"?view=print\" title=\"Print this page\">",
"       Print",
"      </a>",
"     </div>",
"    </div>",
"   </div>",
"   <!-- menuMessage.jsp -->",
"   <!-- /menuMessage.jsp -->",
"  </div>",
"  <!-- header -->",
" </div>",
" <!-- topPanel -->",
" <div id=\"leftPanel\">",
"  <ul>",
"   <li>",
"    <a href=\"UTD.htm?3/45/3806\">",
"     Specialties",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?18/22/18798\">",
"     Patient Information",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?3/13/3294\">",
"     What's New",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?0/37/606\">",
"     Calculators",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?0/40/654\">",
"     Authors and Editors",
"    </a>",
"   </li>",
"  </ul>",
" </div>",
" <!-- leftPanel -->",
" <div id=\"rightPanel\">",
"  <noscript>",
"   <div id=\"javascriptDisabled\">",
"    It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"   </div>",
"  </noscript>",
"  <div id=\"printHeader\">",
"   <div id=\"printHeaderLogo\">",
"    <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"    </img>",
"   </div>",
"   <div id=\"printHeaderText\">",
"    Official reprint from UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"    <a href=\"file://www.uptodate.com\">",
"     www.uptodate.com",
"    </a>",
"    <br>",
"     &copy;2013 UpToDate",
"     <sup>",
"      &reg;",
"     </sup>",
"    </br>",
"   </div>",
"   <div id=\"printHeaderLinks\">",
"    <a href=\"#\" id=\"printHeaderPrint\" rel=\"\" title=\"Click here to print\">",
"     Print",
"    </a>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"     Back",
"    </a>",
"   </div>",
"  </div>",
"  <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" id=\"tocTable\" width=\"100%\">",
"   <trs>",
"    <tds>",
"     <h1>",
"      Contents:",
"			Peds environmental emergencies",
"     </h1>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds valign=\"top\">",
"     <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"100%\">",
"      <trs>",
"       <tds>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?24/16/24839\">",
"           Approach to the patient with a suspected spider bite: An overview",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?17/17/17689\">",
"           Clinical features of radiation exposure in children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?15/43/16056\">",
"           Clinical manifestations of hypothermia in children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?21/23/21878\">",
"           Heat illness (other than heat stroke) in children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?9/63/10234\">",
"           Heat stroke in children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?27/7/27769\">",
"           High altitude disease: Unique pediatric considerations",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?19/57/20377\">",
"           Initial management of animal and human bites",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?27/35/28216\">",
"           Insect bites",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?42/0/43016\">",
"           Jellyfish stings",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?5/52/5962\">",
"           Management of Crotalinae (rattlesnake, water moccasin [cottonmouth], or copperhead) bites in the United States",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?0/48/775\">",
"           Management of Elapidae (coral snake) bites in the United States",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?24/38/25193\">",
"           Management of radiation exposure in children following a nuclear disaster",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?41/26/42408\">",
"           Marine envenomations from corals, sea urchins, fish, or stingrays",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?18/41/19096\">",
"           Marine toxins",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?30/44/31431\">",
"           Principles of snake bite management worldwide",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?27/24/28038\">",
"           Soft tissue infections due to dog and cat bites",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?7/22/7530\">",
"           Treatment of hypothermia in children",
"          </a>",
"         </li>",
"        </ul>",
"       </tds>",
"      </trs>",
"     </div>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"     <img height=\"10\" src=\"./../images/spacer.myextg\" width=\"1\"/>",
"    </tds>",
"   </trs>",
"  </div>",
"  <div id=\"footer\">",
"   <div id=\"footerNav\">",
"    <ul>",
"     <li>",
"      <a href=\"file://www.wolterskluwerhealth.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Wolters Kluwer Health",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.factsandcomparisons.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Facts &amp; Comparisons&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medispan.com\" rel=\"nofollow\" target=\"_blank\">",
"       Medi-Span&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationordersets.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Order Sets",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationmedical.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Medical",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://pharmacyonesource.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Pharmacy OneSource&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medicom.com.cn/\" rel=\"nofollow\" target=\"_blank\">",
"       Medicom",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.lexi.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Lexicomp",
"      </a>",
"     </li>",
"     <li class=\"last\">",
"      <a href=\"/home/privacy-policy\">",
"       Privacy Policy",
"      </a>",
"     </li>",
"    </ul>",
"   </div>",
"   <div id=\"footerLogo\">",
"    <a href=\"./toc\">",
"     Wolters Kluwer Health | UpToDate",
"    </a>",
"   </div>",
"   <div id=\"supportFooter\">",
"    <span class=\"sfInfo\">",
"     &copy; 2013 UpToDate, Inc. All rights reserved.",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Release: 21.3 - C21.34",
"    </span>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <span class=\"sfInfo\">",
"     <a href=\"/home/terms-use\">",
"      Terms of Use",
"     </a>",
"    </span>",
"    <br/>",
"    <span class=\"sfInfo\">",
"     Licensed to:",
"     <span class=\"emphasis\">",
"      UpToDate Marketing Professional",
"     </span>",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Support Tag: [0505-95.154.198.148-301AFE66FE-14]",
"     <br/>",
"    </span>",
"   </div>",
"  </div>",
" </div>",
" <!-- rightPanel -->",
"</body>"].join("\n");
var script_f0_55_894=[""].join("\n");
var outline_f0_55_894=null;
var title_f0_55_895="Dysuria prepubertal female";
var content_f0_55_895=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F69182&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F69182&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 589px\">",
"   <div class=\"ttl\">",
"    Dysuria in the prepubertal female without conjunctivitis, arthritis, or generalized rash",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 569px; height: 560px; background-image: url(data:image/gif;base64,R0lGODlhOQIwAsQAAP///wAAAIiIiERERLu7uyIiImZmZt3d3ZmZmTMzMxEREczMzO7u7lVVVXd3d6qqqj8/P5+fnw8PD8/Pzx8fH9/f37+/v+/v719fX39/f6+vr09PT29vby8vL4+PjwAAACH5BAAAAAAALAAAAAA5AjACAAX/ICCOZGmeaKqubOu+cCzPdG3feK7vfO//wKBwSCwaj8ikcslsOp/QqHRKrVqv2Kx2y+16v+CweEwum8/otHrNbrvf8Lh8Tq/b7/i8fs/v+/+AgYKDhIWGh4iJiouMUwGPkJGSk5SVlpeYmZmNnJ2eRQF4oZ+kpaY0o3app6ytriKrdLGvtLWMs3K4tru8gbpwv73Cw6pGAwIkAgNKwcTOz2yzCAmPBcgsygDHKNsj2SvdMAiQCCXN0OjpYrEEAdffLuEl8vBAAgrm6vr7ZLENBiYIFHhULgC1AOWUjSM4MECBBdquicgmkCCDAY/wbRPwKAFEgwQBIFDwSCKCAvn4/6lcqSWWNQDtHAJQUO4BPncABKDMJg9AAQcRky2jCcBmOwYjji0IANHAMpw6tQEdwcDAw5Qss2qF4g+giJMHJIUlIHLnsm1VIQGkNyBspAMOAihAduykCIEAApC1S4DaAIhhD5g4t7Ww4R6xHgSYGpXoCL1lc54FOg5pgrUSJc8sV2LpAaVMATR4uhfliH8qCB9ezXqGtIMvK8qEbDfbwmnVMAuF2bBAzAC6ORr8WFpbNcABBGNtzbw5KlHOo0t3oVpN9enYV19Hsz2796zdzYT/Tl7f+H7l0zM/P4a9+ve83IeRD7++K/pf8NvfT0qT//8ABvgffwQWeIJ+BiaoIP8MCC7o4IODQSjhhDk0SOGFBFqI4Ybwacjhh+R5COKI04lI4onroaiiGwK26OKLMMYo44w0XrLieyZmeKN6OfLX447C/GifkEDuQmSHRYaYZIRLZnckjk06GeVjU5ZYZV5XahXjhVtm6cx5T4JXQ5he5gEml2OWScyZFLKpZi9uShjnm7aswlEDIryUApkrjeJAAiIsBdEKfNI5h50KEKUnCoXyMwoDLyUwFaGGxpeMNQpAioxwHpHQ6D6pEKCAAwUwcMBBAI1UEiyVGnkpAwpYJYCgADjlKZojGAAZagcosMAAk7Laai127lSSXbzd2iYJ7eQZCQJ9BfCXsMO+Uqz/s7OGNpqyE67SrGhelYAaltVae+lXUHU0KLVyMjvKqZB8dhy75Z4y54P31ttfmss+py8r+S4Y8L+cDJygwQQvgnCBCyeMSJfdwuiwpVV+OrGZV1p88R0aW7kxNB1LF/LHuWRM8jMjO5fyySyazPIuE2xgAZYWbDABkDHPHErNN7/8CgUBAC10kkIHHbTPtEQgSQRJKh0J00i7coEEkEhwQZJTV3111K5wAAkHTXr9CNhcu1IBJBU0efYjaZftCgQBQDAl3HK77YoGAWgwJd562/32lXX7LfjghBdu+J41Jo4JLYo37rgmh/+wMqXmEjI5wZfvyXghmevb+YGbWx65/w+fM3kf56MjNl/og5ReLX71BOF6FxZ+K0RPOszeaixuPcLYMirEbkNDCSDFbSur2GR8WOueYPsIzwOB+wsLIbRc6jjwnhxMCeDZgvA3aHq9vSU4JgCgMkT/w/Qx3DM+9vyOEFigATCQTVyPLCCbADoNVLxP80JIAQwgm1DACzgkKABnqFS5ETgAeC9pQEcYoCp3NOuADbggqkRCEpxAjyREOcYATAOAsURmI5DQX0PKIUIFdtAkJKQX/OIngvnBggDZCMADRjAXbxTgALBaoE+AEgDvjQomoeCVr0RyGdMhrzP1E5X9/pcAZUyqWdu6SxIB0qtfBYuHyBjJRRKgnP8a0gYloCGLCIhiE22QUSokqMpVjjdDGpZwewBYiv2WoRPgeMYbEERAWh4BEMjMr1kNCYkBwkVH8pWgiousVSQI6Bf9hUKB0Lvks6I1LTMqJzk9MaFd6kLC3j3iM9fgJHLKyMA62kB7gukLQOpBkx5OJJCVAUATITOTTW2ROqzzoQLIcj7jkeAfWAQeEsF1gnGtcVOZwp31RhiRpahxMyToiTNB58pXlsCU7xgArCYoqpJ8Q4EHHGBe1LiQgZTwINuLpBMBZgIGyEQEEiQIRhxiyXc+IoMGhKe8+MksELIwMxPpCBp9mT/ZLFQE+7yKDRvZTQY5ISoWbaAgdFcpMgn/Z5gx4GhLUFdRf+UnmL4oqUm9INIstHQIL1WTSGNqBZoCwaZZmilKAYFTl51UoylVqQx0ClSeCnWoj0tqT6Wg1KYq9ahM9SlUgzqlpU41d1K9qh+sijKtUjVKXPWqHZcUVrG6JqtmxVjF0tqHsg7DrWwF5lrjqge4womuT3CqXv3Tib36NXFitev7HnYIwWLIsK28RWEDWwfE8sCxZ/UqZCGLVUNQFkKT7etiJdtYzVqWsbLwLEnrCDEulLaxEgNGagfXsKiutLOvjcZY3dbaKNTWOrPFbWxpm9sr3DYNvwVDcC82XCYUtwzHNW1vo2anIuYJoYP1rQj+RL/mMUqt/wn13qK4+QY/oY9WlGNtMhJVju3Oc6QAEJ+kWnBZdt1DUdClqG7V+8XrEq5Y9xAfp5qnu1CNqlQHTNULZXioS+X3JfuVL3A/SCpTbbCC12ivyF4VK2vQylaJ3cIqdEUWJXoxusCgsKwurExydZcEHGZmF4EFYqRdSzgCQBZeMoxeLTqLHKokcMl8mJNjmWbGOl5wJm9MkBybWHDXAmC2IJLFINfUXfhk5Gm8IuEkD2TJoimxYL01im1O2ckuPpdI0jUcBT95yP48ZUQHVWUxj4OhnaLxGrhcQ4GuGcw+S24S9LyO5Z6Bz57zMxUALVxBI9fQLCM0KBA9Z0b3ebdlU/80ESRNO0evDtJco7QQNK1hSxca08xdrWlFjdoXxeG02MtswTarVVU3QsJybTVsX83qq7pasZ/lbGhXnWtZ75rWvbb1rHE9WqFOoANMC0UEOtCzNRw72QBYdrMJ8WwsSfsP1VY2s4UKN6pRLXBs6HYAvp0IcZMbEOaO21GdBgmotYHdj3C3IeAdAHn3gd72rijVHiGBOOx73Iv4d78FIfCpZgASGYjDwR+RcEUsPAAND8TDIy7UtQWgbW+wOMYRofFBdHyqGAgABuYQ8pEzouSFQPlVLRCAmcmB5S5fBMwLMXOtgjsON1dEzgOxc7z6/OdAD7o5/gqJ7BH9r0Y/utL/KUGdpSOdrMzIXohvAGs8W108TQqTfOy6dT6oBrFVF+0Run5iqns91lNPktalXnZv7uHrBYb6ntneMrO/He1tL9La7V53t7tAfc5TDU/iKzu8twDwWAg7r5MSiWvKoHpCPPJK7XlN8x7I8UlBBmQQLzm6i0CegTcH5pf5vbMQPvR+D+8ITtKR0TcLfD3QVethEYn03rPFJIrFAKR8A/eZGe/jOkr2Rj9pz9eK92heAedLMHgkwJ0EiuGMAaD7+hIDQZ66+ogQzwdS3I9I94zMZ/EM4D1gBVgyHFEOsuQc0hIor1YN6N3/8okTvbSDGks8huwREgoIF57vnxcu8scA//dHUHoxgNHTGxAhHNLiRoSETxO0AAcBUGkGFAXoKxeREd4neQ3wRS8RGO3QO4sUSO3QDgggHHNUZ76Dfnh0fKdBREJkDaDHfiqie5BwDFQkACHoGR6mE2okR9ZFdiSgAA8AK9cUFg9wD4KxDfYHGbsXFJsXCiwGU8Y3g2b0AO3AZHjCS3eEhbrwE9akGQOwDCFYTLrEP+izTA2AJwswTCWoDQRUP9yletoQeR+YHNX3eSSIE20IEQ7gPfjEhsPkgyUAejkECToYRZmygR8CfrkySRHhAACRSAgBDxNFgy8wC39oF79CDvLEhATwLZEEistkZJ0HgC4YKPuEEN8SFf960YlFtgqDBBzI0nyBsX/AcQASlADQckmcMQC9GIAAEBe2hIl05GV3eAB5WCt7iC6QEEOYVIfCA3odmBcLhIuRp3jAlhThYoarlygdxkiw93vsZQJLUUW1Aij2dIKlIj5NKIxMuEPP42WPVYXhYgDqyIqjsEsEgI+2F4yrJ4eXQSvbsg2B4Y2XgkVs+I6pmEctKHmaA30eNH1PmH6vhz5RISoA2YfNtJA4ZH2pqCuCYT3pRYQTkYZX14jzEH7kkCfAc0DJYYkPmZIR+UjbU04DIUiwoXmhOAqjiAyyNw7GQVA3VYWNRxI5+RtvZH9IqY8kkE4AIXsJYHp3JBj0d4L/OBZQKyiKcfiA5ChD9/AIA9CTIKGModCGueg/NGE7DMhIBwQU0wgJcUaSIyE/oWGMuRd1qPgCkBJ5g2Z8HGN4baCNxDZ2gMkCN1hjnqZbiBl3aqeXqSdbe1kM5bhjjzl3kylkkRmYlXlqWQeZi7kD7DMYxFeToRkUPbB8O/B8nil3zmd8DOhB8XB63ECbnlKa9rWZkZF5JjCaNaCaiImbeEmTvxkK3+CbZuSVQ/WZmBmZGFUEyPkYwnley2kC65cC0Zk+P8KaRTCOKgBe7eeahomKz9ljZSZABLRCQcGAZ7FB2bRB5UQUMNmPwDOFuTlb14lC+TMAG3R+/WMQxjSM/ymEQRr0gMqQfvskThL4T+u0oM5FnXMIA/z5gG/JQSURgmpRF/iQE4CCgutyiZmYdUoHm5FAYnlhRDWhEdmyQzxBhg85AAvZhmGUKVl0gMkBooxomqsXQ2mUFC6qi1zkKzoBRI4BCzuET8qERUG6AISoEwzAAFV0PrcppTpapfEQo2uYR8Nkn8t4DEG0GRz5hxNRpOGJOU0QC88pYyhhSGJBSrcUFJfYDfz3SQcQjU4oAJJIh5FVAvkZYzyKDIFBiScYSJcCHH05ZIL6DfIkAAagiwZREATgqLwYoVbaAnJ6Er8ILZXUpZsyAA+AEtVzT9G4p/9SKGhKQgRJGmskRP+gwWRUGafIoBi9Ak0MkKVhKBBLlBqH2adhCFGAmhzbdE5+uRlNpqS7kRPtuCiueE3lOZwQOZtFAaweOWUX6at39BIcuZoOY6rMF0MJxksOFRSyVwCv+qKICBMGlUf+w0tT2ZiTGaoHap5MYZA3KlDCShUdVDwEqpWnBA8Jaj8tqRcMOKzcKaHnWqFr1ixo6RTXYACLKK9eMarVaabGFQT0iANG6K66OWy6OgPZyRXbeqY+sE9v1APUpbGn+WeCaam26VoUuwRcd5gcW6mNljDcmnegZpl6OpghW7FH8LEym1F1tbI1+7Kg+RU7yQNAm5lCi107K5lG25xaFE5K27L/lbWxv/a0RVuqIntMvBefLOSe/1qC/HcSTtGfD6YWTBuid9eZace1PjsCsVENvcRBF/GjTgqliRhh5fejHhaQATqxY+J0hPsITVe4TtWzMCsu4QIWeARKv3oAixqH0mmtgfosuHFKWMsjoLW4EskYKNFD+UWvB5C31mA7vES62/QT0cpKgrsfhOkjXUsCmRsb6Uq6QylOqKtGpAuTpVsNM1mmsqtrntt3w+trxcuzDNO5R7u1sMu8Ugu1xytscau8OkK8R5uBckEXVlsCwLlpBhK7z1u9w4g+CECVMfC9/3e9yHu0f1JGkNdC/lkAJFE8vZG7SJFP+JBgDKhCJYFh/wrkoIBInB7TvtFbFfV7UBD1Rj2YrIk4Ee0YpT9UXczYq3Wrh3lygij5lb6AuB7sOMyZvHxaP93QDYlan5SbiowKemq6fhMFwAggqdm4eHUSwkfbANcgRlPYDcG6DL3Si0hhuvwzwQ7pqhZcjBlZpM0qvm5LLDYcvX3kEHuhT9fguwyIJ1AqE/86lPurLvKqPy9UpwZBEwObo1t1V+IZvTXgnc1LWBRzmSK8xiDpBEyMsk6cxq+Js4lQx/WIx+NpvH+Aaq1DahtysyqwtICEmnn8VcJbbI1cyLMrAtrbQ/Lwvc2nxm2Vso75upBMvid7vooMA5e8yEaVs2dsyvgSyf/ly0oTikAF+ggdNkHNp4DFt1GarLOPfFiqjMCPqg0/ikXoI7A5OMpDVMtfdSfP1bGbdbLgSbPdosq0S8KRi0icoRe4SJERMYvIpzq27A3k5RO0yccpQV9N3MkijMNfEU3TnEQeiZCDl0tNRIXdDMEHBmf8tccMBmAPNmDPiisiHMW+Aad4eJYDMRCxTBCDB5XGXMoQDCsjFhoYRsCc+Xm7sqT2KdHs28Yx8Ed/Oc/Iap5+ehcxJM7H8y2CamQk7bSY/HfnWgV1bGXukKoc3LY2xkwmMC4pDR3k67ynDMHoYs8zPbRo5rt31s/9EseMydCc3Dq3jCQ7ndSB3NRvm8v//qzR3MHUqHx2WS0w0AzVPb3UHk3VR23VKhvWTevIZ23OzPDBILxRhDzIpvZ9kYbGcBxmb6x3c33XQJLTIEPXeJ1pfr3XPlMBPTMKE7BxpUDYwnLYgv0yFxA3ShMBcLM1p/DYEBDZk93YLxNykWByrcDZkODZN8LXwzABkjBtp2DakYDaNRg1cPMIPVcKr61uf+0z7JZvp3Dbdf0y3rYLvb3bLHNwFPcKwu3HJHM2iG02F+cjbG0JWRJztgDd9fE5pC10rqKY4NHc2g0grrHdT3fHLmUY1V3O5E2Z4J144n06YD2zT4TdLDHedky0WVtULp3e7S3W8/1qb006+x0k/+qN35tMwwB+tesd2EOgvsMXPHNMqmxbBojsrKKz1ZurtX5NeXIbrwp+eO7BhakhnGzc4GmtRcoR0ULw4fPQvRCqCJyW4vG9JoyrRYF7AwhOdR6+4AVeqSGIwVfw4Bj91QNeIVIt4O9HflBotvPJE/0plwS4CnXJoQMoGufahPgHEbTM4clIEQ0hAP55DEwxgWasYznOjLwREi2kE/WbvxPkfw6UQjzRECMkFyN5EArsoe2wQ/HM4m6cXcnszNpavhRM4Xo9E0UIUkzoPQ0QzB/py0hURkj4PF9apEiohFDYk2TxhHJLRI535UMhEQ1MTBsM4fL1G2KJTW3En4IhxP9mWEUX/RhHKobLMA5k8RJQoaJhiic20WR4XmvvVV7hvGjpFSn1RakuXgKbaBqk6BPVnOikC4tOKRSfmkeriACfyJNcqc3rlECRqwwTdcI1tIszDNZh7hSmBLlvCofXbIrIaqjN9y2kGIJ1EQmmoSsxDuoerRP1bJ5x1uNCKyoNdn5qDt99TgLneA3HbqsCW66Sm48AaZcv4Y/rKMTrxJXwXEiOV5ExuelflshiRu9gjke2QqbdkA0/jJAZXz6DGhTszpPDuFDZKgKfOoZ8ruulUmFYRuLbiWIVXUK+suoAT+AjQA3KcewLUNAHL9DK2JQLnyuLiJMIkcUOQe0+2aj/sEHx7lKWFBHG9go8ZRzU7BfuZHi/IQ8Jhk4ORV2SskyVKZ8X1VDpDAUcWQgp29zziRUVMKamXL9SJr1JlaTv+1IDHC0EhypdN/4CJp7gQP4JMI1luH7zaHaxOK0O4fEbKI4Ko47eg+8ChU/jPr+NHz1mQM3xpPotRD0vRm3gff/jU835qL+2gH7d9HT5qV+Yqz/hytzXOzDjNCAcjsDgNUSmdDydEm7WIL6+sL9TJkCJruu9IqIXFg4OhFfCk3+fw/95wX4CsJf5HR4Qo4D7fE/TxU/7MV/DKyCxKsD9G00Y7MPj4X9eYTHv1m/jueN6G37633+ach+0citE1TNL/1wOAkgAFALAKA+wAkERBAacACJsAELxJkxLvGJAGALggAUESISMaAsgBiZlILFoJYisLXfE/YK9WwRtFSwsDgFCraC+ERQBRVEwAAyyMcBB7+DrNYisGOCsvVUxnBGM9MH86fD4dIFVWl5iZmpucnIifYKGgnaSbomenpaqrrK2umqKWQbBHLCIMOiwMbbxmpoYuKmxrdzqHKAUre0C0AE8KLSorEhxGdBQ4wksBFwZ3CXlFGTGen4J4HAVOAjz2q0omCAo4N4N3DEeNDQALCgQNNwh5qXQDxZqHizbpY+fP2PIvpB7JXEixVIRK0q8iHEjx44WMxUoYktPgAPuAP/sQkEggUgWa3IEXEMGicmAIX/sQkRLRwwG2ATIcZFtmgAE4lCKe2l0nKqI51YwaBKD3VJ3amq1qDn06k08RlsOAkBwzYIBSxKO6DoAwcmupjzCjetKo9xyde/i7UiXhVsSfx6UPLlMQAJoXdicXKPOWWCbyQgsa/aFzoA/B42Iq0x02xWABZdi2mspIhmBPhIYKjJAHOF3U+a5o3Z14bZ/AVGW7GOIgLUTUBj5ULivdtuWLvMiT75CtHJKzZ9DDw3yk0kYL7TihgruMMzlBKhcL47TyxAXKGYwsBHFujj11KhY+Xz0EvMwX9T4cOQCB3xx/YTI0UxsJlyln2WB4DH/B2o4yfECAgxkUUBOfnRHgnHLRZfhRvVBx6GGH8LlISlxTAKiXk2BYcAfJnIkIosvYgjjcTLS6JGLnCSwYo0T3dgCGAdItmMrPQrZ4Y5EFpnkW0rK2COSTFbyJJRwTUCBBxcEcIEHFEwAo5RT1vglmBg5OWZGZrIIQQASrBkABE2iGSdErDDykonU2BlXmdGdNNowqsSB1ZJyZhgBKBHASSihSCZgwip9evKnOfWYkGeIKPJ5W5SSlgJpjIpGRwESFNAoJqjRIekPK55ShCenJ36UaWivdsJASc6d+lwGSGRQaq5oegjfAk3M5xMMCrAD3BEwbHODfjisBkO0yBbU/8CxWww4XhYKXAHeAsbOYQQSV8CCKQtxzFGHFLeusCw3zx6wmAM9lMBHSU/wpykJ1l1RBRFUtReUCdYmskKjuP6aHJYwXOBrwmByyJlY30gKHAsEjSVNhQ3gAGRZd4jARr1rGDPpUMq8NIAB/VzhQAMWL6fxJnuyAE8NsEnYhcYc88EtkA24QQKB7NYQAD2VLAYOUADjoSNhpzlqgKMzPpwcBgFgEGbVU3IIGhAFbXGEzYHeypMBR++7BDXLuEqQya4uU8gTQok9xQtnz2yuvVg1Zs7dinxShAjS1HvVTDtpGhUSu+HG9EoBDDDsJ+hIjfDWd1kQgAVaX65kxNwA4P+ZpSxsU0se+2xBR2uho0NUdid/FzQX2aJMyMrcflF6zReOpjczr6ENBh08G6QA0KbzV9JigGFnGgALvuRAUqrNx/rTXBw8aOd3Zc359kIGO0O/FS++AmBsnJfIfwboV9LaXriaYLgs0A7ZQMnDsXj6PeQd67kBqosL+2NA++I1sB7UKQvVcUHfDKKHAhjCOoiZQWb4Fbol+EZQn/oeB3vXQe9xhFW/otnWWGUqUKEihSpcYSjkcsIPtsgjQJLZw0j4sEDNCYb0MZKedJgoH/LIdx184aJ4eCkgsoiIOrThEJFon+coMYdO/FAUP8hEDlbRTFksVw+nSEUvzkWIWAT/I9WUs8UNkrE5Z9zeFb+3Rii90YNHTCMU6ShGpvgwjp6bHRJQ14nRFU0L2oOVHc3IwkMiMpGKXCQjUdGURkIykpJMRRrJoQM+1IsiQLFcDAvpyU+CEo6zOwrH6oWCBxSuJIxgRMgQwT9iVM9HXQwlLWtpywxZ0j90WMpSUnkARjgqT5eJCho4uaFbIjOZypzjCqiwB5WwRGh7W8YPyoLBq0jRRsvcJje76b9mxpIwhlFZDlQphjX0xla8G2QnvenOd8IzlwLcTgLN6RLINAgKe8smIeHpz38ikzkkaqc2AWrQg36SOTnqJ0MR6tCH5tGIBYUoRSvqRok21KIa3WgR/+s4S46CNKQQwyhBRWrSkzpMjS5EKUtbaiI9PpGZLp0pTfEyyUmutKY63WlKf8jTnwKVpEkMKlGLmheY3tGoSl1qGEHI1KdC9ZteiipVq8rFnlo1q1pFqlS16tWocpUUYf0qWeN5pLKilaljtUta2xrUtfbPrXJV5k3rilNWwHWueuVaR1eR170Ctkh/PRNeA2tYTw72FU9K7GEb+0U5Ldaxkp0iY4dk2clidol9TWpmOzsmSYIItDv0LGkhW9jHclaWpV3tSP0a2tPKkbWyTRKSGFtb6cw2t+CDLS55G1PdAvdFsVAC6jIZpdcaoQwSw21sg+tcDQ1XAc0w7m9RBf+Vei0Uj819LndVSr8SzKNewmKnR1GiAOkRUA84kAcMgsnc7sI3OcMtAAqAoQ3QeYO83iXES3jmMc3ot4zxHXBd5lvOJHiterbdwjJm8ZssRA6N/CQwhft5yX3dtzOaWvC5vEA8LhBPNJWtcGkNXLQpiC/A8mWwFwpoFheQS8QknnFJ/4jc1I6Yxpm9LWq7akwdA9nHce2ta0cb5COn1shExjGSmyxW3wp1yNV1MpWjFMnQXlnJVd6yjU0LZS6DWcufvWyYyyzm1hbZzGqeMJqTvOYt59jN232zmeMsZCnTuc5mmsAGNjcCC2ygS5rgs58BAGhB5znMdt6EqBodAFL/ccLRjU60ns1kqE8gihOXRkKmKQ3mRWviAmyCgQQaxglRI6HUnlZ0nDiABA6UwtUwgPWqPx2nCiChAqXANQx0XWsug3oTanqTKob9a1vHSQMB0MAqlM3sY8OZUMRexbShTeVgWzvbd9Y2t5kEaruCG5LdPuy3FYXtcf+z3JtF91zV7WV269XdcTo3vN0pb2DVO95OlS+ttp3vrToVG9g0Rb/9ar+m/rut9xY40fRycDInHK0Ld9RV7KAEYTBiW92yoANhIIj7/eAMYRmLUQxQngvRO+J0DTjFA5Oz8bBBZSwzgh9Dd5uR72YZOG8B6prxjB+r3KoTX8E2glc7sRhg/27Vc8vOj950Nuik4SkP+i3vLb1aAKNC47HdzL/gmRXgQzfjCU5uoDeMIAGd6mB1Krji06ejE8SZrQOExxOkALNDSChmuTvjkGKdtKv9qffWYuC/OvgxFx7gWCV84rN6+DY3fu2LR3zkqfp4icSPmpcgFrmuWnmoXp4igNTEQvD8eaWGngsZh/GBrQAuaEhBKoMwZQqetQW3ef70S009izvTAIl5A2awy84lL+lf3JXllbnXvVF532FwJlhcNsv8CKBZBAcLLpbaZT7q922JZaBGYl/nh/sqpYK4FWAerFMs99Xq/UrUqQq1EFb8ofULIrR4OwXsBVvbX1Tng92iTf+d/zkRAL7OVBHg/70fXyUgURngWTXgWy2gKEUgUD3gBFYgS13g5GWgS22gT3UgTX1buJFgIoXgTg1gjZ3gXqXgMa0guVHWC8JgAcqgYbUgmdRgYN1gRexgDiZTDwaRD+obDQphu8VgEcoVEBIWEircETJhWoVVCUrhFKbQE6abGSGWFfpTFGahFr4TFxaSEnohdGFhGI6hvZWhHYnhGUbZR1USG3YTGKohHHJTFYlWDWUZHZqhCpoeCn2ZHnqRHf6huQ0iICKRIKZZwvCYIb4hHy7fqSwiI4IRIjZTABTX1EwZJLaLcoHOe0miE+Ig/UjX9WEim/nhCWCXjpzZJ0b/FEHpAFAoAopVQeepliL+D3rZHnttxxqyIvu5In0pgH0B34ZtTSzIABscX1moYi32IhBRYjgcWFEcxdcIWK7EQoMFzuNEGDM2o2b9ohkkgfgRY9Vco4fNHQuEWDcSoQuCk0DIYnxUoyY+H93RwosVEzeqYxM54vaNUCHm4+U845ORoz/+40DuoydaI0EWpC0e5CoSYiIu5EU15JydopxFZEWSSR4qokZeZOfIIR3xYkci3FF1oUiuI0nuoUkeYhqCpEqepE2VpEtyEKH5yKHFBU3+WaBNEU4amk7K5PZI2qPVRVBC2hQR5U9+z6bBQKfBhVIGAFMikVNCJVI+DKqR/5qpxYVVrglWOpFWqhpVdo6sBQCt1YVYkqUXmSVYbg+vBYCv1QVbuqUXwaVabo+x5YVdphFe0uXWOBty9CUd/eVeXk614QVhkpFhCmZiKuZimhQVOuZjTmFGQuZk3tUYhuRu8SAZXea1bRQRbaZC1uBnciBoshEbiiYI+mIgmmZnhqJqnqGYjN4cZuZzYEMmmIW+tKYXxsIzTIIalEUpQkTBYcJJZMtQYOQSTgMSJIAGVUJtWoIIOacI8aZtOopzPiITkoNkrM44COcleIp1HmdqTgMOoABwfgF4cgJ6mgx1kuYLkoMD2IQJ4EnJncH4MFgQvOIJpIC7NEsM2METRP+BALzevOUmHnQM7tTngSXBWQSBathBCdyB7BlnM9WDeiECW1iQMzlTgLZev+gByq3mFhTdQOFJzfkF2LiGLbRHUmgMcVIKUQgfvs0mC7xYFRiHOtQGjTqKz8HecmqdWFwDJsbGPfTNzLlMjrpONgxjC9gN4PlgRDSK28SP4twAig6cfq5EHfyNixonNdQNgc7oeFYilcYAaLhO1B3AT9wBUPxddL5oxYHMJ4RE9WCDFESfUsTSaR6ZU6TfMMTPLTxP36Uo/RQGF6hOGcTGitSm7jCe6HEBOeUAPBhNoCJp07yDcajpZUjPhHaHbBQp7hBdngCYFIijfDhpDkaErcz/R/zoBwShqHm1l2+YwACtjzu4hwDUH5g66hbUaEi0Kv5wg3qUR2Y4SmywB6dmC5xWYpU60wLcaoeaqooJ4RsN1EuKp7U+4RtlF7ZCHLcioZ4KV4Gu5GuyZph6axEyh3pOhLompLmOq2WaQx+lqXlqArsmKYV+3wiIUIXs634FYSc4UwMw53lWZ6UMQ2yypBa+ZzGlKQHYqys87HpK7FC5KyZIzxU0LCZYJ8K2IboaKg3lQZXaHk9UgR6owHuMi4S6aTashsVBQUksDr4ggtTcAwDhgXqh5K5yQgpsQbIYzYvRgdqcA02QBYKUl252AXPaQ+MkozGowS9QSqVeTJBi/0uFzl/O7IKnFENAuIPNyINPEOnATtS/zgxzYozJTWqSxs8PbGfHTquhXoinxkvgJAZiUIqZRmqbCumLVkjWBsThNJAdDFz57dNdeCYpoJ15YdOX1qnBekc+2KjbPikXSA/UDYDDDk0+zF3ddup9DYOmEmvVGqdg6GsZLE9gIOod2Awsyi1MVuwlVC4fXO7N1lzpjKr5ecd3SS6qfoFUsI/cFhDnZkuz2mPo0g/fki5D+Kd1lESt1my6bEXDueG1aoLv1sL54EaVPmsTCMOG7m5olqvOtkK/7hG5atThusIMvRvSnq+4OmOIWhT6uia8tgq9TqL78mB3bkLEdqsVkv8D7pXCymom/lpCjdovwWGe/R6d5vXht1bDOXaCAN/v6xYwDjACLW5KAmMCAwsk/V7M3L3YAPhAs6rs1MysFKwGvkyMGSAAI7yA8TxCIO0BA4pvvaJD0OqC0XhLQYQwA6we7pwcFmhByO7BKr3ssO6CLh6whGXrA38XA0CI5/Yu1R7vNPioLRhNflnIKpFAnI5B2nobATfnepXE2RrpPpAMfUUxF5MTjzJppOJB2AKTd6CFpTawx95e67jNOeAtm+rd3iYp4B6AFocE25hAEpOE2EJgDdsmBpHNASjdD+wx2toOmr4EPsgtNS3wCGgjBmcidjoxOEFxCSAp6CJrGWD/w+mahDjEQQvDzyGnxV9Ir2CJMRhAKo0mwHCAqnfowCjjKsihXfSE7lVosv2Q3RZ8GEU68O19gsNKywiPS/Fy6vr8BPMewNwWhiu7TtZaMw2TrQ1zAfYqKOP0cNxY8Bm0gARF7y+dEwHknYSMgD16sikuc/zWsiaQr8EhB7gCGT+/1D1jgvqSif4CNPi2LwXDkD/TmEL3GHKe69v+kf5ycCUUZzEWdGma7wfTh6QA0kSDQUVngkcv8je/K/tqtJ+ENIeAdA1dtEfCr+0YhHL6gL/o0yHINAMnqDNVaJVekPoEwoTE8A9/C9CSIUJb0Usj3X0EgAooDTQI01J7NI6+/8SQNs71NMp2CgdD2E/MoW2JLBmPUGZYi1tGwzTR1ehjNA5ZnLXmkWnSHUWylvHkQC5L7IJaaHNSf+lXM+ZR5/HU+gZabyo60YA6aR6ghh/oeIbcXs8oZXVtmDPpzPKK7bU3Xkwz51MyqLMyXLbm/apYzMCb3grBQMGGAnUA/IE556peT7ZE2vNq83Vru/YYHXRss3ZFMTRtM9ZtWjRt13aCDA1Bt8IuTCfHkoIIFSf/tidvyyiNXgc71EU+dwRyU69yMySNesMAsEM5+wvu8KcOyEEP2J5+vAzM4h8yXgtfzGoKSGh56OtO78F/Cu2AtjR1U954AlMaQ3GjsLEhtP+oGpdAMo6f3/Ky7GALa1RPb5wX8dVD2B73L3u1UdP3+hpoT/MGOpzDY5sN2qgM9rmFgEsyBGNpNPmxG9yKgCs233rpHCyxRUY45JHTG8SOLz/27ljF8MxdgLf3gIstMMyDKa9ujp+4HS9qZPdvix8npB6j/IiwOQ9QwNJj2Xmch6fMecd0dR6rDbxA5+6NrRKBFKQ2hBt5fU8EdMvFhf1zmPcjRpB5R1CBqlAsmssjbMP5Q8r5nEs4cqw5ndu5hEOqc7M5btqrSGPgnpevda+An4cQbu42oeuqmNoLbwREZaxeMe0wFEBQeRRF+bgDpksB07jsIKgwZjL6cidnMxf/iDn53hnz3KB+8dHYDFF4OtbGAqCO9Ki7ODpktwA4gAV7gQ5E8ktcqSALLtF0Op727QgIsqjb+q0f+iWn3xWA3+3Qop28+okyT9dOzXziAWsERF3LsiKf+bIz+6MbTLcr5/yVj52gSxKAR9+su8W1HrcH4IFdh7KLexhngkrM+zLddmzXx7zM48rduzdTVL+7tsF/78CHOyvM7YpvBPkKumQrfKHz1wwQNHyqApd2iqI/Xz4Td+6+6nVOPAi6jQzMM4g5/MRmPMfvu+gB9yePPAKedOg4wNfmQA8ALYCCHE0XAaYvzqbbLBGTMbPqC8EgEJAHwbTUAspoXNqggVRk//czC/WpxnxRz7w73EQhgzE1NF2TVjuXeu08LC0+YHHw3DzUmHiciozB7vcWJM3Bxvgap8w5Ivxk/2/rNAAkDAAqtYuKD8XTtcGVuujgzuveCLumSIUQADksuw7cnY3vgg06WTglJ7W0Vn1Dl/ytoED2hGrhh53Z8cLXp+7vRKpPZK4qQ8piK/hQGPLWIZ1h8/eAyzjIWf7l67VUwKMRqF+u1qmCMM5SvLvzwmozKLY1e4poa3O2tL7jdzb3Tjnk+DDtx6PtL/wlSHdMUn+4ZgJgPDi/Z/9oHlTd77X4J+z335htm7/Mo3/6v/n6s//5F/z7v5RY03/9q5D843/+60///vM/CADiSJbmiabqyrbuC8fyTNf2jef6zvf+DwwKh8Si8YhMKpfMpvMJjUqn1Kr1is1qt9yu9wsOi8fksvmMTqvX7Lb7DY/L5/S6fR0CADs=);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f0_55_895=[""].join("\n");
var outline_f0_55_895=null;
